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Abstract 
Recent studies suggest that genetic polymorphisms may influence inter-individual 
differences observed in toxicokinetics of mercury (Hg), a potent toxicant of concern to 
the general population and occupationally exposed workers (e.g., dentists). This work 
hypothesized that polymorphisms in glutathione pathway and selenoprotein genes would 
associate with Hg biomarker levels, modify the impact of Hg on blood pressure, and alter 
enzyme activity of encoded proteins. We utilized a multi-dimensional approach by 
considering two forms of Hg (methylmercury from fish consumption; elemental Hg from 
dental amalgams) through measurement in biomarkers and 23 polymorphisms in two 
populations- the Michigan Dental Association cohort (MDA, n=511) and the Early Life 
Exposures in Mexico to Environmental Toxicants cohort (ELEMENT, n=353 mothers, 
368 children). In the MDA cohort, mean (±SD) urine (1.04±1.18 μg/L) and hair Hg levels 
(0.49±0.63 μg/g), indicative of elemental Hg and methylmercury exposure, respectively, 
mirrored US population averages, with dentists exhibiting the highest concentrations of 
both. While elevated compared to the US population, biomarker Hg levels among 
ELEMENT mothers (hair) and children (hair, blood, urine) reflected low-level exposures.  
 Simple and multivariate linear regression models investigated the association of 
polymorphisms in glutathione pathway and selenoprotein genes with Hg biomarker levels 
in both cohorts. Statistical modeling in the MDA cohort tested for significant interactions 
between genotype and exposure sources (Hg intake from fish, dental amalgams) on 
biomarker (hair, urine) levels, though the ELEMENT cohort lacked exposure data. 
 
 
xiii 
 
Several polymorphisms were found to be associated with Hg accumulation and 
elimination as measured in hair (lower hair Hg: GSTP1: rs1695, rs1138272; SEPP1: 
rs7579; higher hair Hg: GSS: rs3761144) and urine (lower urine Hg: GSTT1 deletion; 
SEPP1: rs7579). All significant associations (p<0.05) were observed in the MDA cohort, 
with the exception of the rs7579 „T‟ allele (SEPP1) which correlated with lower urine Hg 
concentrations in both cohorts. No associations were significant after correction for 
multiple testing  
 We further assessed the impact of Hg and polymorphism-Hg interactions on 
systolic and diastolic blood pressure (SBP, DBP) in the MDA cohort. In multivariate 
models, hair Hg levels were significantly associated with increasing DBP (β=2.76 
mmHg, p=0.02). Contrariwise, urine Hg levels were associated with decreasing SBP (β=-
1.80 mmHg; p=0.04), a relationship driven by the male subgroup. Significant interactions 
between polymorphisms and Hg biomarkers were not observed in SBP or DBP models. 
 Mechanisms underlying epidemiological associations were explored through in 
vitro characterization of enzymatic activity and heavy metal inhibition of four GSTP1 
variants encoded by two nonsynonymous polymorphisms (rs1695: 105Ile/Val, 
rs1138272: 114Ala/Val). Kinetic parameters varied significantly (p<0.01) depending on 
genotype. Allozymes with 105Ile had better catalytic efficiency and greater electrophilic 
substrate affinity (105Ile Km=0.33 mM; 105Val Km=1.15 mM). Inorganic Hg and 
methylmercury inhibited all GSTP1 variants. Genotype influenced the extent of 
inhibition, and GSTP1 105Val 114Ala was the most sensitive to inhibition by both Hg 
species.    
 
 
xiv 
 
 Overall, evidence from two epidemiological cohorts and in vitro enzymatic assays 
relate genetic polymorphisms in selected selenoprotein and glutathione pathway genes to 
variability in Hg toxicokinetics. Exploration of such genetic factors will help ascertain 
sources of biomarker variability and narrow the gap between perceived and true health 
risks accompanying methylmercury and inorganic Hg exposure.  
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Chapter 1 
Introduction 
 
1.1 Background  
1.1.1 Mercury 
 Mercury (Hg), a potent toxicant, is deemed by the Environmental Protection 
Agency (US EPA, 1997) and the ATSDR to be a top three priority pollutant of concern 
(ATSDR, 1999). Mercury exists as several inorganic and organic species, and the 
speciation of Hg dictates targeted organs and toxicity (Clarkson and Magos, 2006). 
Inorganic Hg exposure is mainly to the elemental (Hg
0
) or mercuric (Hg
2+
) forms while 
exposure to organic Hg is primarily via the methylated (MeHg
+
) form. The chemical 
forms of Hg absorb and distribute differently in the body and often cause toxicity through 
divergent mechanisms. In the end, humans are exposed to Hg from multiple sources, 
including dental amalgams, fish, vaccines, thermostats, compact fluorescent light bulbs 
(CFL), mining practices, and thermometers (ATSDR, 1999; Clarkson and Magos, 2006).  
 
1.1.1.1 Methylmercury 
Humans are predominantly exposed to methylmercury via fish consumption 
(Clarkson and Magos, 2006). Due to the prevalence of coal-fired power plants, which 
release Hg upon coal combustion, and the increasing need for energy, especially in the 
developing world, release of Hg is increasing worldwide (Millman et al., 2008; Swain et 
 
 
 
2 
al., 2007). This is evident in fish and fish-eating animal species across the globe 
(Scheuhammer et al., 2007). After chemical transformation in the atmosphere, inorganic 
Hg deposits in water systems, is transformed into methylmercury by bacteria, 
accumulates in fish and biomagnifies up the food chain. Due to its affinity for thiol 
groups and ability to cross the blood brain barrier, methylmercury has a long half-life in 
the body and resides in the brain and proteinaceous tissue of fish-eating species (ATSDR, 
1999).  
The nervous system is a well-establish target of methylmercury, and recent 
studies link methylmercury exposure to cardiovascular problems and immunotoxicity 
(Clarkson and Magos, 2006; Roman et al., 2011; Sweet and Zelikoff, 2001). 
Methylmercury poisoning following high dose exposure, as observed in Minamata Bay in 
the 1950s, results in a slew of neurological symptoms including sensory disturbances in 
the extremities, ataxia, and disequilibrium. In utero methylmercury exposure precedes 
limb deformations, coordination problems, dysarthria and mental retardation (ATSDR, 
1999; Eto, 2000).  
The adverse health effects of chronic, low dose exposure to methylmercury are 
less well characterized, though evidence suggests several outcomes (e.g., neurological, 
cardiovascular) may be affected by low dose exposure in both prenatally exposed 
children and adults. Methylmercury impairs cognitive development (learning, memory, 
attention) among children exposed in utero from mothers‟ consumption of pilot whale 
meat (Grandjean et al., 1997). Likewise, prenatal methylmercury exposure has been 
linked to decreased IQ (Trasande et al., 2005), increased blood pressure in 7 year old 
children (Sørensen et al., 1999) and altered autonomic modulation of heart rate variability 
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in 14 year old children (Grandjean et al., 2004). Despite potential effects on developing 
children, 8% of American, 89% of Taiwanese, and 13% of South Korean women of 
childbearing age exceed the EPA recommended blood Hg level (a biomarker for 
primarily methylmercury exposure) of 5.8 µg/L while Hg levels remain relatively 
unknown in many countries such as Mexico (Hsu et al., 2007; Lee et al., 2009; Trasande 
et al., 2005). Regulatory guidelines for methylmercury intake typically target women of 
child-bearing age as prenatal development is deemed the most vulnerable exposure time 
point (NRC, 2000). However, fish contain nutrients beneficial for neurodevelopment, and 
as a result, the benefit-risk analysis surrounding fish consumption is constantly 
reevaluated (Cohen et al., 2005a, 2005b).  
Associations between methylmercury and adverse health effects have been 
documented in adult populations with low to moderately high exposures from fish 
consumption. Carta et al. (2003) found males with median blood Hg of 44 μg/L from 
frequent fresh tuna consumption performed worse on neurobehavioral tests compared to 
controls (median blood Hg: 3.9 µg/L). Methylmercury exposure may be linked to acute 
myocardial infarction and increased blood pressure, and the evidence for the association 
with the former was compelling enough for an US EPA committee to recommend 
inclusion of this health outcome in analyses impacting Hg emission regulations (Roman 
et al., 2011). The relationship between methylmercury and increased blood pressure is 
inconsistent though several studies found significant associations among adults between 
increasing systolic and/or diastolic blood pressure (SBP, DBP) and hair (Fillion et al., 
2006) or blood (Choi et al., 2009; Valera et al., 2009) Hg levels in primarily subsistence 
fish or marine mammal consuming populations.  
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1.1.1.2 Inorganic Mercury 
Dental amalgams comprise the main source of exposure to inorganic Hg in the 
general population and certain occupational groups (dentists, miners, manufacturers of 
chloralkali) experience elevated inorganic Hg exposures (ATSDR, 1999, Martin et al., 
1995). Elemental Hg constitutes 50% of the composition of dental amalgam fillings. 
Mercury vapor (Hg
0
) is inhaled when released from amalgams in the mouth, and this 
exposure influences urine Hg levels (Dye et al., 2005). Upon absorption in the lungs, Hg
0
 
is oxidized to inorganic Hg
2+
 which binds to thiol groups of proteins, and this may lead to 
toxicity. The primary target for inorganic Hg is the kidney, though it can also affect the 
nervous system (Clarkson and Magos, 2006)  
Toxic effects from high dose inorganic Hg exposure have been characterized. 
Construction workers with acute elemental Hg exposure resulting in urine levels above 
100 μg/L had multiple neuropsychological symptoms including increased temper, 
anxiety, and forgetfulness (Bluhm et al., 1992).  High doses of inorganic Hg further led to 
renal tube damage and proteinuria (ATSDR, 1999). Various studies of occupationally 
exposed workers have also found associations between chronic, lower dose exposures to 
inorganic Hg and declines in cognitive and motor function (Echeverria et al., 2005, 
2006). Echeverria et al. (2005) found dentists exposed to Hg vapor had adverse effects on 
hand steadiness, memory and cognitive flexibility. Thirty percent of dentists with 
elevated Hg levels (20 μg/g in tissues) experienced polyneuropathies (Shapiro et al., 
1982). Little is known about the effect of inorganic Hg exposure on the cardiovascular 
system in humans, though animal studies suggest that inorganic Hg may depress heart 
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rate and blood pressure (Massaroni et al., 1995; Rhee and Choi, 1989; Rossoni et al., 
1999).  
 
1.1.2 Absorption, Distribution, Metabolism and Elimination (ADME) of Mercury 
The differential health effects observed with methylmercury and elemental 
(inorganic) Hg can be partially attributed to divergent absorption, distribution, 
metabolism, and elimination (ADME) of the two Hg species in the body. An estimated 
95% of methylmercury consumed from fish is absorbed into the bloodstream from the 
gastrointestinal tract (for reviews see Clarkson et al., 2007; Mergler et al., 2007). A large 
proportion of methylmercury binds to hemoglobin in the blood while the freely movable 
fraction binds to low molecular weight thiol groups such as cysteine (Doi et al., 1983). 
Methylmercury-cysteine complexes resemble methionine and enter cells via large neutral 
amino acid carriers, enabling this toxicant to cross both blood brain and placental barriers 
(Simmons-Willis et al., 2002). Methylmercury is primarily eliminated through the biliary 
system following conjugation with glutathione (Ballatori and Clarkson, 1985) though 
some urinary excretion has been observed (Carta et al., 2003). Binding to hair follicles 
accounts for <10% of elimination (Magos and Clarkson, 2008). Methylmercury 
accumulation in various organs and tissues is not equivalent and typically follows the 
pattern: hair > brain > red blood cells > plasma (Clarkson et al., 2007).  
 The general population is exposed to inorganic Hg primarily as elemental Hg 
vapor (Hg
0
) released from dental amalgams. Approximately 80% of Hg
0
 is absorbed in 
the lungs into the bloodstream and can initially cross cell membranes and the blood brain 
barrier (Clarkson et al., 2007; Hursh et al., 1976). However, Hg
0
 is quickly oxidized via 
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the catalase pathway to the mercuric form, Hg
2+
, a transformation that diminishes the 
ability to cross lipophilic barriers (Clarkson et al., 2007). Over time, the majority of the 
inorganic Hg body burden is found in the kidney (Cherian et al., 1978; Hursh et al., 
1976). Glutathione conjugation with Hg
2+
 promotes excretion through the biliary system, 
and urinary excretion is a major elimination pathway for inorganic Hg (Ballatori and 
Clarkson, 1985; Berglund et al., 2005; Cherian et al., 1978).    
 
1.1.3 Inter-Individual Variability 
1.1.3.1 Inter-individual Variability and Mercury Biomarkers 
Given the multifaceted ADME mechanisms for Hg, it is not surprising that inter-
individual variability exists in accumulation of both methylmercury and inorganic Hg as 
assessed by common biomarkers of exposure (blood, hair, urine). Hair, whole blood, and 
erythrocytes are biomarkers of methylmercury exposure from fish consumption while 
urine, whole blood, and plasma have been used to measure inorganic Hg exposure 
(Berglund et al., 2005; Cherian et al., 1978; Clarkson et al., 2007). Total Hg in hair is 
assumed to be 80% organic, though this proportion ranges from 79 to 99%. Correlation of 
both organic and inorganic Hg fractions in hair with fish consumption suggest that the 
inorganic portion may result from demethylation of methylmercury (Berglund et al., 
2005), though some exposure to Hg vapor can be reflected in the hair of occupationally 
exposed individuals (Morton et al., 2004). In general, methylmercury bound to cysteine is 
incorporated into the growing hair follicle and as such, this biomarker reflects average 
body burden over time with each centimeter of hair approximating one month of 
exposure (Mergler et al., 2007).  
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Blood Hg reflects methylmercury exposure from recently consumed fish before 
distribution to other tissues. Inorganic Hg can also be found in the blood, particularly in 
the plasma. Fish consumption correlates with total Hg in whole blood and erythrocytes 
and with organic Hg in whole blood, erythrocytes, and plasma while dental amalgams 
correlate with the inorganic fraction in plasma and whole blood (Berglund et al., 2005). 
Variability exists in the proportion of organic Hg that localizes to erythrocytes (76-100%) 
versus plasma (5-20%) and the proportion of blood inorganic Hg found in erythrocytes 
(15-54%) versus plasma (30-81%) according to Berglund et al. (2005). Substantial 
variability has been observed in the half-life of methylmercury in various tissues or 
biomarkers. For example, Birke et al. (1972) observed methylmercury elimination rates 
following fish consumption in a handful of individuals and calculated half-lives ranging 
from 33-120 days in hair (n=5), 99-120 days in blood cells (n=2) and 47-130 days in 
plasma (n=2).  
Urine Hg, the common biomarker for elemental or inorganic Hg exposure, is 
typically >98% inorganic (Berglund et al., 2005; Cherian et al., 1978). Urine Hg 
associates with dental amalgams in the general population (Berglund et al., 2005; Dye et 
al., 2005) and occupational exposure to inorganic Hg (Gibb et al., 2008; Morton et al., 
2004; Paruchuri et al., 2010). Variability in urinary Hg excretion may correlate with 
different retention rates in the kidney as observed in humans (Hursh et al., 1976) and 
mice (Ekstrand et al., 2009), the latter of which are strain and gender dependent.   
Mercury biomarker ratios, specifically the hair to blood ratio, provide further 
indication of the immense inter-individual variability in Hg toxicokinetics. The hair to 
blood ratio is generally assumed to be 250:1 though average values have ranged from 140 
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to 370 in studied populations and the range is even wider (maximum >600) among 
individuals (Bartell et al., 2000; Berglund et al., 2005; Budtz-Jørgensen et al., 2004). 
Multiple factors underlie the observed differences including age (Budtz-Jørgensen et al., 
2004), fraction of blood Hg that is organic (Berglund et al., 2005), and fish consumption 
patterns as infrequent fish consumers will not achieve a steady state Hg level in their 
blood (Bartell et al., 2000). Variability in factors involved in the ADME of Hg may 
additionally contribute to inter-individual differences in distribution of Hg to the hair and 
the blood, and these same factors may influence Hg distribution to the brain or other 
target organs.  
 
1.1.3.2 Inter-individual Variability and Mercury Intake 
 Current risk assessment often fails to account for the inter-individual differences 
in body burden that arise from variability in Hg metabolism and detoxification, and this 
variability may influence susceptibility to Hg accumulation and subsequent toxicity. 
Differential Hg accumulation was evident when Canuel et al. (2006) predicted hair Hg 
levels based on average parameters (e.g., methylmercury half-life, hair growth rate, hair 
to blood ratio), fish consumption data, and fish Hg levels in several subsistence fish 
eating populations and compared them to actual hair Hg measurements. Wide variability 
between predicted and measured hair Hg levels was observed with a maximum 14-fold 
difference in one population. Similarly, Lipfert (1997) calculated the ratio of hair Hg to 
Hg intake estimated from fish consumption using data from 11 studies and observed 
substantial variation in the hair-to-intake ratios between studies (range 2.3 to 18). 
Variability in genes involved in Hg metabolism and elimination may partially underlie 
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observed differences in Hg intake and biomarkers as well as variability in half-life and 
biomarker distribution (section 1.1.3.1).  
 
1.1.4 Genetic Polymorphisms and Mercury  
Gene-environment interaction studies are of increasing importance to the risk 
assessment of chemical exposures (Omenn, 2001). In the normative risk assessment 
process, mean values of effect are often used to characterize the hazard of a given drug or 
exposure to protect public health, while outliers, which may represent subpopulations 
susceptible to certain exposures, are largely ignored. While pharmacology (de Leon et al., 
2005; Ingelman-Sundberg, 2004) and cancer research (Ravn-Haren et al., 2006; Rothman 
et al., 2001) studies have invested in this field, gene-environment considerations have 
only recently become standard practice in toxicology.   
Single nucleotide polymorphisms (SNPs) are prevalent forms of variation that 
involve change of one base pair in DNA and may alter expression levels or function of 
encoded proteins. Deletion and insertion polymorphisms (ranging from one base pair to 
an entire gene) are found in some genes. Genetic polymorphisms in biotransformation 
enzymes such as glutathione s-transferases (GSTs) and cytochrome P450s modify the 
effects of environmental exposures on cancer development and drug metabolism (see 
reviews: Ingelman-Sundberg, 2004; Rothman et al., 2001). 
Toxicological characterization of metals has recently considered genetic 
susceptibility. For example, a SNP in arsenic (+3 oxidation state) methyltransferase 
(AS3MT) is associated with increased formation of the toxic metabolite monomethylated 
arsenic (Hernández et al., 2008). Likewise, other SNPs in the arsenic metabolic pathway 
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have been shown to alter metabolite proportions (Engström et al., 2007; Lindberg et al., 
2007; Marcos et al., 2006). Risk for chronic beryllium disease in occupationally exposed 
workers is influenced by genotype of a major histocompatibility complex class II marker 
(Richeldi et al., 1993, 1997). Polymorphisms in the vitamin D receptor (VDR) and δ-
aminolevulinic acid dehydrogenase (ALAD) influence lead concentrations in urine 
(Gundacker et al., 2009).  
Gene-environment studies have great potential to enhance the risk assessment of Hg 
and improve the use of Hg biomarkers through better understanding of the mechanisms 
underlying inter-individual variability. Recent epidemiological studies link 
polymorphisms in GSH pathway genes to altered hair, blood, and urine Hg levels 
(Custodio et al., 2004, 2005; Engström et al., 2008; Gundacker et al., 2007, 2009). Table 
1.1 details the study populations, polymorphisms genotyped, biomarkers analyzed, and 
significant results (p<0.05) observed in these studies. Overall, seven polymorphisms in 
six GSH pathway genes were genotyped and each polymorphism was significantly 
associated with at least one biomarker in one or more statistical test (e.g., association 
with median biomarker levels, effect modification on relationship between exposure 
source and biomarker). Deletion polymorphisms for GST theta 1 (GSTT1) and GST mu 1 
(GSTM1), known to decrease catalytic efficiency of the GST system, were significantly 
more frequent among Austrian students with hair Hg levels above the median (Gundacker 
et al., 2007). Minor alleles of SNPs in subunits of glutamyl-cysteine ligase (rs17883901 
in GCLC; rs41303970 in GCLM), the rate limiting enzyme for GSH synthesis are known 
to decrease promoter activity and gene expression (Koide et al., 2003; Nakamura et al., 
2002). These detrimental alleles were associated with increased Hg biomarker levels 
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following methylmercury exposure (Custodio et al., 2004; Engström et al., 2008; 
Gundacker et al., 2009) or inorganic Hg exposure (Custodio et al., 2005). Many of the 
significant results in these studies involved polymorphism combinations (comparing 
individuals with minor alleles for two different loci to the rest of the population). 
Gundacker et al. (2009) additionally observed a significant relationship between a 
metallothionein SNP and higher hair Hg levels (not reported in Table 1.1). 
Collectively, these early studies call for increased attention to genetics in Hg risk 
assessment. However, the small number of polymorphisms studied (n=7) from primarily 
one pathway and the existing discrepancies among studies point to the need for additional 
research characterizing gene-environment interactions pertaining to Hg exposure and 
biomarkers. For example, Custodio et al. (2004) found higher erythrocyte Hg levels in 
individuals with the minor allele of a nonsynonymous SNP in GST pi 1 (GSTP1, 
rs1138272) compared to polyunsaturated fatty acid levels, an indicator of fish 
consumption, while Engström et al. (2008) observed the opposite relationship. A variety 
of factors may underlie discrepancies among studies including sources of exposure, 
genotype frequencies in the study populations, biomarkers analyzed, statistical 
methodology, and power to detect an association. Polymorphisms studied to date may not 
adequately describe variability in the ADME of inorganic Hg. Only one study of 
occupationally exposed gold miners observed a significant association between genotype 
(GCLM, rs41303970) and inorganic Hg exposure biomarkers (Custodio et al., 2005).    
 Beyond the influence of genetic polymorphisms on Hg retention and distribution 
to hair, blood, and urine, there is evidence that polymorphisms may impact the 
relationship between Hg exposure and adverse health effects. A series of studies 
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involving occupationally exposed male dentists and female dental assistants found 
significant additive or modifying effects of polymorphisms on the association between 
urine Hg levels and atypical urinary porphyrin excretion (Woods et al., 2005) or between 
urine Hg and performance on various neurobehavioral tests (Echeverria et al., 2005, 
2006, 2010). Interactions between blood Hg concentrations and polymorphisms 
influencing adverse health outcomes were also observed. The offspring of mothers with 
GSTM1 and GSTT1 deletions and higher blood Hg levels had increased risk for low birth 
weight (Lee et al., 2009). Genotype of matrix metalloproteinase, MMP-9, impacted 
MMP-9 protein levels among Brazilians with low blood and plasma Hg levels, and 
increased expression of this protein is associated with multiple adverse cardiovascular 
effects (Jacob-Ferreira et al., 2010). The impact of genetic factors on Hg-associated 
health effects such as the aforementioned overt and sub-clinical outcomes calls for 
incorporation of genetic variability in studies of Hg and its toxic effects on the 
cardiovascular and nervous systems of adults and developing children.  
 
1.1.5 Gene Classes of Interest 
Alterations to expression or enzyme activity of proteins and enzymes involved in the 
ADME of methylmercury and inorganic Hg due to genetic polymorphisms have the 
potential to modify Hg accumulation in the body and the ensuing toxic effects. Important 
protein classes include those that bind and transport Hg (e.g., selenoproteins, 
hemoglobin), enzymes involved in GSH and cysteine conjugation of Hg (e.g., GSTs, 
GCLC, GCLM), and enzymes protecting against reactive oxygen species created by Hg 
(glutathione peroxidases, GPX). This dissertation focuses specifically on GSH pathway 
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and selenoprotein genes due to the prevalence of polymorphisms in these classes as well 
as their importance in Hg distribution, detoxification, and elimination. Polymorphisms 
are ubiquitous among the genes encoding GSTs, GSH synthesizing enzymes and 
selenoproteins. For example, GST pi 1 (GSTP1) alone has 158 SNPs with minor allele 
frequencies (MAFs) ranging from <1% to 50% in various ethnic populations, including 
14 nonsynonymous (amino acid changing) SNPs according to the NCBI database. Many 
GST isozymes have overlapping substrate specificities and can compensate for one 
another if necessary. However, individuals with several detrimental polymorphisms 
resulting in low expression or activity of multiple GSTs could have compromised 
antioxidant systems less capable of conjugating toxicants with GSH (Ginsberg et al., 
2009).   
Glutathione binds inorganic Hg and methylmercury enabling cellular efflux via 
transporters (e.g., multi-drug resistance proteins) and ultimately elimination via fecal 
excretion, though entero-hepatic cycling of methylmercury-GSH conjugates also occurs 
(Ballatori and Clarkson, 1985). Polymorphisms in genes of the GSH synthesis pathway 
(GCLM, GCLC, GSS, GSR) could impact the concentration of GSH available for this 
process. Though not absolutely necessary for GSH conjugation of Hg to occur, GSTs 
(GSTP1, GSTM1, GSTM3, GSTT1, GSTO1) may catalyze the conjugation reaction or 
may act as transporters of Hg-GSH conjugates (Ballatori and Clarkson, 1985). Genetic 
variation in γ-glutamyltransferase 1 (GGT1) could affect methylmercury and inorganic 
Hg metabolism. GGT1 cleaves Hg-GSH conjugates, a process that is essential to uptake 
of methylmercury or inorganic Hg (as cysteine conjugates) by multiple cell types 
including enterocytes of the gastrointestinal tract and proximal tubules cells of the kidney 
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(Bridges and Zallups, 2005). In mice, GGT knockouts excrete more methylmercury and 
accumulate less inorganic Hg in the kidneys following treatment with the respective Hg 
species (Ballatori et al., 1998). Hence, polymorphisms drastically altering expression or 
activity of GGT1 could impact the elimination rates and distribution of either Hg form in 
the body. The role of a given gene in the Hg metabolism and elimination pathway must 
be considered when contemplating the possible impact (positive or negative) of a 
polymorphism that diminishes gene expression or enzyme activity on Hg toxicokinetics.  
Selenoproteins are dually employed in Hg toxicokinetics by combatting the 
oxidative stress created by Hg and by binding the toxicant directly (Chen et al., 2006).  
Selenoproteins contain a unique amino acid, selenocysteine, that can bind and transport 
Hg-selenium or MeHg
+
. With up to ten selenocysteine residues per protein depending on 
the isoform, selenoprotein P1 (SEPP1) is particularly equipped for this task (Suzuki et al., 
1998; for review: Khan and Wang, 2009). Genotype of SEPP1 influences isoform 
prevalence and gene expression, and variation in these parameters may reduce protective 
binding of Hg and/or alter Hg distribution to various tissues such as the kidney or brain 
(Jureša et al., 2005; Méplan et al., 2007, 2009).  Another class of selenoproteins, 
glutathione peroxidases (e.g., GPX1, GPX2, GPX4), typically contain one selenocysteine 
residue each and have potent antioxidant properties. Both Hg exposure (Chen et al., 
2006) and polymorphisms in the encoding genes (Méplan et al., 2008; Ravn-Haren et al., 
2006) can influence expression and activity levels of these proteins.   
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1.1.6 In Vitro Characterization of Polymorphic Gene Products    
Associations between genetic polymorphisms and Hg biomarker levels or Hg 
associated health effects are evident in several epidemiological cohorts (section 1.1.4). 
However, as in many gene-environment cohort studies, the underlying mechanisms are 
often unknown. A significantly associated polymorphism could truly impact gene 
expression or protein structure and function, or that polymorphism could merely be a 
marker for a different locus of functional importance. For example, in vitro studies of 
GSTP1 have discovered several SNPs that alter enzyme activity (substrate affinity, 
catalytic efficiency) or gene expression and have also identified SNPs in linkage 
disequilibrium that lack functional significance (Hu et al., 1997; Kitteringham et al., 
2007; Moyer et al., 2008; Zimniak et al., 1994). Laboratory based, in vitro methods 
discovered a dependence of GPX1 activity in human erythrocytes on genotype of a 
nonsynonymous SNP and selenium status (Jablonska et al., 2009). Li and Woods (2009) 
found a nonsynonymous SNP in coproporphrinogen oxidase (CPOX) decreased catalytic 
efficiency, especially in the presence of inorganic Hg. Such in vitro tests complement 
associative findings in epidemiological cohorts.   
 
1.2 Knowledge Gaps 
Despite decades of Hg research, knowledge gaps remain in Hg exposure 
assessment, cardiotoxic effects of Hg, and genetic factors related to Hg ADME and 
subsequent toxicity. Mercury body burdens of dental professionals require monitoring 
due to their dual exposure- occupational exposure to Hg vapor via dental amalgams and 
to methylmercury from fish consumption, the latter of which may be higher than the 
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average population according to socioeconomic status (Hightower and Moore, 2003). 
Dentists historically exhibited relatively high Hg levels (head and wrist Hg >20 µg/g; 
Shapiro et al., 1982), but in recent years, restoration with Hg-containing amalgam has 
declined (Eklund, 2010) and safety precautions have increased. Therefore, Hg body 
burden among dental professionals has decreased (Echeverria et al., 2005). While general 
population exposures are well characterized in many regions of the world, population 
data in countries such as Mexico remain unknown despite the targeting of Hg pollution 
and exposure as a prominent environmental issue in North America (Pilgrim et al., 2000). 
Neurodevelopmental problems associated with prenatal lead exposure have been 
observed in the Mexican population, though methylmercury exposure, another potential 
contributor to developmental effects, has not been approximated (Surkan et al., 2008).  
The impact of methylmercury exposure on cardiovascular health has recently 
been realized (Roman et al., 2011). Evidence linking methylmercury to increased blood 
pressure is somewhat inconsistent and was observed primarily among subsistence fish 
and marine mammal consumers with relatively high exposures (Choi et al., 2009; Fillion 
et al., 2006; Valera et al., 2009). The influence of low level methylmercury exposure, 
observed in most populations, on blood pressure is unknown. Furthermore, while animal 
studies link acute, high dose inorganic Hg exposure to decreased blood pressure and heart 
rate (Massaroni et al., 1995; Rhee and Choi, 1989; Rossoni et al., 1999), cardiovascular 
health effects associated with elemental/inorganic Hg exposure have not been evaluated 
in humans.        
Genetic factors are hypothesized to underlie a portion of the inter-individual 
variability observed in Hg half-life, biomarker distribution, and toxicity, though only 
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recently have gene-Hg relationships been explored. To date, several cohort studies 
analyzed seven polymorphisms in GSH pathway genes with respect to their associations 
with Hg biomarker concentrations (Table 1.1). Significant relationships observed were 
often inconsistent between studies and disproportionately favored associations with 
methylmercury biomarkers. A comprehensive assessment of more polymorphisms in 
GSH pathway genes using exposure information pertaining to both methylmercury and 
elemental Hg is necessary to further explore the contribution of this pathway to Hg 
toxicokinetic variability. Additionally, the influence of polymorphisms in other gene 
classes implicated in the ADME of Hg (e.g., selenoproteins) remains undetermined and 
merits investigation. Genetic polymorphisms influencing Hg accumulation and 
distribution may furthermore modify susceptibility to health effects following elemental 
Hg and/or methylmercury exposure such as altered blood pressure.    
Beyond epidemiological studies assessing gene-Hg interactions, laboratory-based 
mechanistic analyses are needed to explore the biological plausibility of population-based 
associative findings. In vitro assays provide quick and informative assessment of the 
functional impact of a given polymorphism on gene expression or enzyme activity, and 
additionally allow for isolated analysis of the interaction between toxicants and specific 
proteins. A U.S. National Research Council (NRC) recommendation calls for 
development of these high throughput in vitro assays in an effort to improve toxicity 
testing and risk assessment (NRC, 2007). Ideally, a multitude of polymorphisms should 
be assessed in this manner to better understand the potential systemic impacts of multi-
loci genotype combinations of interest.          
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1.3 Objective 
This dissertation aims to further our understanding of the association of genetic 
polymorphisms with Hg body burden and toxicity by utilizing epidemiological and in 
vitro approaches. Polymorphisms in genes implicated in the distribution, metabolism, 
and elimination of Hg are hypothesized to affect individual susceptibility to Hg 
accumulation in biomarkers, to modify the relationship between Hg and blood 
pressure, and to alter enzyme activity of encoded protein products. This work builds 
upon previous studies by using a holistic approach considering two forms of Hg (through 
analytical measurement of urine, hair, and blood biomarkers) and various sources of 
exposure (e.g. fish, dental amalgam) in two populations (Michigan dental professionals 
and Mexican mother-child pairs). Furthermore, this study reevaluates the associations of 
previously studied functional polymorphisms (n=6), and assesses novel SNPs (n=17) in 
GSH-related and selenoprotein genes which may modify Hg metabolism. Possible 
mechanisms underlying epidemiological associations are explored by means of in vitro 
tests on four genetically engineered GSTP1 allozymes that compare enzymatic activity 
and Hg inhibition among the variant proteins. Overall, these studies investigate the 
impact of genetic factors on Hg toxicokinetics and toxicodynamics in humans. Research 
on the relationship between genetic variation and Hg metabolism and elimination will 
help ascertain sources of biomarker variability and narrow the gap between perceived and 
true health risks accompanying methylmercury and inorganic Hg exposure.  
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1.4 Specific Aims 
The following specific aims explore the aforementioned hypotheses in two  
epidemiological cohorts and in vitro: 
AIM 1: Epidemiological Biomarker Studies.  
With gene-environment modeling approaches, couple the genotype of 23 polymorphisms 
in fourteen genes involved in Hg metabolism with Hg biomarkers (urine, hair, blood) to 
elucidate polymorphisms statistically linked to higher body burden in two genetically 
dissimilar populations. 
AIM 1.1:  In the Michigan Dental Association (MDA) cohort. 
Sample 515 dental professionals with occupational exposure to inorganic Hg from 
work with dental amalgams and methylmercury exposure from fish consumption, 
and determine if fifteen polymorphisms in glutathione enzymes and 
selenoproteins associate with urine and hair biomarker levels.  
AIM 1.2:  In the Early Life Exposures in Mexico to Environmental Toxicants 
(ELEMENT) Cohort.                                                                                                         
Sample 400 mother-child pairs from Mexico City and investigate associations 
between 17 polymorphisms and blood, hair and urine Hg biomarker levels and 
ratios. 
AIM 2: Epidemiological Study: Cardiovascular Outcomes, Hg and Polymorphisms. 
Measure blood pressure in a subset of the MDA cohort (n=262), and assess the impact of 
Hg exposure and mercury-polymorphism interactions on this outcome.  
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AIM 3: In Vitro Studies: Enzyme Activity Assessment.  
Genetically engineer two key polymorphic genes associated with Hg toxicokinetics 
(GSTP1-105, GSTP1-114), assess enzymatic activity of the protein products in the 
presence of and absence of methylmercury, inorganic Hg and several other heavy metals, 
and determine whether in vitro results provide mechanistic understanding of associations 
found in previous studies and evaluated in Aims #1 and 2.   
 
 
 
 
 
 
 
 
  
 
 
 
 
Table 1.1 Significant Associations Between Genetic Polymorphisms and Mercury Biomarker Levels in Recent Epidemiological 
Studies.  
 
Reference Population n Hg 
Biomarkers 
Exposure 
Sources 
Polymorphisms 
Assessed 
Polymorphisms Significantly 
Associated with Higher 
Biomarker Hg Levels 
Polymorphisms 
Significantly Associated 
with Lower Biomarker 
Hg Levels 
Custodio et 
al., 2004 
Swedish 
adults 
365 erythrocytes fish GCLC (rs17883901), 
GCLM (rs41303970), 
GSTP1-105, -114 (rs1695, 
rs1138272), GSTA1 
(rs3957396), GSTT1 and 
GSTM1 deletion 
GCLC T and/or GSTP1-114 T 
carriers had steeper regression 
of erythrocyte Hg on 
polyunsaturated fatty acids 
  
Custodio et 
al., 2005 
Ecuadorian 
gold miners 
and buyers 
309 whole blood, 
plasma, urine 
gold 
mining 
practices 
GCLC, GCLM, GSTP1-
105, GSTP1-114, GSTA1, 
GSTT1 and GSTM1 
deletion 
GCLM T and elevated blood, 
plasma, urine Hg in 
moderately exposed miners 
  
Gundacker 
et al., 2007 
Austrian 
students 
174 to 222 whole blood, 
urine, hair 
fish GSTT1 and GSTM1 
deletion 
GSTT1/M1 deletions and hair 
Hg   
Engström 
et al., 2008 
Swedish 
adults 
292 erythrocytes fish GCLC , GCLM, GSTP1-
105, GSTP1-114 
GCLM TT and erythrocyte Hg 
(adjusted for polyunsaturated 
fatty acids) 
GSTP1-105 G and/or 
GSTP1-114 T have less 
steep regression of 
erythrocyte Hg on 
polyunsaturated fatty acids 
Gundacker 
et al., 2009 
Austrian 
students 
184 to 304 whole blood, 
hair, urine 
dental 
amalgam, 
fish 
GCLC, GSTP1-105, 
GSTP1-114, GSTA1, 
GSTT1 and GSTM1 
deletion, metallothionein 
SNPs 
GSTP1-105 G and unadjusted 
median blood and hair Hg; in 
CATREG analysis on 
dichotomized Hg levels: 
GSTP1-114 T and/or GCLC T 
and hair Hg; GSTP1-114 T 
and/or GCLC T on blood Hg, 
near sig; GSTM1 deletion 
and/or GSTP1-105 G on hair 
Hg; GSTT1 deletion and 
GSTP1-114 T on Hair Hg   
GSTA1 A and unadjusted 
median blood Hg 
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Chapter 2 
Glutathione Enzyme and Selenoprotein Polymorphisms Associate with Mercury 
Biomarker Levels in Michigan Dental Professionals
1
 
 
2.1 Introduction 
Mercury toxicokinetics and toxicodynamics are largely influenced by the chemical 
form of the metal. Though humans are exposed to mercury through a variety of sources 
(e.g. vaccines, thermostats, compact fluorescent lights), the main sources of elemental 
mercury (inorganic) and methylmercury (organic) exposure come from dental amalgams 
and fish consumption, respectively (ATSDR, 1999; Clarkson and Magos, 2006). Urine is 
commonly used to measure elemental mercury exposure and blood or hair to measure 
methylmercury exposure (Berglund et al., 2005; Clarkson et al., 2007). However, each 
biomarker shows tremendous inter-individual variation, and this complicates risk 
assessment.  For example, mercury typically accumulates 250 times more in the hair than 
it does in the blood, though this ratio ranges widely among individuals (ATSDR, 1999; 
Berglund et al., 2005). The half-life of methylmercury in hair ranges from 33 to 120 days 
(Birke et al., 1972), and the half-life of inhaled elemental mercury ranges from 35-90 
days in the whole body (Hursh et al., 1976). Failure to understand such inter-individual 
variation in the accumulation of mercury, its distribution to various biomarkers and its 
                                                            
1 This chapter is accepted for publication with minor alterations in Toxicology and Applied Pharmacology (expected 
2011). Co-authors: J.M. Goodrich, Y. Wang, B. Gillespie, R. Werner, A. Franzblau, N. Basu.    
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half-life in the body may lead to risk assessment decisions that fail to protect the most 
susceptible individuals.  
Inter-individual variation in mercury biomarkers may be partly explained by genetic 
factors.  For example, mercury is eliminated following conjugation with glutathione, a 
process that may involve glutathione s-transferases (GSTs; GST theta 1, GSTT1; GST 
mu 1, GSTM1; GST pi 1, GSTP1) and indirectly depends on enzymes of the glutathione 
synthesis and degradation pathways (glutamate-cysteine ligase catalytic and modifier 
submits, GCLC, GCLM; glutathione synthetase, GSS; glutathione reductase, GSR; γ-
glutamyltransferase 1, GGT1) (Ballatori and Clarkson, 1985; Rooney 2007). 
Selenoproteins (e.g. selenoprotein pi 1, SEPP1; glutathione peroxidases, GPX) combat 
the oxidative stress created by mercury and bind the toxicant directly via selenocysteine 
residues (Chen et al., 2006). Genetic polymorphisms are ubiquitous among these 
glutathione and selenoprotein genes that facilitate the distribution, metabolism and 
elimination of mercury. As documented in recent epidemiological studies, such 
polymorphisms may influence mercury biomarker levels, which may ultimately improve 
understanding of inter-individual variability following exposure to methylmercury 
(Custodio et al., 2004; Engström et al., 2008; Gundacker et al., 2007; Gundacker et al., 
2009) and elemental mercury (Custodio et al. 2005; Gundacker et al., 2009).  
The aforementioned studies provide early evidence that genetic polymorphisms in 
key mercury handling genes may underlie differences in mercury distribution and 
accumulation in exposure biomarkers.  However, discrepancies exist among the studies 
(see Table 1.1 for more details). For example, Custodio et al. (2004) found an association 
between the minor allele (T) of the GSTP1-114 polymorphism (rs1138272) and increased 
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blood mercury levels while Engström et al. (2008) found the opposite in subjects with 
higher fish consumption.  Disparate findings may be related to differences between the 
studies in terms of biomarkers examined, statistical power and methodologies utilized, 
sources of mercury exposure, and polymorphism frequency. Alternatively, lack of 
replication of a polymorphism-Hg association may be due to a false positive.  
Here we aim to address these limitations and help improve understanding of gene-
environment interactions influencing mercury biomarker levels by studying both forms of 
mercury (through analytical measurement of biomarkers in urine and hair), various 
sources of exposure (dental amalgams and fish as determined from surveys), and 
additional polymorphisms in glutathione-related (GSTT1, GSTM1, GSTP1, GSTM3, 
GGT1, GSS, GSR, GCLC, GCLM) and selenoprotein (SEPP1, GPX1, GPX4) genes in a 
group of dental professionals that are exposed to mercury via occupational and 
environmental routes. Polymorphisms in the listed genes, which are important in the 
metabolism and elimination of mercury, are hypothesized to affect individual 
susceptibility to elemental mercury and/or methylmercury accumulation in the body as 
assessed by urine and hair biomarkers.  
 
2.2 Materials and Methods 
2.2.1 Study Population 
A convenience sample of 515 dental professionals (dentists, hygienists, and other 
related professions) was recruited during the 2009 (n=231) and 2010 (n=284) Michigan 
Dental Association (MDA) Annual Conventions. Institutional Review Board (IRB) 
approval was obtained for this study from the University of Michigan (HUM00027621). 
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2.2.2 Survey Data  
For each participant a self-administered survey provided information on subject 
demographics (e.g., age, gender, weight), occupational practices (e.g., hours worked per 
week, number of amalgams removed and placed per week), and personal exposures to 
elemental mercury (amalgams in subject‟s mouth) and methylmercury (fish 
consumption). Subjects provided detailed information on fish consumption (e.g., portion 
size, type of fish, monthly consumption). Fish data were used to estimate a mercury 
intake variable (ug per kg body weight per day) using mercury concentration data from 
the U.S. Food and Drug Administration for each fish species (Bahnick et al., 1994; 
Mierzykowski et al., 2001; US FDA).  
 
2.2.3 Mercury Exposure Assessment  
 Spot urine samples, biomarkers of elemental mercury exposure, (>30 mL) were 
collected from each participant and stored frozen. Hair samples, biomarkers for 
methylmercury, (>10 mg) were cut from the occipital region of the scalp, and the first 2 
cm of hair closest to the scalp (proximal end) were used for measurement. Total mercury 
levels in urine and hair were measured using a direct mercury analyzer (DMA-80, 
Milestone Inc., CT) according to U.S. EPA Method 7473 as previously described (Basu 
et al., 2010; Paruchuri et al., 2010). Quality control measures included incorporating one 
blank, one replicate sample, and a certified reference material (CRM; hair: NIES Japan 
CRM#13; two urine CRMs: QMEQAS08U-01 and ClinChek; dogfish liver: DOLT, 
National Research Council Canada) in every batch of 10-15 samples. All samples 
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exceeded the theoretical method detection limits, defined as 3x SD of blanks, (0.03 ug/L 
mercury for urine and 0.01 ug/g mercury for hair). Mean (±SD) recovery of mercury 
from CRMs was 94.4 ± 15.4%. Mean within day (3.1 ± 1.7%) and between day (6.7 ± 
6.8%) variability of CRMs were similar to that of duplicated subject samples. 
 
2.2.4 Genotype Analysis 
To obtain DNA from buccal cells, subjects swabbed the inside of their cheeks 
with four cotton swabs for fifteen seconds each. Cotton swabs were stored at room 
temperature in 0.5 mL of buffer (100 mM sodium chloride, 10 mM Tris base, 10 mM 
EDTA, 0.5% sodium dodecyl sulfate with 0.1 mg/mL of Proteinase K, according to Min 
et al., 2006). DNA was purified from buccal cells using Promega SV Wizard Genomic 
DNA purification kits (Promega Corporation, Madison, WI), and DNA quantification 
was performed using PicoGreen reagent with relative fluorescence measured by a Perkin 
Elmer HTS 7000 Plus Bioassay Reader (Shelton, CT).  
Over the two study years, fifteen polymorphisms were genotyped in glutathione s-
transferases, glutathione synthesizing enzymes, and selenoproteins, but in a given study 
year ten or eleven polymorphisms were genotyped. Eleven polymorphisms were selected 
based on functional impacts on gene expression or enzyme activity associated with 
genotype in previous research (summarized in Table 2.2), while the remaining 
polymorphisms were selected as tag SNPs in genes of interest. Fourteen polymorphisms 
(rs1695, rs1138272, rs3877899, rs713041, rs7579, rs17883901, rs41303970, rs1050450, 
rs5751901, rs7483, rs3761144, rs1002149, rs2911678, GSTT1 deletion) were genotyped 
using Taqman Allelic Discrimination Assays (Applied Biosystems; Livak et al., 1995). 
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Results were read and interpreted using an ABI 7700 (Carlsbad, CA). All primers and 
probes were pre-designed by Applied Biosystems except for the GSTT1 deletion 
genotyping which utilized primers and probes designed by Mordukhovich et al. (2009). 
The GSTM1 deletion polymorphism was genotyped in the 2009 samples using the PCR-
based method of Lee et al. (2009). GSTT1 and GSTM1 genotyping resulted in two distinct 
groups: deletion homozygotes and individuals with at least one intact copy of the gene. 
 
2.2.5 Statistical Analyses  
All statistical analyses were performed using PASW Statistics v18 (Chicago, IL). 
The 2009 and 2010 data were grouped together given that demographics, mercury 
biomarker levels and exposures had similar distributions both years. In all analyses, 
mercury values were natural log-transformed to achieve normality. The association of 
genetic polymorphisms with mercury biomarker levels (hair or urine) was studied via 
simple linear regression models with one ordinal variable per polymorphism (coded 
1=major homozygote, 2=heterozygote, 3=minor homozygote) in each model. Genotype 
coding assumed an additive impact of each additional variant allele on any potential 
association between genotype and biomarker levels, regardless of direction. The 
association of genetics with urine mercury and hair mercury levels adjusted for predictors 
was assessed by multiple linear regression. Base models without genetic variables were 
first created. All variables (e.g., demographics, fish consumption, occupational 
exposures) were included in the base model, and insignificant variables (p>0.05) were 
removed via a manual backward selection process. Final base models consisted of 
significant predictors of hair or urine mercury (p<0.05 for parameter estimate) unless 
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otherwise noted. The effect of genotype (main effect and interaction with each exposure 
predictor variable) was then assessed with separate models for each polymorphism. 
Models with separate dummy variables for heterozygotes and minor homozygotes and 
interaction terms for each were also run (data not shown). The effect estimates 
(magnitude, direction, significance) for genotype obtained from this method, which did 
not assume genetic additivity, were similar to results reported here.  
According to the method of Levine and Fahy (1945), which has been shown to 
reduce variability of metal excretion associated with spot urine samples, urine mercury 
levels were adjusted for the mean specific gravity (1.017) of the study population (Lee et 
al., 1996; Mason and Calder, 1994). The linear regression models described were run 
with unadjusted and adjusted urine. Parameter estimates did not notably change and 
significance only changed in a few instances in specific gravity adjusted models. 
Unadjusted models are reported here unless otherwise noted. In all urine mercury models, 
eight subjects were excluded due to a history of kidney disease (lithiasis, pyelonephritis, 
and/or orthostatic proteinuria) that may have influenced urinary excretion of mercury. 
Statistical significance was defined as p<0.05. Correction for multiple testing 
would necessitate a p value <0.002 to attain significance after accounting for 30 
independent tests (two Hg biomarkers with fifteen polymorphisms). No estimates for 
polymorphism-Hg biomarker relationships in this study had significance of p<0.002. As 
such, nominally significant results (p<0.05) are reported and discussed as interesting 
trends to consider in future research.    
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2.3 Results  
2.3.1 Descriptive Statistics 
The majority of the 515 participants provided urine (n=502) and hair (n=505). 
Subjects lacking both biomarker samples and demographic information were excluded 
(n=4). Sixty-one percent of all subjects were female, and the majority of the population 
(>90%) self-identified racially as Caucasian. Table 2.1 provides average (±SD) 
demographic and occupational variables for the total population and occupation-stratified 
population (dentists, n=243 vs. non-dentists, n=268). Genders were unequally distributed 
in the occupational groups as 24% of dentists were female compared to 95% of non-
dentists (e.g., dental hygienists, dental assistants). Stratification of subjects into two 
occupational groups yielded significant differences (p<0.05) between the groups. On 
average, dentists were older, removed and placed more dental amalgams in the office, 
and had more amalgams in their own mouths compared with non-dentists.  
 
2.3.2 Mercury Biomarkers 
Average mercury biomarker levels are reported in Table 2.1. Urine mercury 
(mean ±SD, 1.04±1.18 ug/L; median 0.66 ug/L) ranged from 0.03 to 9.26 ug/L with a 
distribution resembling that of the U.S. population according to the National Health and 
Nutrition Examination Survey (NHANES 2003-2004, median 0.48 ug/L; CDC, 2009). 
Dentists had significantly higher urine mercury levels compared to non-dentists (1.37±1.3 
ug/L vs. 0.75±0.97 ug/L; p<0.001 for ANOVA comparing natural log-transformed 
values). The distribution of hair mercury (0.49±0.63 ug/g; range 0.02 to 6.15 ug/g) also 
resembled NHANES data from 1999-2000 (mean 0.47 ug/g; McDowell et al., 2004). 
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Dentists had significantly higher hair mercury levels compared to non-dentists (0.69±0.81 
vs. 0.31±0.33 ug/g; p<0.001) even though the estimated mercury intake from fish 
consumption was not significantly different between the two groups.  
 
2.3.3 Genotype and Mercury Biomarkers 
All genotyped polymorphisms achieved Hardy-Weinburg Equilibrium (HWE). 
Minor allele frequencies (MAF) for each polymorphism were generally similar to 
HapMap reference Caucasian population MAFs (Table 2.2). In statistical models 
comparing mercury levels among genotype groups, all polymorphisms were divided into 
major homozygote, heterozygote, and minor homozygote groups with the exception of 
GSTM1 and GSTT1 deletion polymorphisms which were divided into two genotype 
groups (double deletion vs. at least one intact copy).  
Simple linear models were used to test the differences in mean natural log-
transformed urine (ug/L) or hair (ug/g) mercury levels among genotype groups for each 
polymorphism (Table 2.3). Three statistically significant associations emerged.  Urine 
levels were lower among individuals with double deletion of GSTT1 compared to those 
with the intact gene (means: 0.82 vs. 1.06 ug/L; p-value=0.03). Likewise, individuals 
with the T allele for SEPP1 3‟UTR (rs7579) had lower urine mercury levels (means: 
CC=1.08, CT=1.04, TT=0.91 ug/L; p=0.03). Hair mercury levels differed by GSTP1-105 
(rs1695) genotype with minor homozygotes (GG) exhibiting the lowest hair mercury 
measurements (means: AA=0.52, AG=0.51, GG=0.29 ug/g; p-value=0.004).   
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2.3.4 Linear Regression Modeling of Urine Biomarker 
Linear regression was used to model natural log-transformed urine mercury levels 
with significant exposure variables. In the final base model, significant predictors were 
number of dental amalgams in the subjects‟ mouth („amalgam‟), amalgams removed or 
placed per week in the dental office („amalgam handled‟, an ordinal variable), and 
occupation (dentist vs. non-dentist; Table 2.4). The categories for „amalgam handled‟ 
were defined as follows: reference (0 amalgams handled), low (1 to 20 per week), 
medium (21 to 45), and high (>45). The effect of genotype for each polymorphism was 
tested (main effect, interactions between genotype and the three exposure variables). For 
all models, only the interactions between genotype and „amalgam‟ are reported here as 
amalgams were the dominant predictor of urine Hg levels. The number of subjects in 
each model ranged from 204 to 466 depending on the polymorphism; not all 
polymorphisms were genotyped both years, and some subjects did not provide adequate 
DNA to complete the genotyping.  
Urine mercury models with genotype (main effect or interaction) are reported in 
Table 2.4.  Nominally significant (p<0.05) main effects of genotype were observed for 
SEPP1 3‟UTR (β estimate: -0.26 ug/L change to ln(urine Hg) per T allele) and GSTT1 
deletion (-0.25 ug/L ln(urine Hg) with double deletion), though the latter was only 
observed when urine was first adjusted for specific gravity (data not shown). A 
significant interaction was observed with SEPP1 3‟UTR T alleles and personal amalgams 
(β=0.04 ug/L change to ln(urine Hg) per T allele per amalgam), though the interactions 
with amalgam handled and occupation were not significant (data not shown).  
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2.3.5 Linear Regression Modeling of Hair Biomarker 
Hair mercury levels were modeled using statistical methods similar to urine 
mercury modeling.  The final base model included the most significant predictor of hair 
Hg, „fish Hg‟ (calculated ug Hg intake per kg body weight per day from fish 
consumption, p<0.001 for parameter estimate; see Table 2.5). Addition of genotype into 
the model resulted in two genotypes with significant main effects (GSTP1-105 β=-0.22 
ug/g change to ln(hair Hg) per minor allele; GSTP1-114, rs1138272, β=-0.31 ug/g). 
Significant interactions between genotype and fish Hg were also observed in models with 
SEPP1 3‟UTR and GSS 5‟ (rs3761144). Individuals with the minor allele (T) of SEPP1 
3‟UTR accumulated less mercury in the hair per intake from fish consumption (β=-1.61 
ug/g change to ln(hair Hg) per T allele per 1 ug fish Hg intake per kg body weight per 
day). The opposite relationship was observed with the minor allele of GSS 5‟ (G) and fish 
Hg (β=1.88 ug/g).  To highlight the nature of these results, two scatterplots of hair 
mercury by mercury intake from fish (both natural log-transformed) are shown stratified 
by SEPP1 3‟UTR genotype (Figure 2.1A) and GSS 5‟ genotype (Figure 2.1B). 
Significant results (main effect or genotype-by-exposure variable interactions) were not 
observed for any other polymorphism in the models of urine or hair mercury.  
 
2.4 Discussion  
Recent epidemiological studies suggest that seven genetic polymorphisms in GSTs 
and glutathione synthesizing enzymes may influence mercury accumulation in common 
biomarkers (hair, blood, urine) following exposure to elemental mercury or 
methylmercury (Custodio et al., 2004, 2005; Engström et al., 2008; Gundacker et al., 
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2007, 2009). Here, we build upon these studies and assess the association of fifteen 
polymorphisms in GSTs, glutathione synthesizing enzymes and selenoproteins with the 
accumulation of both elemental mercury and methylmercury in urine and hair 
biomarkers, respectively, in a population of occupationally and environmentally exposed 
dental professionals. Our results suggest that five polymorphisms associate with 
accumulation of mercury in urine (GSTT1 deletion), hair (GSTP1-105, GSTP1-114, GSS 
5‟) or both (SEPP1 3‟UTR).   
Dental professionals provide a convenient sample to assess mercury-gene 
interactions as they share common exposure routes with the general population (e.g. fish 
consumption, personal amalgams) along with an additional occupational exposure. While 
dentists‟ occupational exposures are typically higher than the average population, a shift 
towards use of composite resin fillings and safer handling of mercury may result in 
dentists having urine biomarker levels comparable to that of the general U.S. population 
(Eklund et al., 2010).  Here, participating dentists and other related professionals (e.g., 
dental hygienists, dental assistants) exhibited urine and hair mercury levels similar to that 
of the general U.S. population according to NHANES (CDC, 2009; McDowell et al., 
2004). The best predictors of urine mercury levels were personal dental amalgams and 
occupational exposure to amalgams with dentists having the greatest exposure and 
biomarker levels. Study subjects displayed a wide range of methylmercury exposure from 
fish consumption, enabling the study of both mercury forms.  
Immense variability in mercury biomarker measurements and half-lives has been 
observed in human populations, complicating risk assessment of both elemental and 
methylmercury (Berglund et al., 2005; Birke et al., 1972; Hursh et al., 1976). Differential 
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metabolism of mercury in the body could affect its half-life and reactivity, as conjugated 
mercury is less able to induce oxidative stress, bind to thiol groups, and/or inhibit 
proteins in the body. Functional GSTs, adequate glutathione and selenoproteins are 
essential for protection against mercury (Ballatori and Clarkson, 1985; Chen et al., 2006; 
Clarkson and Magos, 2006). Polymorphisms are ubiquitous among the genes encoding 
these mercury-handling proteins and have the potential to modify mercury toxicokinetics, 
reflected partially in biomarker levels, via altered enzyme activity or gene expression. 
Previous studies assessing the association of genetic polymorphisms with mercury 
biomarkers focused on seven variants in glutathione synthesizing enzymes and 
glutathione s-transferases, six of which were genotyped here (see Table 1.1 for a 
summary of key results from these studies). Our results follow several trends previously 
reported, and this study further explores genotype-mercury relationships that were 
inconsistent in past research. Custodio et al. (2005) found the T allele of GCLM 
rs41303970 to be associated with increased blood, plasma and urine mercury in gold 
miners occupationally exposed to elemental mercury. Our study did not find associations 
between urine mercury levels and GCLM genotype. Genotype associations may differ 
based on the level of exposure as the miners had almost seven-fold higher urinary 
mercury compared to the dental population (miners: median=4.5 ug/L, maximum=230 
ug/L; dental population: median=0.7 ug/L, maximum=9.3 ug/L). Other studies have 
explored the influence of glutathione-related polymorphisms on urine mercury levels, and 
a lack of significant outcomes indicate that the polymorphisms studied to date may not 
influence variability observed in urinary excretion of elemental mercury. Alternatively, 
given that the impact of an individual polymorphism on mercury accumulation is 
 
 
43 
expected to be small, studies to date, including the present, may have insufficient 
statistical power to detect some associations.    
Two previous epidemiological studies have assessed the relationship between 
glutathione-related polymorphisms and hair mercury levels (Gundacker et al., 2007, 
2009), and four explored the modification of polymorphisms on methylmercury 
accumulation from fish consumption using blood as an exposure biomarker (Custodio et 
al., 2004; Engström et al., 2008; Gundacker et al. 2007, 2009). Several associative 
findings linking polymorphisms to hair or blood biomarker levels were inconsistent 
among studies (Table 1.1). Gundacker et al. found GSTM1 and GSTT1 deletions together 
(2007) or in combination with other SNPs (2009) to associate with higher hair mercury 
levels. The present study did not observe significant associations between GSTM1 or 
GSTT1 deletion polymorphisms with hair mercury levels when modeling the effects of 
single polymorphisms or combined genotype (both intact vs. one or more deletions). 
Conflicting relationships between two GSTP1 SNPs (105, rs1695 A>G and 114, 
rs1138272 C>T) and hair or blood biomarkers were observed among past studies. Given 
that both SNPs encode amino acid changes in GSTP1 that decrease enzyme activity (Ali-
Osman et al., 1997), these SNPs may alter the ability of GSTP1 to conjugate glutathione 
to mercury or transport mercury-glutathione conjugates. This study suggests that the 
GSTP1-105 G allele is linked to decreased hair mercury levels (Table 2.3 and Table 2.5), 
though it has no significant effect modification on the relationship between mercury 
intake from fish consumption and hair levels. Likewise, the GSTP1-114 T allele has a 
negative main effect in the adjusted model but no significant interaction with mercury 
intake from fish. Engström et al. (2008) found that carriers of GSTP1-105 G and/or 
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GSTP1-114 T accumulated less mercury in erythrocytes per measured polyunsaturated 
fatty acids (an indicator of fish consumption), suggesting a similar trend as the findings 
of this study for GSTP1 variant alleles. In contrast, other studies found associations 
between GSTP1-105 G or GSTP1-114 T and higher hair or blood biomarker 
measurements, after adjustment for fish consumption in many cases and often in 
combination with other polymorphisms (Custodio et al., 2004; Gundacker et al., 2009). 
Several factors may influence these incongruent results. While hair and blood, especially 
erythrocytes, are both biomarkers for methylmercury exposure, two centimeters of scalp 
hair represent the average exposure over two months with a lag period of approximately 
one month while blood mercury levels reach a steady-state among consistent fish 
consumers but fluctuate among infrequent consumers (Berglund et al., 2005). Thus, while 
similar gene-mercury relationships could be observed in models of hair and blood 
mercury, they may be influenced by the frequency, duration, and dose of the exposure. 
Several significant findings in previous studies for GSTP1-105 and GSTP1-114 involved 
polymorphism combinations. Our sample size was not large enough to confidently test 
combinations of all fifteen polymorphisms studied.  
This study expanded upon previous work by exploring gene-mercury biomarker 
relationships with nine additional SNPs in glutathione-related enzymes (n=5) and 
selenoproteins (n=4).  Two SNPs (SEPP1 3‟UTR, and GSS 5‟) had significant main 
effects and/or interactions with exposure sources in regression models of urine and/or 
hair mercury levels. While these SNPs displayed nominally significant associations 
(p<0.05), none had p-values that maintained significance after multiple test correction 
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(p<0.002). As such, the results should be interpreted with caution and viewed as potential 
trends worthy of future exploration.  
Genotype of the SEPP1 3‟UTR SNP was significantly associated with both urine 
(positive interaction with amalgam) and hair Hg (negative interaction with fish mercury) 
in linear regression models. This SNP is found in the 3‟ untranslated region (UTR), a 
gene region crucial to the regulation of selenocysteine incorporation. Selenocysteine is an 
amino acid unique to selenoproteins that can bind mercury-selenium (HgSe) conjugates 
or methylmercury (Khan and Wang, 2009). Expression of SEPP1 depends on genotype 
and selenium availability and can also be influenced by gender and BMI (Méplan et al., 
2007, 2009). The 3‟UTR T allele is linked to greater SEPP1 expression among people 
supplemented with selenium and higher prevalence of the 60 kDa isoform of SEPP1 
which has more selenocysteine residues and greater mercury binding capacity (Méplan et 
al., 2007, 2009).  Elevated elemental mercury exposure increases SEPP1 expression and 
the ability of SEPP1 to bind mercury as evident in highly exposed miners (Chen et al., 
2006). In the dental population, individuals with CT or TT genotype had lower urine 
mercury levels on average (Table 2.3). However, the T allele modified the relationship 
between the source of exposure, dental amalgams, and urine mercury levels. At higher 
exposure levels, CT/TT individuals excrete more mercury in the urine per amalgam 
compared to those with the CC genotype (Table 2.4; β=0.04 ug/L change to ln(Urine Hg) 
per T allele per amalgam). The opposite relationship is observed for the hair biomarker 
whereby each additional T allele is associated with less accumulation of mercury in the 
hair given methylmercury intake from fish (Figure 2.1A; β=-1.61 ug/g change to ln(hair 
Hg) per T allele per unit Hg intake from fish). Expression changes of SEPP1 linked to the 
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T genotype may explain the complex relationship observed between SEPP1 genotype, 
mercury biomarker levels, and exposures to mercury that may be complicated further by 
micronutrient status (e.g. selenium) and chemical speciation of mercury. Higher 
expression of SEPP1 from the CT or TT genotypes could affect mercury binding and 
subsequent distribution to various tissues. Excretion of elemental mercury and 
methylmercury via urine and hair, respectively, may be differentially modified by this 
SNP which warrants further investigation and incorporation of selenium biomarker levels 
into multivariate analysis. 
Glutathione synthetase (GSS) is involved in glutathione synthesis, and a SNP 
upstream of the coding region (rs3761144, C>G) may modify the relationship between 
mercury intake from fish consumption and hair mercury levels. With each variant allele 
(G), more mercury is accumulated in the hair given intake from fish consumption (Figure 
2.1B, Table 2.5; 1.88 ug/g change to ln(hair Hg) per G allele per unit intake from fish). 
This SNP, which is associated with sporadic amyotrophic lateral sclerosis among 
individuals with past heavy metal exposure, may influence expression of GSS directly or 
may be a marker for an expression-altering SNP (Morahan et al., 2007). Decreased 
expression of GSS leading to decreased glutathione synthesis could impact the body‟s 
ability to eliminate methylmercury as a glutathione conjugate with the higher body 
burden reflected in hair mercury levels.  
We found several nominally significant associations between polymorphisms in 
glutathione-related enzymes and SEPP1 and elemental mercury or methylmercury 
biomarker levels in a population of dental professionals despite several study limitations. 
This cross-sectional study was dependent upon self-reporting of mercury exposures (fish 
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consumption, number of amalgams handled). Though the voluntary nature of subject 
participation could lead to selection bias, our subjects did not know their mercury levels 
or genotype prior to participation in the study, and we obtained a range of mercury 
biomarker levels similar to that of the general US population (CDC, 2009; McDowell et 
al., 2004).  
In the dually exposed MDA cohort, total Hg in urine was predicted by amalgam 
exposures and occupation, and hair Hg levels correlated with estimated mercury intake 
from fish. As such, total Hg in urine and hair were assumed to reflect elemental mercury 
and methylmercury exposures, respectively. While urine and hair are often used as 
biomarkers of different mercury species (Berglund et al., 2005), cohorts occupationally 
exposed to elemental mercury attribute a fraction of hair Hg to the elemental mercury 
exposure source (Wranová et al., 2008). Likewise, in populations with negligible 
elemental mercury exposure, urine Hg concentrations correlate with fish consumption 
(Ohno et al., 2007). While the possibility of such biomarker crossover cannot be 
eliminated, urine and hair Hg concentrations in the MDA cohort primarily reflect 
elemental mercury and methylmercury exposures, respectively.    
In genotype analyses, the sample size was decreased due to inadequate DNA from 
a subset of subjects, and not all polymorphisms were genotyped each collection year 
resulting in sample sizes as small as 204 in some models. Previous gene-mercury 
biomarker studies found significant associations of dual polymorphism combinations 
with mercury biomarker levels. However, due to the sample size and number of loci 
genotyped, polymorphism combinations could not be tested confidently in this study 
without encountering probable errors of multiple testing or insufficient statistical power 
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due to small numbers of cases with some genotype combinations. Without studying 
polymorphism combinations, we may have missed several significant relationships with 
mercury biomarkers that would mirror findings in previous studies. Overall, while several 
significant genotype-mercury biomarker relationships were observed (p<0.05), none 
remain significant after correction for multiple testing (p<0.002). As such, the nominally 
significant results reported in the MDA cohort should be considered trends and require 
further exploration in future cohort studies with greater power.  
Inconsistencies among polymorphism-mercury biomarker studies and the lack of 
significant associations (p<0.002) observed after correcting for multiple testing in the 
MDA cohort could reflect complications inherent to studies of complex genetic traits. If 
polymorphisms in glutathione-related and selenoprotein genes have any true impact on 
Hg toxicokinetics, the influence of one individual polymorphism is expected to be quite 
small (e.g., explain <1% of toxicokinetic variability) and would be difficult to detect in a 
small cohort or replicate in another cohort. Further complications arise when studying 
ubiquitous gene families such as GSTs that upregulate expression following mercury 
exposure (Brambila et al., 2002) and are able to compensate for dysfunctional isozymes 
due to overlapping substrate specificity. Thus, the combination of a multitude of 
polymorphisms impacting gene expression and enzyme activity in various genes is 
expected to underlie the true variability observed in human mercury toxicokinetics.   
In conclusion, this study adds to growing knowledge about genetic associations with 
mercury biomarker levels and inter-individual variability in the toxicokinetics of 
elemental mercury and methylmercury. Results suggest that five polymorphisms in 
GSTP1, GSTT1, GSS and SEPP1 may influence urine and hair mercury levels, though 
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results should be interpreted with caution and further investigation is warranted. Future 
research on genetic factors influencing mercury toxicokinetics should assess both major 
mercury exposure sources (amalgam, fish consumption) using all three biomarkers (urine, 
blood, hair) in larger cohorts and more polymorphisms in glutathione related enzymes, 
selenoproteins, and proteins involved in mercury transport to help ascertain sources of 
biomarker variability and to narrow the gap between the perceived and true health risks 
accompanying mercury exposure.  
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Figure and Tables  
Figure 2.1 Hair Hg vs. Hg Intake from Fish Stratified by A) SEPP1 3’UTR (C>T) 
Genotype or B) GSS 5’ (C>G) Genotype. Note: hair Hg and Hg intake are natural log-
transformed, though axes are labeled with untransformed units for ease of interpretation.  
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Table 2.1 Demographic and Exposure Variables. Mean (SD) for the total population 
and occupation stratified populations. 
 
  Total 
Population 
Occupation Stratified  
Dentists Non- 
Dentists 
N 511 243 268 
% Female  61.3  24.3 94.8  
BMI  (kg/m
2
) 26.4 (4.7) 26.4 (4.0) 26.5 (5.3) 
Age (years) 52.1 (12.1) 56.1 (11.6) 48.3 (11.2)
b 
Hours worked/ week  
(in past 6 months) 
27.9 (11.6) 29.1 (11.1) 27.0 (11.9)
a 
# Amalgam (personal)  4.1 (4.1) 4.6 (4.2) 3.7 (3.9)
a 
# Amalgam placed/ week 12.1 (25.8) 20.4 (31.1) 4.7 (16.7)
b 
# Amalgam removed/ week 13.3 (23.1) 23.2 (27.2) 4.4 (13.4)
b 
Hg Intake  
(ug/kg body weight/day) 
0.08 (0.13) 0.09 (0.14) 0.08 (0.12) 
Urine Hg (ug/L) 1.04 (1.18) 1.37 (1.3) 0.75 (0.97)
b 
Hair Hg (ug/g) 0.49 (0.63) 0.69 (0.81) 0.31 (0.33)
b 
 
a,b
  denote p-value <0.05 and  <0.001, respectively, for ANOVA test comparing 
dentists and non-dentists. ANOVA comparing urine and hair Hg used natural log-
transformed values.  
 
  
 
 
 
Table 2.2 Genotype Frequencies. Genotype data for 15 polymorphisms in glutathione S-transferases, glutathione synthesizing 
enzymes, and selenoproteins. Most polymorphisms were selected due to known functional impacts. Associations between 
polymorphisms and alterations to gene expression, protein structure, or enzyme activity are summarized in the table with references. 
SNPs without known functional impacts were selected as tag SNPs.   
 
Gene  db SNP ID Alleles SNP Details N
 
Minor allele 
frequency Functional Impact
d 
 
Reference 
GSTP1 rs1695 A>G 105 Ile>Val 485
a 
0.32 105Val ↓ catalytic efficiency Ali-Osman et al. 1997 
GSTP1 rs1138272 C>T 114 Ala>Val 475
a 
0.08 114Val ↓ catalytic efficiency? Ali-Osman et al. 1997 
GCLM rs41303970 C>T 5' near gene 481
a 
0.19 T ↓ promoter activity Nakamura et al. 2002 
SEPP1 rs3877899 C>T 234 Ala>Thr 485
a 
0.24 Thr ↓ 60kDa isoform Méplan et al. 2009 
SEPP1 rs7579 C>T 3' UTR 479
a 
0.28 C ↓expression, ↓60 kDa isoform Méplan et al. 2007, 2009 
GSTT1 N/A  + > - Deletion 437
a 
0.41 -- ↓ expression Moyer et al. 2007 
GPX1 rs1050450 C>T 200 Pro>Leu 223
b 
0.28 200Leu ↓activity, Se-dependent Jablonska et al. 2009 
GPX4 rs713041 C>T 3' UTR 226
b 
0.45 T ↓ expression/protein levels Méplan et al. 2008 
GCLC rs17883901 G>A 5' near gene 230
b 
0.08 A ↓ promoter activity Koide et al. 2003 
GSTM1 N/A - > + Deletion  209
b 
0.32 -- ↓ activity Bell et al. 1992 
GGT1 rs5751901 T>C Intron 251
c
 0.36   
GSTM3 rs7483 G>A 224 Val>Ile 243
c 
0.26 224Val ↓catalytic efficiency Tetlow et al. 2004 
GSS rs3761144 C>G 5' near gene  255
c 
0.40   
GSR rs1002149 G>T 5' near gene 240
c 
0.18   
GSR rs2911678 T>A Intron 250
c 
0.24   
 
a 
Number genotyped including subjects from 2009 and 2010. 
b
 Number genotyped including subjects from 2009. 
c
 Number genotyped including subjects from 2010. 
d Activity refers to enzymatic activity unless otherwise indicated, and „?‟ indicates an unclear association. The 60 kDa isoform of 
SEPP1 is the isoform with the most selenocysteine residues.   
5
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Table 2.3 Simple Linear Regression: Genotype and Mean Urine and Hair Hg.  Beta 
estimates (p-value, bolded if p<0.05) are reported for correlations between genotype and natural-
log transformed urine Hg or hair Hg.  
 
Polymorphism 
Urine Hg Model: 
β  ug/L (p-value)  
Hair Hg Model: 
β ug/g (p-value) 
GSTP1-105 -0.05 (0.52) -0.22 (0.004) 
GSTP1-114 0.01 (0.96) -0.19 (0.16) 
GCLM 5' -0.08 (0.32) 0.02 (0.86) 
SEPP1-234 0.07 (0.34) 0.01 (0.92) 
SEPP1  3'UTR -0.16 (0.03) 0.03 (0.67) 
GSTT1 deletion -0.27 (0.03) 0.03 (0.84) 
GPX1-200 -0.11 (0.28) 0.12 (0.29) 
GPX4 3'UTR -0.03 (0.77) -0.1 (0.31) 
GCLC 5' 0.05 (0.78) 0.01 (0.98) 
GSTM1 deletion -0.02 (0.91) -0.04 (0.79) 
GGT1 intron -0.05 (0.62) -0.16 (0.12) 
GSTM3-224 -0.07 (0.47) -0.08 (0.45) 
GSS 5' -0.05 (0.53) -0.02 (0.82) 
GSR 5' -0.01 (0.93) -0.07 (0.55) 
GSR intron 0.1 (0.33) 0.14 (0.22) 
 
  
   
 
Table 2. 4 Predictors of Urine Hg and Influence of Genotype. Parameter estimates (β) are reported for models of natural log-
transformed urine Hg levels with exposure predictor variables, genotype, and genotype-by-amalgam interactions. Estimates 
indicate change to ln-transformed urine Hg (ug/L) per unit predictor.  
 
Polymorphism n
a
 Adj. r
2
 Amalgam 
Amalgam 
Handled Non-Dentist Genotype 
Amalgam* 
Genotype 
Base Model 492 0.233 0.08
d 
0.12
c 
-0.45
d 
  GSTP1-105 206, 214, 46 0.231 0.09
c 
0.11
b 
-0.45
d 
0.01 -0.006 
GSTP1-114 388, 66, 2 0.225 0.06 0.11
b 
-0.45
d 
-0.002 0.01 
GCLM 5' 310, 126, 27 0.244 0.11
d 
0.11
b 
-0.46
d 
0.03 -0.02 
SEPP1-234 267, 173, 25 0.228 0.1
d 
0.1
b 
-0.48
d 
0.05 -0.02 
SEPP1  3'UTR 240, 186, 35 0.254 0.03 0.11
b 
-0.44
d 
-0.26
c 
0.04
b 
GSTT1 deletion 347, 71
 
0.237 0.08
b 
0.12
b 
-0.4
d 
-0.18 0 
GPX1-200 114, 82, 21 0.211 0.11
c 
0.15 -0.39
b 
0.08 -0.03 
GPX4 3'UTR 67, 107, 46 0.208 0.09
b 
0.16
b 
-0.39
b 
0.07 -0.01 
GCLC 5' 193, 28, 3 0.208 0.08 0.15 -0.39
b 
0.11 -0.004 
GSTM1 deletion 93, 111
 
0.217 0.09
b 
0.16 -0.42
b 
0.17 -0.01 
GGT1 intron 93, 122, 23 0.251 0.1
b 
0.07 -0.52
d 
-0.01 0 
GSTM3-224 134, 77, 19 0.241 0.02 0.06 -0.48
d 
-0.14 0.05 
GSS 5' 91, 110, 41 0.245 0.14
c 
0.07 -0.52
d 
0.01 -0.02 
GSR 5' 155, 64, 7 0.228 0.12
b 
0.05 -0.53
d 
0.05 -0.02 
GSR intron 140, 82, 15 0.238 0.09
b 
0.07 -0.54
d 
0.02 0.01 
 
a
 Number of subjects in model in each genotype group. Genotype groups are major homozygote, heterozygote, minor homozygote 
except in the case of GSTT1 (gene present vs. double deletion) and GSTM1 (double deletion vs. gene present) 
b,c,d
 denote p-value ≤0.05, <0.01, and <0.001, respectively, for parameter estimate.  
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Table 2.5 Predictors of Hair Hg and Influence of Genotype. Parameter estimates (β) are reported for models of natural log-
transformed hair Hg levels with exposure variable (estimated Hg intake from fish consumption, ug per kg body weight per day), 
genotype, and genotype-by-fish Hg interactions. Estimates indicate change to ln-transformed hair Hg (ug/g) per unit predictor. 
Polymorphism n
a
 Adj. r
2
 Fish Hg Genotype Genotype*Fish Hg 
Base Model 
 
0.186 3.62
d 
    
GSTP1-105 214, 216, 44 0.197 2.87
c 
-0.22
c 
0.42 
GSTP1-114 393, 69, 2 0.195 2.91
c 
-0.31
b 
0.67 
GCLM 5' 315, 127, 28 0.184 4.49
d 
0.06 -0.63 
SEPP1-234 272, 176, 26 0.187 2.41
b 
-0.04  0.78 
SEPP1  3'UTR 245, 188, 36 0.194 6.22
d 
0.15 -1.61
c 
GSTT1 deletion 356, 70 0.179 2.38 -0.01 1.07 
GPX1-200 113, 84, 21 0.224 3.65
c 
0.04 0.06 
GPX4 3'UTR 70, 104, 47 0.231 2.69 -0.12 0.55 
GCLC 5' 192, 30, 3 0.228 4.53
c 
0.07 -0.6 
GSTM1 deletion 92, 112 0.247 5.51
d 
0.04 -1.04 
GGT1 intron 96, 124, 25 0.161 6.05
d 
-0.09 -1.32 
GSTM3-224 137, 80, 21 0.131 3.58
c 
0.02 -0.29 
GSS 5' 94, 111, 44 0.147 0.34 -0.15 1.88
b 
GSR 5' 159, 67, 8 0.12 1.4 -0.21 1.1 
GSR intron 143, 86, 15 0.139 1.7 0.06 1.18 
 
a
 Number of subjects in model in each genotype group. Genotype groups are major homozygote, heterozygote, minor homozygote 
except in the case of GSTT1 (gene present vs. double deletion) and GSTM1 (double deletion vs. gene present) 
b,c,d 
 denote p-value ≤0.05, <0.01 and <0.001, respectively, for parameter estimate.  
5
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Chapter 3 
Genetic Polymorphisms and Mercury Biomarker Distribution in 
Mexican Mother-Child Pairs 
 
3.1 Introduction 
 Mercury (Hg) is a potent toxicant that exists in multiple forms and has toxic 
effects on the nervous, cardiovascular, and immune systems, among others (ATSDR and 
CDC, 2009; NRC, 2000; Roman et al., 2011).  Humans are mainly exposed to organic Hg 
as methylmercury from fish consumption and to elemental Hg via dental amalgams 
(Clarkson et al., 2007). Prenatal development is a particularly sensitive period for 
methylmercury exposure, due to its known effects on neurodevelopment, and as such, 
risk assessment decisions on safe exposure levels are often geared towards women of 
child-bearing age (NRC, 2000). In 2000, Mexico, Canada and the U.S. deemed Hg 
pollution and the associated human health risks a large enough issue to form the North 
American Regional Action Plan on Mercury (Pilgrim et al., 2000).  
 Despite the toxicity of Hg and its elevation to a priority pollutant in North 
America, little data exists on sources of exposure and Hg biomarker levels in Mexicans. 
The few studies measuring Hg in Mexican populations focused on small samples of fish-
eating populations living near bodies of water (Guentzel et al., 2007; Trasande et al., 
2010) or workers and residents of mining and waste disposal sites contaminated with 
inorganic Hg and other heavy metals (Costilla-Salazar et al., 2011; de Lourdes Sotos-
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Ríos et al., 2010; Diaz-Barriga et al., 1993). Mercury exposure assessment of fish caught 
in waters in and around Mexico have revealed commonly consumed fish species to have 
a wide range of Hg contamination, some of which exceed maximum permissible levels 
set by various regulatory bodies (Guentzel et al., 2007; Ruelas-Inzunza et al., 2011a, 
2011b; Soto-Jiménez et al., 2010; Trasande et al., 2010). Given information on fish 
consumption patterns of the general population (Soto-Jiménez et al., 2010), some 
Mexicans may be at risk from exposures to methylmercury and possibly to inorganic Hg 
(from dental amalgams and other sources). Women of child bearing age and their 
children are a potentially susceptible group, but to our knowledge, their Hg exposures 
have not been characterized in the general Mexican population.   
 Exposure assessment is an important part of Hg risk assessment though it is 
complicated by variability in common biomarkers. Hair and blood (whole blood or 
erythrocytes) are mostly indicators of methylmercury exposure while urine and plasma 
reflect exposure to elemental/inorganic Hg (Berglund et al., 2005; for review see 
Clarkson et al., 2007). Immense inter-individual and inter-population variability has been 
observed among these biomarkers with respect to Hg half-life, biomarker Hg 
concentration to Hg intake ratios, and proportion inorganic Hg (Berglund et al., 2005; 
Birke et al., 1972). Furthermore, the hair Hg to blood Hg ratio (hair:blood), often used in 
risk assessment to extrapolate blood Hg levels from hair or vice versa (NRC, 2000), is 
usually assumed to be 250:1 though this ratio ranges widely (Berglund et al., 2005; 
Budtz-Jørgensen et al., 2004). Recent studies link genetic polymorphisms in genes of the 
glutathione pathway to variability in methylmercury (Custodio et al., 2004; Engström et 
al., 2008; Gundacker et al., 2009) and inorganic Hg biomarkers (Custodio et al., 2005; 
 62 
 
Gundacker et al., 2009). Glutathione conjugation is one mechanism that detoxifies and 
aids in elimination of Hg from the body (Ballatori and Clarkson, 1985). Glutathione s-
transferase (GST) and glutathione synthesizing genes are highly polymorphic, and 
genetic variation in these genes along with other gene classes involved in Hg 
toxicokinetics (e.g., selenoproteins) may be important to individual accumulation of Hg 
in the body and subsequent health risks. 
 This study seeks to address several knowledge gaps in epidemiological Hg 
research using the Early Life Exposures in Mexico to Environmental Toxicants 
(ELEMENT) cohort, a sample of mother-child pairs recruited from Mexico City. 
Mercury body burden was assessed using common biomarkers in children (hair, blood, 
urine) and mothers (hair). Additionally, 17 single nucleotide polymorphisms (SNPs) in 
glutathione (GSH) pathway and selenoprotein genes implicated in Hg metabolism and 
elimination were genotyped in ELEMENT subjects. Finally, genotype was related to Hg 
biomarker levels to test the hypothesis that SNPs in GSH pathway and selenoprotein 
genes will impact Hg body burden and Hg distribution as reflected in biomarker 
concentrations.    
  
3.2 Materials and Methods 
3.2.1 Study Population 
This study included participants from the ELEMENT birth cohort study, a 
collection of three mother-child cohorts recruited before or during pregnancy between 
1994 and 2002 with the intention of assessing the impact of prenatal lead exposure on 
development. Subjects of all three cohorts are Mexico City residents originally recruited 
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from three maternity hospitals serving low to moderate income individuals in Mexico 
City. For further information on subject recruitment and study design, see Cantonwine et 
al. (2010) and Surkan et al. (2008). This study utilizes data collected from a subset of 
ELEMENT mother-child pairs attending a recent follow-up visit (2007-2009) when the 
children were 6-15 years old. At the follow-up visit, biomarkers for Hg measurement 
were collected from the children and mothers (hair, blood, urine) along with demographic 
information, and anthropometric measurements. DNA was purified from blood samples 
for genotyping. The final sample was limited to subjects with genotype data (n=355 
mothers, 369 children). Sample size was further reduced in individual models as many 
mother-child pairs had missing data points (e.g., urine Hg biomarkers, mother‟s 
education, successful genotype of certain SNPs). Subjects with missing data points were 
excluded on an analysis by analysis basis.  Mothers signed a letter of informed consent 
before participating, and research protocols were approved by Ethics and Research 
Committees of all participating organizations including the University of Michigan and 
the National Institute of Public Health of Mexico.  
 
3.2.2 Mercury Exposure Assessment 
Analytical measurement of total Hg in children‟s blood and urine samples and 
hair from both mothers and children was performed using the Direct Mercury Analyzer 
80 (DMA-80, Milestone Inc., CT) according to U.S. EPA Method 7473 as previously 
described (Basu et al., 2010; Paruchuri et al., 2010). Eight hundred μL of urine, 250 μL 
of blood, or 5-10 mg of hair from the 2 cm closet to the scalp were used for analysis. 
Prior to analysis, hair samples were washed with acetone, rinsed three times with Milli-Q 
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water and dried overnight. Following placement of quartz or nickel sampling boats 
containing the human biomarkers into the DMA-80, decomposition at 800 C liberated 
Hg from the sample as a vapor, which was subsequently carried to an absorbance cell 
(253.65 nm) by oxygen for Hg quantification.  
Accuracy and precision were assessed by measuring duplicate samples and five 
certified reference materials (CRM) including NIES CRM #13 (human hair; Japanese 
National Institute for Environment Studies) and DOLT-4 (dogfish liver; Canadian 
National Research Council). Mean recovery of five different CRMs was 90.8% (mean of 
each ranged from 81.5 to 102.2%). Within day and between day variability of CRMs 
(mean 4.1% and 8%, respectively) was similar to that of duplicated samples. The 
analytical detection limit, calculated as three times the standard deviation of blank values, 
was 0.01 µg/g for hair samples, 0.08 µg/L for urine, and 0.17 µg/L for blood. Four urine 
samples fell below the detection limit. The specific gravity of urine samples was 
measured using a refractometer (PAL-10S, Atago U.S.A., Inc., WA). Urine Hg values 
were adjusted to the average specific gravity (1.017) to reduce variability in excretion 
associated with spot urine samples (Levine and Fahy 1945; Mason and Calder 1994).  
 
3.2.3 Genotype Analysis 
DNA was purified from whole blood using DNeasy Blood and Tissue Kits 
according to the manufacturer‟s protocol (Qiagen, Valencia, CA). Single nucleotide 
polymorphisms (SNPs) in glutathione synthesizing enzymes (n=2), glutathione s-
transferases (GST, n=10), and selenoproteins (n=5) were genotyped in 355 mothers and 
369 children (see Table 3.1 for list of SNPs). Ten SNPs were selected based on known 
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functional impacts (e.g., altered enzyme activity, gene expression; summarized in Table 
3.1) of the genotype. The remaining seven SNPs were tag SNPs in glutathione-related 
and selenoprotein genes of interest. Genotyping was performed using the Sequenom 
iPLEX Gold platform according to a published protocol (Gabriel et al., 2009).  
 
3.2.4 Statistical Analysis  
 Statistical operations were performed with PASW® v. 18 (Chicago, IL). 
Descriptive statistics for all variables were first computed for mothers and children. 
Mercury biomarker levels and ratios were natural log-transformed to achieve normality in 
all analyses. To minimize variability among children associated with age and gender, 
growth parameters (e.g., BMI, waist circumference) were converted into percentiles 
based on the distributions of these parameters in US children of the same age (by year) 
and gender according to the US Centers for Disease Control and Prevention database 
(http://www.cdc.gov/growthcharts/percentile_data_files.htm). Bivariate analysis (Pearson 
correlation) determined the association of demographic, anthropometric and Hg 
biomarker variables with one another.  
Linear regression further explored predictors of Hg biomarker levels and ratios 
and the association of genotype with these outcomes in both simple and multivariate 
models. The association of genotype (of the respective children or mothers) with six Hg 
biomarker variables (children‟s hair, urine, blood Hg levels, hair to blood and blood to 
urine ratios; mother‟s hair Hg) was assessed in linear regression with each SNP coded as 
one variable assuming additivity of variant alleles (1= major homozygote, 
2=heterozygote, 3=minor homozygote). In multivariate models, available variables (age, 
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mother‟s education, gender, BMI and waist circumference- percentile for children) were 
tested as predictors of Hg biomarkers in linear regression models without genetic factors. 
While none of the variables were consistently significant predictors of all Hg biomarkers 
or biomarker ratios, BMI, age, mother‟s education, and gender (in children‟s models) 
were selected for adjustment in models with genotype. Hair to blood ratio models 
additionally controlled for urine Hg as an indicator of inorganic exposure which can 
influence whole blood Hg. Genetic variables were added into the final models (one SNP 
per model). Though statistical tests were run with both unadjusted and specific gravity 
adjusted urine Hg, tests reported here used specific gravity adjusted urine unless 
otherwise indicated.  
 
3.3 Results 
3.3.1 Descriptive Statistics 
Current demographic information and anthropometric measurements were 
collected from ELEMENT cohort mother-child pairs participating in a follow-up visit 
between 2007 and 2009. Table 3.2 describes characteristics of the mothers and children 
with genotype data used in this study. Demographic variables and anthropometric 
measurements (e.g., age, BMI, education) of the subjects reported in Table 3.2 were 
similar to that of all ELEMENT subjects attending a follow-up visit during the same time 
frame (n=697, data not shown). Mercury exposure source data (e.g., fish consumption 
frequency, number of dental amalgams) was not available for ELEMENT participants.   
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3.3.2 Mercury Biomarkers 
 Mercury levels were quantified in hair, blood, and urine samples from the 
children and hair from the mothers (Table 3.3A). Not all mother-child pairs provided 
each biomarker of interest (n=238 with four). As such, analyses for each biomarker or 
biomarker ratio include all subjects with that specific biomarker and other model 
variables. The distribution of hair Hg concentrations of mothers (median, range: 0.39, 
0.03-4.19 µg/g) was similar to that of the children (0.38, 0.03-5.1 µg/g). Blood Hg levels 
in children ranged from 0.18-11.2 µg/L while urine Hg ranged from 0.06-9.34 µg/L. Age 
stratification revealed significant differences (p<0.05, ANOVA comparing natural log-
transformed data) between two age groups of ELEMENT children for hair, blood, and 
urine Hg with younger children (ages 6-11 years) having higher biomarker levels (Table 
3.3B). Children from each of the three combined ELEMENT cohorts were treated the 
same with respect to initial recruitment and follow-up visits. Even so, a cohort effect 
could underlie the Hg biomarker differences observed between the younger and older 
children who were originally from different ELEMENT sampling groups, though this is 
unlikely since cohort was not a significant predictor in any multivariate Hg biomarker 
model (data not shown). Stratification by gender did not reveal differences in mean or 
median biomarker levels. 
 Biomarker ratios (hair:blood=ng Hg/ g hair divided by µg Hg/ L blood; 
blood:urine=µg Hg/ L blood divided by µg Hg/ L urine) were calculated for the children 
(Tables 3.3A, B) as these ratios are influenced by type of Hg exposure but also reflect 
inter-individual variability in the distribution and handling of Hg. The blood:urine was 
more variable than the hair:blood (10 fold difference between the 90
th
 and 10
th
 percentiles 
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versus 3 fold difference), and this variability decreased (7 fold difference) when urine 
was adjusted for specific gravity. 
 
3.3.3 Bivariate Analyses 
 Correlations between Hg biomarkers, biomarker ratios, and select demographic 
variables were assessed using natural log-transformed biomarker values (Table 3.4). 
Children‟s age was negatively associated with biomarker levels (hair, blood, specific 
gravity adjusted urine) and mother‟s education was positively correlated with children‟s 
hair and blood (and mothers‟ hair, data not shown).  As observed by others (Berglund et 
al., 2005), blood and hair Hg levels of the same individuals were highly correlated 
(r=0.77, p<0.001). Although the strongest mother-child biomarker correlation was 
between hair Hg levels (r=0.47, p<0.001), mothers‟ hair Hg was also correlated with 
children‟s blood (r=0.37, p<0.001) and urine Hg (0.19, p<0.01).  
 
3.3.4 Genotype Data 
 Seventeen SNPs were genotyped in mother-child pairs of the ELEMENT cohort 
using the Sequenom iPLEX Gold Platform (Table 3.1). Four SNPs had minor allele 
frequencies (MAF) below 5% (GCLC rs17883901, GSTM1 rs1065411, GSTO1 
rs11509438, GSTP1 rs1138272) in this population. All SNPs were in Hardy-Weinberg 
Equilibrium except one; GPX4 rs713041 had a higher prevalence of heterozygotes than 
expected (p=0.002). Two SNPs were genotyped for the first time, to our knowledge, in a 
Mexican population (GCLC rs17883901, GCLM rs41303970). Comparing the genotype 
data of the remaining fourteen SNPs to that of populations with Mexican ancestry 
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previously genotyped (e.g., HapMap MXL, Table 3.1) reveal similar MAFs among most 
SNPs. MAF differences observed (i.e., GSTP1 rs749174) may be influenced by the 
ancestry of the populations. HapMap MXL consists of individuals with Mexican descent 
living in the United States (Los Angeles, CA), and here we have genotyped residents of 
Mexico City with unknown proportions of Indigenous, Spanish and African ancestry. 
 
3.3.5 Genotype and Mercury 
  The influence 17 SNPs in genes involved in Hg distribution, metabolism, and 
elimination on Hg accumulation was assessed via the association with Hg biomarker 
concentrations. Table 3.6 summarizes significant (p<0.05) or near significant (p<0.10) 
relationships observed between SNPs and biomarkers as observed in simple linear 
regression models or multivariate models adjusting for age, BMI (percentile in children‟s 
models, kg/m
2
 in mothers‟ models), gender and education (years completed by the 
mother, an indicator of socioeconomic status). Multivariate models for hair:blood 
additionally controlled for urine Hg to account for the inorganic fraction of exposure.  All 
urine Hg levels were first adjusted to average specific gravity to reduce variability in the 
reported analyses (Mason and Calder, 1994). Table 5.5 reports parameter estimates of the 
base multivariate models before addition of genotype.  
 Eight SNPs displayed near significant (0.05<p<0.1) parameter estimates for 
simple and/or multivariate regression models of Hg biomarkers or biomarker ratios, 
though only one SNP (SEPP1, rs7579) attained statistical significance in the multivariate 
urine Hg model (β= -0.14 ug/L change to ln(urine Hg) per minor allele, p=0.03). Apart 
from the relationship between rs7579 and urine Hg, no SNP significantly influenced Hg 
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biomarker levels. Furthermore, the borderline significant (0.05<p<0.1) relationships 
observed between SNPs and biomarker levels did not replicate in both simple and 
multivariate models with two exceptions: the aforementioned SEPP1 (rs7579) with urine 
Hg and GSTP1 (rs1695) with blood:urine. GSTP1 rs1695 trended towards a negative 
relationship between minor alleles and blood:urine in simple (β=-0.11, p=0.08) and 
multivariate (β=-0.1, p=0.099) linear regression models. No polymorphism-Hg biomarker 
relationship was significant after correcting for multiple testing.   
 
3.4 Discussion 
This study reports Hg biomarker levels (hair, blood, urine) and genotype 
frequency of 17 SNPs in key antioxidant and detoxification genes of the glutathione and 
selenoprotein families in mothers (n=355) and children (n=369) from the ELEMENT 
cohort.  To our knowledge, this is the first Hg biomarker assessment performed in a 
cohort representing the general Mexican population and the first to report genotype 
frequencies for 17 SNPs in a population residing in Mexico. Furthermore, we explored 
the relationship between Hg biomarkers and SNPs and found one significant relationship 
between the minor allele of SEPP1 rs7579 and decreasing urine Hg levels, though due to 
multiple testing this association could have occurred by chance alone.  
Mothers and children living in Mexico City have higher Hg levels in hair, blood, 
and urine biomarkers than that of similarly aged subgroups of the U.S. population 
(comparing medians) according to NHANES (National Health and Nutrition Examination 
Survey). These differences are the most substantial when comparing Mexican and 
American children‟s hair and blood Hg levels, especially among 6-11 year old children. 
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Hair Hg levels of Mexican mothers are approximately two-fold higher than that of 
American women of child-bearing age (medians 0.39 vs. 0.19 µg/g; McDowell et al., 
2004). ELEMENT children‟s hair Hg levels are three times greater than U.S. children 
aged 1-5 years (medians 0.38 vs. 0.11 µg/g; McDowell et al., 2004). While this 
difference may be partially due to exposure (e.g., fish consumption) and toxicokinetic 
differences existing between the age groups, comparison of blood Hg levels between 
ELEMENT and NHANES children of similar age suggest that Mexican children may 
have greater exposure (Caldwell et al., 2009). Blood Hg differences are the most 
pronounced when comparing younger (6-11 years) Mexican and American children 
(medians 1.36 vs. 0.40 µg/L) as opposed to Mexican (13-15 years) and American (12-19 
years) adolescents (1.14 vs. 0.50 µg/L). Since hair and blood Hg are typically biomarkers 
of methylmercury exposure (Berglund et al., 2005; Clarkson et al., 2007), this data 
suggests that ELEMENT children may have greater exposure to methylmercury 
compared to their American counterparts. Variation is also observed, albeit to a lesser 
extent, among urine Hg levels from the two populations, signifying the presence of 
elemental or inorganic Hg exposures among Mexican children (ELEMENT median: 6-11 
year olds- 0.53 μg/L, 13-15 year olds- 0.44 μg/L vs. NHANES median: 6-11 year olds- 
0.19 µg/L, 12-19 year olds- 0.32 µg/L; ATSDR and CDC, 2009).   
 This is the first cohort study, to our knowledge, to quantify Hg biomarker levels 
in a general Mexican population. Previous studies assessing methylmercury exposure in 
Mexico focused on populations with heavy fish consumption living near bodies of water. 
In these highly exposed populations, 58% (Guentzel et al., 2007) and 26% (Trasande et 
al., 2010) had hair Hg greater than 1 µg/g compared to approximately 10% of ELEMENT 
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mothers and children. While information on fish consumption patterns was not available 
for the ELEMENT cohort, national fish consumption surveys in Mexico reveal a majority 
of the population (85%) to consume fish with 35% consuming fish at least once per week 
(Soto-Jiménez et al., 2010). While fish intake estimates in Mexico imply much lower 
consumption compared with many other regions of the world, Hg levels in popular fish 
species are particularly elevated in certain regions of Mexico (Ruelas-Inzunza et al., 
2011a, 2011b; Soto-Jiménez et al., 2010; Trasande et al., 2010). For example, 65-90% of 
fish species collected in the Southern Gulf of California coast had Hg levels exceeding 
regulatory standards set by the WHO, the US or Mexican governments (Soto-Jiménez et 
al., 2010). Thus, fish consumption of contaminated species may underlie the hair and 
blood Hg levels observed here.  
 Previous studies analyzing elemental or inorganic Hg exposures in Mexico using 
urine as a biomarker focused on populations living or working near contaminated regions 
such as former Hg mining sites or hazardous waste landfills (Costilla-Salazar et al., 2011; 
Díaz-Barriga et al., 1993). To our knowledge, this is the first study to quantify urine Hg 
levels in Mexican children from the general population. While not reaching levels of 
concern, urine Hg in Mexican children was slightly higher than that of American children 
(ATSDR and CDC, 2009). Information on exposures from dental amalgams and other 
inorganic Hg sources was not available for this cohort. Dental caries are prevalent among 
Mexican children (>75%), especially in families with lower SES and/or less parental 
education (Casanova-Rosado et al., 2005; Medina-Solis et al., 2009). A large proportion 
of the children may therefore be exposed to elemental Hg via dental amalgams. However, 
while SES is negatively associated with preventative dental care, it is also negatively 
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associated with curative care, and as such children with low SES may have fewer Hg-
containing dental amalgams compared with the wealthy (Medina-Solis et al., 2009).  
 The hair:blood is used in risk assessment to extrapolate blood Hg levels from hair 
Hg and vice versa. Calculations of important parameters such as the reference dose for 
daily methylmercury intake often use a widely accepted hair:blood average of 250 (NRC, 
2000) even though variability in this ratio has been observed on both population and 
individual levels. This variability depends on many factors including age, Hg exposure 
level, and genetic factors (Berglund et al., 2005; Budtz-Jørgensen et al., 2004). Younger 
ELEMENT children (ages 6-11 years) had a significantly higher hair:blood median 
compared to older children (315 vs. 273). This difference is consistent with a Faroe 
Islands study that found median hair:blood of 369 and 248 for 7 and 14 year olds, 
respectively (Budtz-Jørgensen et al., 2004), and suggests that young children may 
incorporate Hg into the hair at dissimilar rates compared to adolescents and adults as 
observed with other metals such as aluminum and selenium (Paschal et al., 1989). The 
blood:urine is less well studied, and here we found Hg levels in blood to be 2.63 times 
more concentrated than in urine (Table 3.3), and the ratio was not dependent on age. The 
blood:urine may fluctuate based on the extent of inorganic Hg exposure, and this is 
reflected in the variability of the blood:urine.  
 We assess the association of seventeen SNPs in glutathione synthesizing (n=2), 
GST (n=10), and selenoprotein (n=5) genes with hair, blood, and urine Hg biomarker 
levels, hair:blood and blood:urine in the ELEMENT cohort. Two SNPs (GCLC 
rs17883901, GCLM rs41303970) had not been previously genotyped in a population with 
Mexican ancestry. Minor allele frequencies (MAFs) of many of the remaining SNPs were 
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similar to MAFs in a HapMap population (MXL) of individuals with Mexican ancestry 
living in Los Angeles, California (e.g., GSTP1 rs1695, SEPP1 rs7579) while MAFs of 
other SNPs differed (e.g., GSTP1 rs6591256, rs1138272). Divergent MAFs are not 
surprising as MXL members and residents of Mexico City could have dissimilar 
proportions of European, Native American and African ancestry as observed in other 
Latino populations in Mexico and Columbia (Florez et al., 2009; Martinez-Fierro et al., 
2009; Martinez-Marignac et al., 2007).     
Genetic polymorphisms in GSTs and glutathione synthesizing genes may impact 
metabolism and elimination of methylmercury (Custodio et al., 2004; Engström et al., 
2008; Gundacker et al., 2009) and inorganic Hg (Custodio et al., 2005) according to 
previous studies including our work with the Michigan Dental Association (MDA) cohort 
(see Chapter 2). A SNP in the regulatory 3‟ untranslated region (UTR) of selenoprotein p 
1 (SEPP1) additionally associated with hair and urine Hg biomarker levels with respect 
to known exposure in the MDA cohort. Exploration of the relationships between 17 SNPs 
and 6 Hg biomarker variables in the ELEMENT cohort was limited by the lack of 
available exposure data (e.g., fish consumption frequency, number of dental amalgams). 
As such, analyses were restricted to simple linear regression models testing the additive 
impact of variant alleles on each Hg biomarker or biomarker ratio (Table 3.6). 
Multivariate regression models additionally adjusted for mother‟s education- an indicator 
of socioeconomic status (SES), BMI, gender, and age. Higher SES could be linked to fish 
consumption and subsequently higher hair and blood Hg levels as observed in other 
populations (Hightower and Moore, 2003) and supported by bivariate analyses revealing 
a significant positive correlation between mother‟s education and children‟s hair Hg, 
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blood Hg, and mother‟s hair Hg (Table 3.4). Furthermore, controlling for SES may 
partially account for confounding effects of ancestry as SES has been inversely 
associated with proportion of Native American ancestry in other Latino populations 
(Florez et al., 2009).  
A solitary SNP- rs7579 in SEPP1- attained statistical significance (p<0.05) in the 
multivariate model for urine Hg (Table 3.6). Given the number of independent models 
tested (>100) and the observed p-value (0.03 for multivariate model with rs7579), such a 
result could be obtained by chance alone. Even so, experimental findings exist in support 
of the possibility that SEPP1 could influence Hg body burden. SEPP1 is a unique protein 
that contains multiple selenocysteine residues which are able to bind both methylmercury 
and inorganic Hg-selenium conjugates (Khan and Wang, 2009). Interestingly, SNP 
rs7579 resides in the 3‟UTR, a regulatory region crucial for selenocysteine incorporation, 
and this SNP is positively associated with SEPP1 expression and increased proportion of 
the 60 kDa isoform, the isoform with the most selenocysteine residues, specifically 
among individuals receiving selenium supplementation (Méplan et al., 2007, 2009). In 
the MDA cohort, the T allele of rs7579 was significantly associated with lower urine Hg. 
However, incorporation of exposure data revealed a significant interaction between T 
alleles and number of dental amalgams among MDA subjects. At higher exposure levels, 
rs7579 T was associated with higher urine Hg levels even though the opposite was 
observed at lower exposures (see Table 2.4, Figure 6.2). While the exposure-SNP 
interaction could not be assessed in the ELEMENT population, a similar main effect of 
rs7579 was observed with decreasing children‟s urine Hg levels and the T allele. 
Therefore, this SNP should be considered in future work on genetic factors and Hg 
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toxicokinetics. Presently, the nominally significant associations between SEPP1 rs7579 T 
and decreased urine Hg in the ELEMENT and MDA cohorts should be merely 
considered trends as neither remains statistically significant after correction for multiple 
testing.  
 The explanation for the paucity of significant SNP-Hg biomarker associations in 
the ELEMENT cohort may be multifaceted. While some studies have found nominally 
significant associations between unadjusted mean or median biomarker levels and SNPs 
(Gundacker et al., 2009; Chapter 2, this dissertation), most significant relationships with 
Hg biomarkers involved interactions between SNPs and exposure sources (Custodio et 
al., 2004; Engström et al., 2008; Gundacker et al., 2009). SNPs genotyped in the 
ELEMENT cohort were selected for their involvement in Hg distribution, metabolism 
and elimination. Therefore, influence of SNPs on Hg biomarker levels would depend on 
the dose of methylmercury or elemental/inorganic Hg exposure from sources such as fish 
consumption and dental amalgams, respectively. Exposure source-SNP interactions were 
not computable in this cohort. Consequently, we tested merely for detectable changes in 
mean biomarker Hg levels, with and without adjustment for age, BMI, education, and 
gender. Significant modification by SNPs genotyped here on Hg uptake and distribution 
to hair, blood, or urine following exposures to methylmercury or elemental Hg could not 
be examined.  
In addition to the lack of exposure source data, overall power to detect significant 
associations was limited by sample size (smallest sample size of 254 in mothers‟ hair Hg 
model with GSTM3 rs1332018) and minor allele frequency in some models (MAF<10% 
for GCLC rs17883901, GCLM rs41303970; GSTP1 rs1138272, GSTO1 rs11509438, 
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GSTM1 rs1065411, SEPP1 rs3877899). Many genotyped SNPs including GSTP1 rs1695 
and rs1138272 (Hu et al., 1997; Chapter 5, this dissertation), SEPP1 rs7579 and 
rs3877899 (Méplan et al., 2009), and GPX4 rs713041 (Méplan et al., 2008) were 
evaluated due to previous research relating these SNPs to changes in protein function or 
gene expression. However, some SNPs (e.g., GSTP1 rs749174, GPX2 rs4902346) are tag 
SNPs, and their impact on gene expression or protein function could be nonexistent or 
might be dependent on another SNP in linkage disequilibrium. Future gene-Hg work 
incorporating tag SNPs may benefit from analyzing haplotypes instead of single SNPs 
(Lake et al., 2003).  
 The limited significance of SNP-Hg relationships observed in this study may be 
further reduced by absence of Hg exposure source data, confounding inherent in studies 
of admixed populations, the limited cross-sectional study design, or errors associated 
with multiple testing. Out of all SNP-Hg biomarker combinations tested, only one SNP 
(SEPP1 rs7579) significantly associated with a biomarker (urine Hg). We cannot rule out 
the possibility that this association occurred by chance or was due to widely different Hg 
exposure levels between SEPP1 genotype groups in this cohort.  
In recently admixed populations such as the Mexican population, ancestry 
proportion (Native American vs. European vs. African) can confound gene-environment 
relationships due to influential SNPs in linkage disequilibrium with the SNP of interest 
and/or disproportionate exposure to toxicants related to race (Gee and Payne-Sturges, 
2004). While we did not perform admixture mapping with ancestry-informative markers 
in this cohort, we controlled for mothers‟ education as SES is often associated with 
percent ancestry (Florez et al., 2009) and toxicant exposure levels. While controlling for 
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SES may partially account for percent ancestry and its potential relationship with 
exposure levels, SES was not significantly correlated with the only biomarker (urine Hg) 
associated with a SNP (SEPP1 rs7579). In the event that SEPP1 rs7579 T was found 
more frequently among individuals of a given race (e.g., Caucasian) and Mexicans with 
higher percent Caucasian ancestry had lower exposure to elemental Hg and/or higher 
prevalence of other SNPs influencing quicker urinary Hg elimination compared with 
Mexicans with predominantly Native American or African descent, rs7579 T would 
appear associated with decreased urine Hg due to these confounding factors. We did not 
fully adjust for percent admixture (merely for SES) and cannot rule out the possibility 
that the relationship between SEPP1 genotype and urine Hg is a spurious association 
brought on by confounding from population stratification.    
The aforementioned limitations negate our ability to provide conclusive evidence 
about the SEPP1 rs7579 SNP and its impact on urine Hg levels and/or inorganic Hg 
metabolism and elimination. Nevertheless, the known impact of this SNP on gene 
expression and isoform prevalence (Méplan et al., 2009) and the similar finding in our 
Michigan Dental Association cohort (see Chapter 2) make rs7579 an intriguing SNP 
worthy of future study pertaining to Hg toxicokinetics.         
Despite several study limitations, this study contributes to Hg exposure 
assessment, and genomics pertaining to a Mexican population. This is the first study, to 
our knowledge, to analyze Hg levels in Mexican mothers and children from a general 
urban population. Furthermore, we report genotype frequencies of SNPs in genes crucial 
to both antioxidant defense and metabolism and elimination of toxicants including Hg in 
a population living in Mexico. Since no outstanding associations between Hg biomarkers 
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and SNPs were observed, the need to assess SNP-exposure source interactions in future 
work is evident.    
 
  
 
 
 
  
  
 
Table 3.1 SNPs Genotyped in ELEMENT Cohort. Descriptions of 17 SNPs genotyped in mother-child pairs (n=355 mothers, 369 
children) compared with reference population with Mexican ancestry. Several SNPs were selected due to known impacts on gene 
expression, protein structure, or enzyme activity summarized in the table (with references). SNPs without listed functional impacts 
were selected as tag SNPs.  
 
 
Gene  dbSNP ID Alleles SNP Details 
MAF
a
, 
ELEMENT 
MAF
b
, 
MXL ref. 
Functional 
Impact
e Reference 
G
S
H
 
S
y
n
th
. 
 GCLC rs17883901 G>A 5‟ near gene 0.04 N/A 
A ↓ promoter 
activity 
Koide et al. 2003 
GCLM rs41303970 C>T 5‟ near gene 0.08 N/A 
T ↓ promoter 
activity 
Nakamura et al. 2002 
G
lu
ta
th
io
n
e 
S
-T
ra
n
sf
er
a
se
 GSTP1 rs1695 G>A Missense (Val105Ile) 0.45 0.45 Val ↓ activity Ali-Osman et al. 1997 
GSTP1 rs749174 C>T Intron 0.13 0.24   
GSTP1 rs1138272 C>T Missense (Ala114Val) 0.01 0.08 Val ↓ activity? Ali-Osman et al. 1997 
GSTP1 rs6591256 A>G 5‟ near gene 0.16 0.31   
GSTP1 rs947895 C>A 3‟ near gene 0.13 0.24   
GSTO1 rs4925 C>A Missense (Ala140Asp) 0.16 0.19 Asp ↓ activity Tanaka-Kagawa et al. 2003 
GSTO1 rs11509438 G>A Missense (Glu208Lys) 0.003 0.02   
GSTM1 rs1065411 C>G Missense(Lys173Asn) 0.04 0.49
c 
Lys ↓ [GSTM1] Moyer et al. 2007 
GSTM3 rs1332018 G>T 5‟ UTR 0.34 0.37   
GSTM3 rs7483 G>A Missense (Val224Ile) 0.47 0.37 Val ↓ activity Tetlow et al. 2004 
S
el
en
o
p
ro
te
in
 SEPP1 rs3877899 C>T Missense (Ala234Thr) 0.09 0.11 Thr ↓60 kDa Méplan et al. 2009 
SEPP1 rs7579 C>T 3‟ UTR 0.43 0.43 
C ↓ [SEPP1], ↓ 
60 kDa 
Méplan et al. 2007, 2009 
GPX4 rs713041 C>T 3‟ UTR 0.29 0.37 T ↓ [GPX4] Méplan et al. 2008 
GPX2 rs4902346 A>G Intron 0.21 0.19
d
   
GPX2 rs2737844 C>T Intron 0.4 0.4   
 
8
0
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a
 MAF= minor allele frequency 
b
 MXL is a HapMap population consisting of individuals of Mexican ancestry living in 
Los Angeles, CA 
c
 Data not available for HapMap MXL. MAF from Mexican Americans in Moyer et al. 
(2007; rs1065411) or Environmental Genome Project, Hispanic population (rs4902346).  
d
 The allele associated with the „detrimental‟ effect is listed followed by a brief 
description. Activity refers to enzymatic activity unless otherwise specified. [Protein 
name] refers to protein concentration, and 60 kDa is an isoform of SEPP1 with the most 
selenocysteine residues.  
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Table 3.2 Characteristics of Mother-Child Pairs of the ELEMENT Cohort.  
 
  
Children Age Stratified Children Mothers 
  
(n=368)
a 
6-11 years 
(n=212) 
13 -15 years 
(n=156) (n=353) 
% Female 46.3 48.6 43.3 100 
Age (years) 11.1 (2.4) 9.1 (1.0) 13.7 (0.6)
d
 36.0 (5.8) 
BMI (kg/m
2
) 20.4 (4.1) 19.0 (3.5) 22.3 (4.2)
d
 28.3 (5.1) 
BMI (percentile)
b
 67.5 (27.9) 67.7 (27.8) 67.3 (28.0) 
 
Education (years)
c
 10.3 (3.1) 10.8 (3.0) 9.5 (3.1)
d
 10.3 (2.9) 
 
a
 Children and mothers with genotype data included here. Some subjects do not have all 
of the demographic data (n=340 children and 329 mothers with education; n=331 
mothers with age).  
b
 BMI percentile compares child‟s BMI to the distribution of same age and gender U.S. 
children.  
c
 Mothers‟ education. 
d 
p<0.001 for ANOVA comparing two age-stratified groups.   
  
Table 3.3 Mercury Biomarker Levels and Ratios of A) All ELEMENT Samples and B) Children Stratified by Age.   
 
 A Biomarker N Mean SD 25th% 50th% 75th% 90th% 95th% 
Children Blood Hg (μg/L) 320 1.69 1.34 0.8 1.28 2.21 3.21 4.44 
Hair Hg (μg/g) 345 0.49 0.44 0.22 0.38 0.63 0.93 1.31 
Urine Hg (μg/L) 346 0.78 1.01 0.28 0.48 0.82 1.75 2.44 
Hair:Blood 304 324 151 218 299 406 518 597 
Blood:Urine 303 3.69 3.31 1.55 2.63 4.93 8.33 10.7 
Mothers Hair Hg (μg/g) 302 0.53 0.47 0.23 0.39 0.7 1.02 1.3 
 
B Biomarker n Mean SD 25th% 50th% 75th% 90th% 95th% 
6-11 yrs Blood Hg (μg/L) 188 1.80 1.42 0.79 1.36 2.39 3.48 4.62 
13-15 yrs  132 1.53
a 
1.22 0.80 1.14 1.81 2.97 4.42 
6-11 yrs Hair Hg (μg/g) 198 0.55 0.49 0.22 0.44 0.77 1.05 1.35 
13-15 yrs  147 0.42
b 
0.35 0.22 0.33
c 
0.52 0.77 0.92 
6-11 yrs Urine Hg (μg/L) 203 0.87 1.13 0.30 0.53 0.98 1.85 2.76 
13-15 yrs  143 0.65
a 
0.80 0.24 0.44 0.73 1.16 1.92 
6-11 yrs Hair:Blood 180 335 153 226 315 409 561 645 
13-15 yrs  124 309 147 207 273
c 
393 504 565 
6-11 yrs Blood:Urine 184 3.64 3.38 1.50 2.49 4.82 7.28 10.7 
13-15 yrs  119 3.77 3.23 1.58 2.68 5.23 9.01 10.7 
 
a,b
 p<0.05, p<0.01 ANOVA comparing natural-log transformed biomarker across two age groups. 
c
 p<0.05 for Median test comparing biomarker medians across two age groups.  
  
8
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Table 3.4 Correlations Between Hg Biomarkers and Demographic Variables. 
Pearson correlation coefficients are reported. All biomarker variables were natural log-
transformed before analysis, and urine Hg was adjusted to the mean specific gravity 
(1.017).  Biomarkers are children‟s unless otherwise indicated. 
 
 
Blood Hg Hair Hg Urine Hg Hair:Blood Blood:Urine 
BMI, percentile -0.01 -0.09 -0.06 -0.10 0.05 
Age -0.15
b
 -0.17
b
 -0.13
a
 -0.04 0.02 
Education 0.13
a
 0.15
b
 0.06 0.01 0.07 
Mother’s Hair Hg 0.37
c
 0.47
c
 0.19
b
 0.1 0.17
a
 
Blood Hg 1 0.77
c
 0.47
c
 -0.27
c
 0.45
c
 
Hair Hg  1 0.37
c
 0.40
c
 0.30
c
 
Urine Hg   1 -0.08 -0.58
c
 
Hair:blood   
 
1 -0.18
b
 
  
a,b,c 
Denote p-value: p<0.05, p<0.01 and p<0.001, for correlation.  
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Table 3.5 Base Models for Hg Biomarkers. Parameter estimates are reported from 
multivariate linear regression before addition of genotype. P-value is indicated by: 
*p<0.05, †p<0.01. All biomarker dependent variables are first natural-log transformed 
and urine is adjusted to mean specific gravity. Biomarkers are for children unless 
otherwise indicated. 
 
Dependent 
Variable Adj. r
2 
n Age Gender BMI
a 
Mother's 
Education 
Urine 
Hg
b 
Blood Hg 0.02 295 -0.04* 0.06 0 0.02   
Hair Hg 0.04 316 -0.05* 0.03 -0.003 0.03* 
 Urine Hg 0.01 317 -0.03 0.14 -0.002 0.01 
 Hair:Blood 0.03 265 -0.01 -0.04 -0.002 0.002 -0.12† 
Blood:Urine 0 279 0.01 -0.08 0.001 0.02 
 Mother's Hair Hg 0.04 277 0.03†   -0.007  0.04*   
 
a
 In children‟s models, BMI is a percentile based on U.S. children of the same age and 
gender. BMI is not transformed (kg/m
2) in mothers‟ models.   
b
 Hair:blood model contains urine Hg (specific gravity adjusted) to control for inorganic 
Hg exposure. 
  
Table 3.6 Linear Regression Modeling of Hg Biomarker: Influence of Genotype. Biomarker variables are natural-log transformed 
and from the children unless otherwise indicated. Urine Hg is adjusted for mean specific gravity. Beta coefficients for genotype with 
p<0.10 are reported and one significant coefficient (p<0.05) is shaded. 
 
  
Simple Linear Model
a 
Multivariate Model
a,b
 
Gene dbSNP ID B
lo
o
d
 
H
a
ir
 
M
o
th
er
's
  
H
a
ir
 
U
ri
n
e 
H
a
ir
:B
lo
o
d
 
B
lo
o
d
:U
ri
n
e 
B
lo
o
d
 
H
a
ir
 
M
o
th
er
's
  
H
a
ir
 
U
ri
n
e 
H
a
ir
:B
lo
o
d
c 
B
lo
o
d
:U
ri
n
e 
GCLC rs17883901 
      
  
 
-0.28 
  
  
GCLM rs41303970 
      
  
    
  
GSTP1 rs1695 
     
-0.11   
    
-0.10 
GSTP1 rs749174 
 
0.17 
    
  
    
  
GSTP1 rs1138272 
      
  
    
  
GSTP1 rs6591256 
      
  
    
  
GSTP1 rs947895 
 
0.16 
    
  
 
-0.19 
  
  
GSTO1 rs4925 
      
  
    
  
GSTO1 rs11509438 
      
  
    
  
GSTM1 rs1065411 
      
  
    
  
GSTM3 rs1332018 
      
  
    
  
GSTM3 rs7483 
      
  
    
  
SEPP1 rs3877899 
    
-0.12 0.20   
    
  
SEPP1 rs7579 
   
-0.10 
  
  
  
-0.14 
 
  
GPX4 rs713041 
      
  
 
-0.15 
  
  
GPX2 rs4902346 
  
-0.14 
   
  
    
  
GPX2 rs2737844 
      
  
    
  
8
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a 
Number of subjects in simple regression models range from 254 to 345 and sample size 
in multivariate models range from 233 to 317. Mothers‟ hair models have the least 
subjects and children‟s hair models have the most subjects. GSTM3 (rs7483) genotype 
models have the smallest sample size.   
b
 Models adjusted for age, BMI (percentile for children or kg/m
2
 for mothers), gender, 
and mother‟s education. 
c
 Hair:blood multivariate model additionally adjusted for urine Hg levels (non-
transformed but specific gravity adjusted) to control for inorganic Hg exposure.  
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Chapter 4 
Methylmercury and Elemental Mercury Differentially Associate with Blood 
Pressure among Dental Professionals
2
 
 
4.1 Introduction 
 Mercury is ranked a top three priority pollutant by the U.S. Environmental 
Protection Agency (EPA; US EPA, 1997) and the Centers for Disease Control (ATSDR, 
2007). The chemical speciation of mercury is complex and dictates its environmental 
fate, human exposure pathways, and toxic impacts (Clarkson and Magos, 2006).  The 
general population is largely exposed to methylmercury (MeHg
+
) through fish 
consumption and to elemental mercury (Hg
0
) through dental amalgams. Approximately 
6,600 tons of mercury is released into the atmosphere annually and concentrations 
continue to rise in many regions of the world (Swain et al., 2007). Accordingly, mercury 
will remain of public health concern for the foreseeable future. 
 Health concerns associated with methylmercury and elemental mercury exposure 
are primarily focused on the nervous system (Clarkson and Magos, 2006; US EPA, 
1997).  However, in recent years epidemiological studies have suggested a negative 
impact of methylmercury on the cardiovascular system.  Methylmercury exposure has 
been linked to acute myocardial infarction, and a US EPA-sponsored committee deemed 
                                                            
2 This chapter is currently (2011) under review for publication in Chemosphere.  Co-authors: J.M. Goodrich, Y. Wang, 
B. Gillespie, R. Werner, A. Franzblau, N. Basu.  
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the evidence compelling to include this outcome in its regulatory risk assessment of 
mercury (Roman et al., 2011). Though discrepancies exist, many studies have also found 
methylmercury-associated increases in diastolic (DBP) and systolic blood
 
pressure (SBP).  
In a study of 251 fish-consumers in the Brazilian Amazon, Fillion et al. (2006) found that 
participants with higher hair mercury, a biomarker for methylmercury exposure, had an 
increased risk of elevated SBP. In a study of 42 male Faroese whalers, Choi et al. (2009) 
found a positive association between blood total mercury levels, also reflective primarily 
of methylmercury exposure,
 
and both SBP and DBP.  In another study from the Faroe 
Islands, Sørensen et
 
al. (1999) found increased SBP and DBP in 7-year-old children in 
relation to prenatal methylmercury exposure, though this association was not observed 
when children were re-evaluated at 14
 
years old (Grandjean et al., 2004). Likewise, 
Valera et al. (2009) found a positive association with blood mercury and SBP in an Inuit 
population.  From the 1999-2000 US National Health and Nutrition Examination Survey 
(NHANES), Vupputuri et al. (2005) found a negative association between blood total 
mercury and SBP but only in women that did not consume fish.  
 The notion that methylmercury may be associated with increased risk of 
hypertension poses several health dilemmas.  Hypertension may affect one billion people 
worldwide (including 65 million in the US) and rates continue to rise (Egan et al., 2010; 
Lawes et al., 2008).  Methylmercury is mainly derived from fish consumption, but fish 
are promoted as an excellent source of nutrients (e.g. omega-3 fatty acids) and protein.  
Scientific reviews have concluded that the heart-protective benefits of fish consumption 
outweigh health risks (Mozaffarian and Rimm, 2006), but when faced with the decision 
many consumers chose to avoid consuming fish (Oken et al., 2003).   
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 In addition to methylmercury exposure, the general public is also exposed to 
elemental mercury largely through dental amalgams. Though several animal studies have 
documented that elemental mercury may decrease myocardial mechanical activity, 
depress heart rate, promote heart arrhythmias, and cause hypotension (Massaroni et al., 
1995; Rhee and Choi, 1989; Rossoni et al., 1999), to our knowledge these relationships 
have not been investigated in an epidemiological study.   
 Hypertension is a multifactorial health trait influenced by environmental and 
genetic factors, many of which remain undiscovered. Genome wide association studies in 
several populations have linked potential single nucleotide polymorphisms (SNPs), 
primarily in genes involved in some aspect of cardiovascular function or regulation, to 
increased blood pressure. However, results are inconsistent across studies, and the 
associated SNPs explain only a fraction (<5%) of blood pressure variability (Adeyemo et 
al., 2009; Levy et al., 2007; for review: Kraja et al., 2011). Oxidative stress is a potential 
mechanism underlying hypertension, and several studies have linked polymorphisms in 
antioxidant enzymes to hypertension (Bessa et al., 2009; Mansego et al., 2011). Recent 
evidence suggests that polymorphisms in antioxidant genes of the glutathione pathway 
may modify metabolism and elimination of methylmercury (Custodio et al., 2004; 
Engström et al., 2008; Gundacker et al., 2007, 2009) and elemental mercury exposure 
(Custodio et al., 2005) as assessed with common biomarkers. Gene-environment 
interactions influencing hypertension are not well studied, and may contribute to the 
onset of this prevalent disease state. Polymorphisms in glutathione pathway genes and 
selenoproteins, two antioxidant gene classes that are involved in the toxicokinetics of 
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mercury, may interact with methylmercury or elemental mercury to modify the toxicants‟ 
impact on blood pressure.       
The goal of this study was to increase understanding of the association between 
mercury exposure (both methylmercury and elemental mercury) and blood pressure in a 
cohort of dental professionals and the modifying effect of polymorphisms in mercury 
metabolizing genes on these relationships. This work extends upon previous studies that 
focused solely on methylmercury exposure by also considering exposures to elemental 
mercury and gene-environment interactions.  Further, mercury exposures in this study are 
more relevant to the general population than the aforementioned studies focused on 
susceptible groups (e.g., indigenous peoples, fish-consumers) with moderate to high 
methylmercury intakes.    
 
4.2 Materials and Methods 
4.2.1 Study Population 
 A convenience sample of 284 dental professionals (dentists, hygienists, dental 
assistants) was recruited during the 2010 Michigan Dental Association (MDA) Annual 
Convention as part of a larger cohort designed to study the influence of genetic variability 
on mercury body burden.  Institutional Review Board (IRB) approval for this work was 
obtained from the University of Michigan (HUM00027621). A self-administered survey 
was used to collect information on demographics (e.g., age, height), occupational 
practices, medical history, and alcohol consumption. Subjects also provided detailed 
information on fish consumption patterns (e.g., portion size, frequency of consumption, 
fish species) which was used to calculate a mercury intake value (μg mercury/kg body 
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weight/day) based on the most recent mercury levels measured in common fish species in 
the US (Bahnick et al., 1994; Mierzykowski et al., 2001; US FDA). Total polyunsaturated 
fatty acid (PUFA; mg/kg body weight/day) and selenium (μg/kg body weight/day) intake 
values from fish consumption were also calculated using the US Department of 
Agriculture Nutrient Database. Subjects reported the number of mercury-containing 
dental amalgams in their own mouths along with the average number per week that they 
remove and place in their dental practice (amalgams handled). Subjects with missing data 
points (e.g., urine mercury, SBP, age) were excluded. Four additional subjects reporting 
kidney disease were excluded due to the potential effects on mercury excretion, resulting 
in a sample size of 262.  
 
4.2.2 Mercury Exposure Assessment 
 Urine is used to assess elemental mercury exposure and hair is used to assess 
methylmercury exposure (Berglund et al., 2005; Clarkson and Magos, 2006).  From each 
participant, spot urine samples (~30-50mL) were collected and stored frozen.  Hair was 
collected by cutting 20-50 strands from the occipital region of the head as close to the 
scalp as possible, wrapping in paper, and then storing at room temperature. 
Total mercury levels were measured using a direct mercury analyzer (DMA-80, 
Milestone Inc., CT) according to US EPA Method 7473.  Briefly, 800 μL of urine or 4-9 
mg of hair from the two cm closest to the scalp were analyzed according to methods we 
have previously described (Basu et al., 2010; Paruchuri et al., 2010).  In every batch of 
10-15 samples, one blank, one replicate sample, and a certified reference material (hair: 
NIES Japan CRM #13; urine: Institut National de Sante Publique Quebec standard 
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QMEQAS08U-01; dogfish liver: DOLT4, National Research Council Canada) were 
included. Specific gravity was measured using a refractometer (PAL-10S, Atago U.S.A., 
Inc., WA). Urine mercury levels were adjusted to reflect the average specific gravity in 
all samples (1.017) according to the method of Levine and Fahy (1945) as this has been 
shown to reduce variability in metal analysis of spot urine samples (Lee et al., 1996; 
Mason and Calder, 1994). All final values reported here are unadjusted.    
 The average theoretical method detection limit (3x standard deviation of blanks) 
was 0.003 µg/g mercury for hair and 0.014 µg/L mercury for urine.  The average 
recovery of mercury was 88.9±1.1% for the hair CRM, 71.5±3.9% for the urine CRM, 
and 91.8±6.6% for DOLT4.  The mercury value in the urine CRM has a range of 
expected values, and our percent recovery was judged according to the reported mean.  
Machine accuracy is deemed high given that recovery of other reference materials (e.g., 
DOLT4) measured alongside the urine CRM had excellent recovery (>90%). Within-day 
(0.7% for hair, 4.2% for urine, 2.8% for DOLT4) and between day (1.0% for hair, 5.4% 
for urine, 6.1% for DOLT4) variability of CRMs were calculated, and these values 
corresponded well to replicate analysis of actual samples provided by participants (data 
not shown).   
 
4.2.3 Blood Pressure and Pulse Assessment 
 Participants were seated for at least five minutes before blood pressure was 
measured.  A commercially available blood pressure device (Omron HEM 432-C) was 
placed over the right brachial artery and used to measure SBP, DBP, and pulse. From 
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each participant, three readings were averaged. Variability within replicates of 
individuals averaged 4.2% (SBP), 4.8% (DBP), and 3.3% (pulse).  
 
4.2.4 Genotype Analysis 
The majority of subjects provided buccal cell samples that were subsequently 
stored at room temperature in buffer described by Min et al. (2006). SV Wizard Genomic 
DNA purification kits (Promega Corporation, Madison, WI) and PicoGreen reagent 
(Invitrogen, Eugene, OR) were used to purify and quantify DNA, respectively, from 
buccal samples. Ten SNPs in glutathione s-transferase (GST), glutathione synthesizing, 
and selenoprotein genes (rs1138272, rs1695, rs3877899, rs41303970, rs7579, rs5751901, 
rs7483, rs3761144, rs1002149, rs2911678) were genotyped using pre-designed Taqman 
Allelic Discrimination Assays (Applied Biosystems, Foster City, CA; Livak et al., 1995), 
and results were interpreted with an ABI 7700 (Carlsbad, CA). One deletion 
polymorphism in GST theta 1 (GSTT1) was additionally genotyped using the method of 
Mordukhovich et al. (2009). All polymorphisms were selected in genes of the mercury 
toxicokinetic pathway and were initially tested for association with mercury biomarker 
levels (see Chapter 2). Several polymorphisms are tag SNPs while others have known 
impacts on gene expression or enzyme function (summarized in Table 2.2). Genotype 
data resulted in three distinct groups (major homozygotes, heterozygotes, minor 
homozygotes) for the ten SNPs, and two groups (gene present or deleted) for the GSTT1 
polymorphism.  
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4.2.5 Statistical Analyses 
 All statistical operations were performed using PASW® Statistics Software (v. 
18; Chicago, IL).  Preliminary data analysis included tabulation of descriptive statistics 
for all measurements. Bivariate (Pearson correlations) and multivariate analyses were 
used to identify factors that influenced SBP and DBP. Blood pressure measurements of 
individuals using hypertension controlling medications were imputed 15 mmHg higher 
(SBP) and 10 mmHg higher (DBP) before linear regression as this has been shown to 
reduce bias and improve statistical power (Tobin et al., 2005). All bivariate and 
multivariate analyses were performed with adjusted and unadjusted SBP and DBP; 
analyses with the latter excluded subjects using anti-hypertensive medication (n=39).  
The backward elimination method was used to determine predictors of SBP and 
DBP (adjusted for medication use) with an initial cut-off significance value of p>0.10. 
Variables considered in the multivariate models were age, BMI, gender, race, occupation 
(dentist vs. non-dentist), alcohol (drinks/day), fish nutrients/toxicants (PUFA, selenium, 
mercury), personal amalgams, and occupational exposures (hours worked/week, 
categorical variable for number of amalgams handled/week). The final model for SBP 
included the only significant predictors (p<0.05): BMI, age, and gender. Significant 
predictors of DBP were BMI and age, though gender was also included in the final model 
to control for gender differences observed in our population. Hair and urine mercury 
(together and in separate models, with unadjusted or specific gravity adjusted urine 
mercury) were added into SBP and DBP base models to assess the association between 
mercury biomarkers and blood pressure after controlling for confounders. Multivariable 
linear regression models were run for the total population and for subgroups (males, 
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females, dentists, non-dentists). Potentially influential subjects were identified using 
statistical diagnostics (e.g. Cook‟s distance, dfbeta) on total population models, and 
removed individually to assess the impact of the subject on the relationships between 
mercury biomarkers and blood pressure.  
Genotype data was added into the final models for adjusted SBP and DBP with 
decreased sample size as not all subjects provided adequate DNA for successful 
genotyping (n=205 to 239 depending on the polymorphism). One ordinal variable per 
polymorphism, assuming additivity of variant alleles, was added into SBP or DBP 
models containing hair or urine mercury. An interaction term with the included mercury 
biomarker was also tested in each model.  
 
 4.3 Results   
4.3.1 Descriptive Statistics 
 Table 4.1 outlines demographics, cardiovascular parameters, and major sources of 
mercury exposure in study participants, and is stratified according to genotype (includes 
subjects successfully genotyped for the SEPP1 3‟UTR locus), gender, occupation 
(dentists versus non-dentists), and anti-hypertensive medication usage. Of all participants, 
38% were males and 44% were dentists. Overall, males were significantly older, had 
greater BMIs and alcohol consumption compared with females while also having higher 
blood pressure and lower pulse. Dentists, of which 80% are males, likewise had similar 
differences compared to non-dentists (dental hygienists, dental assistants and other 
professionals, of whom 94% were female). A significantly larger proportion of 
individuals taking blood pressure medication were males and dentists (χ2 test, p-value 
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<0.05, data not shown). The influence of race-ethnicity on blood pressure could not be 
adequately assessed in this population as 92% of the subjects identified as non-Hispanic 
and Caucasian. Not all individuals provided adequate DNA for successful genotyping of 
all polymorphisms, limiting genetic model sample sizes (n=205 to 239). ANOVA tests 
comparing demographic characteristics, blood pressure, and mercury biomarker levels for 
subjects with genotype (n=232) and those without (n=30) revealed no significant 
differences. 
  
4.3.2 Mercury Exposure Assessment 
Table 4.2 reports total mercury levels in hair and urine. In this population, 
estimated mercury intake from fish consumption was the best predictor of hair mercury 
levels in linear regression modeling, though personal dental amalgams contributed to a 
lesser extent. Occupation and amalgams (personal and handled in the dental practice) 
were the predictors of urine mercury levels (data not shown) indicating hair and urine as 
biomarkers of primarily methylmercury and elemental mercury, respectively, as others 
have previously established (Berglund et al., 2005; Clarkson and Magos, 2006) with 
some crossover in the hair biomarker. All subjects had mercury levels above the method 
detection limit. Mean hair mercury (±SD) was 0.45±0.53 μg/g (range: 0.02-5.18) and 
mean urine mercury was 0.94±0.99 μg/L (range: 0.03-5.54). While median hair and urine 
mercury values were 47% and 31% higher than U.S. population medians reported by 
NHANES (CDC, 2009; McDowell et al., 2004), there is considerable overlap of the 
distributions for both biomarkers between the dental cohort and NHANES (Table 4.2). 
Mean hair and urine mercury levels were significantly higher in males and dentists, the 
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latter of which correspond with greater occupational exposure to amalgams (ANOVA 
p<0.05).    
 
4.3.3 Genotype Data 
Minor allele frequencies of the polymorphisms were similar to that of Caucasian 
populations (HapMap, data not shown). Table 4.3 displays p-values from ANOVA tests 
comparing linear trends among unadjusted means of study parameters for each additional 
variant allele. Cardiovascular parameters and mercury biomarker levels were not 
significantly different among genotype groups for any of the eleven polymorphisms 
though the difference in DBP (adjusted for blood pressure medication use) among 
GSTM3-224 genotype groups was borderline significant (p=0.05) and may have occurred 
by chance alone due to multiple testing.    
 
4.3.4 Blood Pressure Measurement 
Seventy-three participants (28% of study population) displayed hypertension 
(SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg as defined by the US Department of Health 
and Human Services, 2004) and/or were using blood pressure medication at the time of 
measurement. Blood pressure measurements performed by us were in the hypertension 
range for 47 individuals (18%). When mercury exposures were related to blood pressure 
outcomes, several significant associations were found (p<0.05). Bivariate analyses 
estimated that SBP and DBP (adjusted for anti-hypertensive medication use) were 
significantly correlated with hair mercury levels (r=0.22, 0.19, respectively). There were 
no significant bivariate correlations between urine mercury and adjusted SBP (r=0.05) or 
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DBP (r=0.06). BMI and age were significantly positively correlated with adjusted SBP 
(r=0.33, 0.58) and DBP (r=0.38, 0.31)). Hair and urine biomarker measurements were 
also significantly correlated with one another (r=0.29).  
 
4.3.5 Blood Pressure and Mercury Biomarkers 
  Multivariate linear regression modeling of SBP and DBP was used to assess 
associations with urine or hair mercury levels after adjusting for BMI, age, and gender. 
Parameter estimates for total, gender stratified, and dentist only populations in models of 
SBP and DBP adjusted for hypertension-controlling medication use are reported in Table 
4.4. In the majority of models, BMI, age, and gender were significant predictors of these 
outcomes. There was a trend towards positive association of hair mercury with SBP and 
DBP in all models, though this association was only significant when modeling adjusted 
DBP (β=2.76 mmHg DBP increase per 1 ug/g Hg in hair).  Further, the parameter 
estimates were consistently larger in males versus females (e.g., hair Hg parameter 
estimate in DBP model: β=2.94 mmHg among males, 1.87 mmHg among females). 
Alcohol consumption (drinks/day) and dental amalgams were near significant predictors 
(p<0.10) of adjusted DBP. However, inclusion of these parameters in the DBP model did 
not change parameter estimates (significance, magnitude) of mercury biomarkers (data 
not shown).  
The urine mercury and blood pressure relationship differed from hair mercury 
results. Urine mercury levels were associated with decreased SBP (in total population 
model: β= -1.8 mmHg SBP per 1 ug/L Hg in urine), though this was only significant in 
models adjusting for anti-hypertensive medication use and appeared to be driven by the 
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males and the dentists. Urine mercury was not associated with DBP, though negative 
trends were also observed among males and dentists. Even though several model 
parameters were significantly correlated with one another (e.g. BMI and age, hair and 
urine mercury), multicollinearity is not expected to be problematic as variance inflation 
factors were less than 1.5 for all aforementioned regression models.   
The significance levels of parameter estimates for mercury biomarkers in blood 
pressure models were sensitive to several influential subjects discovered via standard 
diagnostic tests. The exclusion of one subject partially diminished the association 
between hair mercury and adjusted DBP (β=2.29 mmHg, p=0.07).  The magnitude and 
significance of the association between urine mercury and decreased SBP were slightly 
diminished when excluding several influential subjects, most of whom had urine mercury 
levels above the 95
th
 percentile (0.06<p<0.13 for new parameter estimates). Adjusting 
urine mercury for specific gravity altered its significance in the total population model of 
SBP (β= -1.71 mmHg, p=0.14), though adjusted urine mercury remained significant in 
models of SBP with males or dentists alone.  
 
4.3.6 Blood Pressure, Mercury Biomarkers, and Genetic Polymorphisms 
The impact of polymorphisms on blood pressure and their interaction with hair or 
urine mercury were examined in the linear regression models of adjusted SBP and DBP 
(Table 4.5 and 4.6, models with hair and urine mercury, respectively). In linear regression 
models with hair mercury, no gene-biomarker interaction terms or genetic main effects 
were significant (p<0.05), though several interaction terms were borderline significant 
(p<0.10), and these polymorphisms warrant further investigation in a larger sample 
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(SEPP1-234, GCLM 5‟, GSTT1 deletion). Likewise, genetic variables in SBP and DBP 
models including urine mercury failed to attain statistical significance apart from one 
main effect (GCLM 5‟, SBP model). Two interaction terms (GSTM3-224 and GSTT1 
deletion with urine mercury) were near significant (p<0.10). The observed nominally 
significant/near significant polymorphism-blood pressure relationships (main effect or 
interaction with mercury) could have occurred by chance alone given the number of tests 
(44 models).   
 
4.4 Discussion  
There are a growing number of studies documenting associations between 
methylmercury exposure and elevated blood pressure but discrepancies exist.  Despite the 
fact that our cohort was not initially designed to study cardiovascular effects of mercury 
exposure and lacks information on one important potential confounder- smoking status, 
our study contributes to data on mercury exposure and blood pressure in several ways. 
Here we report that exposures relevant to the general population to both elemental 
mercury and methylmercury may be associated with altered blood pressure measures, 
though the significance of these results is partially dependent on several subjects with 
higher exposure (>95
th 
percentile for biomarker levels). Interestingly, divergent blood 
pressure results were found for mercury type and may be influenced by gender.  Hair 
mercury levels were associated with increased DBP (after adjustment for anti-
hypertensive medication use according to the method of Tobin et al., 2005). For urine 
mercury, the results from linear regression models suggest that elemental mercury 
exposure is associated with decreased SBP in the total population, and this appears to be 
driven by the male subgroup. While Kobal et al. (2004) previously found an association 
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between extremely high past exposures to elemental mercury (>800 μg/L urinary 
mercury) and increased SBP, to our knowledge this is the first human study to investigate 
elemental mercury exposures relevant to the general population in relation to blood 
pressure. 
Previous studies have reported associations between methylmercury exposure 
biomarkers and increased blood pressure (Choi et al., 2009; Fillion et al., 2006; Sørensen 
et al., 1999; Valera et al., 2009), but these have largely been conducted in populations of 
subsistence fish and marine mammal consumers that experience moderate to high 
methylmercury exposures. Here, we find a similar trend between elevated blood pressure 
and hair mercury levels in a population that is exposed to methylmercury at 
concentrations that better reflect exposures of the general US population (McDowell et 
al., 2004) and other countries (Díez et al., 2008; Gundacker et al., 2007). As expected, the 
male gender, age, and BMI were significant predictors of increased SBP. Likewise, age 
and BMI predicted DBP in multivariate linear regression, factors which are often 
associated with increased risk for hypertension (Greenlund et al., 2009; Kim et al., 2007).  
In addition, we found a trend towards a methylmercury exposure dependent increase in 
SBP and DBP across all sub-groups in our study (e.g., males, females, dentists, excluding 
medication users), though this relationship only attained statistical significance in models 
of adjusted DBP and was partially dependent on one influential subject.  
 The prevalence of hypertension in our study population (28% of total had SBP ≥ 
140 mmHg, DBP ≥ 90 mmHg, and/or reported using anti-hypertensive medication) is 
similar to the US average of 28.9% which continues to increase (Cutler et al., 2008). The 
fact that we found a weak association between “background” methylmercury exposure 
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and increased DBP within this cohort suggests that the magnitude of effect may be more 
pronounced in sensitive or greater exposed groups. These findings are of public health 
concern given that nearly 30% of adults in the US and ~1 billion worldwide may suffer 
from hypertension, and that elevated blood pressure accounts for 54% of strokes, 47% of 
heart disease, and 14% of all deaths (Lawes et al., 2008). 
 This is the first study, to our knowledge, to directly assess the relationship 
between relevant elemental mercury exposure and blood pressure outcomes in a human 
population that experiences background exposures. Dental amalgams typically consist of 
50% mercury by weight (Clarkson and Magos, 2006). Accordingly, urine mercury levels 
among dental practitioners are strongly predicted by the number of amalgams they 
remove or place (Martin et al., 1995).  In the 1970s and 1980s, urine mercury levels in 
dentists regularly exceeded 10 µg/L but values have dropped significantly in recent years 
owing to educational campaigns and a shift towards composite resin fillings (Eklund, 
2010; Shapiro et al., 1982). This decrease is supported by the current study where urine 
biomarkers of elemental mercury exposure among dental professionals in Michigan 
mirrored the general US population (CDC, 2009; Table 4.2), suggesting that our findings 
may have broad relevance to public health.  Despite low-level elemental mercury 
exposure (maximum=5.5 µg/L), associations with SBP were found. Unlike the hair 
mercury associations, a urine mercury-associated decrease in adjusted SBP was observed 
in the total population and was driven by the males and dentists. The significance of this 
association was influenced by several subjects with higher urine mercury levels, and as 
such this relationship should be further explored in a population with a wider range of 
exposure (maximum >10 µg/L). These findings suggest that levels of urine mercury 
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found in the general adult US population, which average 20-100 times less than exposure 
limits set by the World Health Organization (50 µg/L), may be associated with alterations 
in blood pressure and that these may be gender-specific. Elemental mercury exposures 
have decreased tremendously for the general population though certain groups still 
remain at great risk of elemental mercury exposure, such as small-scale gold miners 
(Paruchuri et al., 2010).   
 For hair and urine mercury, gender influenced the observed trends.  At this 
moment it is not clear why elemental mercury-associated decreases in SBP are observed 
in males only, or why methylmercury-associated increases in blood pressure are stronger 
in males, though increasing toxicological and epidemiological studies are stressing the 
importance of considering gender-specific differences in chemical exposures, 
toxicokinetics, and health impacts (Institute of Medicine, 2001; Vahter et al., 2007).  
Experimental rodent studies have documented gender differences in the distribution, 
metabolism, and elimination of methylmercury and inorganic mercury (Ekstrand et al., 
2010; Thomas et al., 1986, 1987).  With respect to hypertension, gender-specific 
differences have been reported in women in terms of age-related onset and metal 
sensitivity (Reckelhoff, 2001; Vahter et al., 2007). The differences observed in this study 
may reflect true gender differences in the relationship between mercury and blood 
pressure, or they may have resulted from random variation due to small sample sizes.  
 In addition to disparate gender results, elemental mercury results differed from the 
methylmercury results in many cases. The effect of elemental mercury on cardiovascular 
function in humans is not well characterized, but there are laboratory animal studies that 
may shed light on our findings. The general trends observed in our elemental mercury-
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exposed male population are consistent with animal studies reporting associations 
between high doses of inorganic mercury and depressed arterial systolic pressure 
(Massaroni et al., 1995; Rhee and Choi, 1989; Rossoni et al., 1999). Differences between 
elemental mercury and methylmercury effects may be realized at the cellular level. One 
purported mechanism by which mercury affects blood pressure is through disruption of 
calcium homeostasis, and there are reported differences between methylmercury and 
elemental mercury in terms of potency, sensitivity towards certain calcium channel 
subtypes, the nature of inhibition, and alteration of channel function (Atchinson, 2003; 
Sakamoto et al., 1996). Evidence in animals and humans suggests that methylmercury-
induced oxidative stress can inhibit production of nitric oxide, a vasodilator, and lead to 
vascular endothelial dysfunction, mechanisms related to hypertension (Dharmashankar 
and Widlansky, 2010; de Marco et al., 2010; Grotto et al., 2009; Mazerik et al., 2010). 
Several differential mechanisms may underlie the opposite association observed between 
elemental mercury and SBP.  Massaroni et al. (1995) found mercuric chloride increased 
autonomic neurotransmitter release in rats experiencing hypotension following treatment. 
Inorganic mercury may furthermore impact blood pressure indirectly via interaction with 
the kidney, an organ specifically targeted by inorganic species of mercury (Clarkson and 
Magos, 2006). Mercurial drugs such as calomel inhibited sodium and chloride 
reabsorption in the kidney and were formerly prescribed as diuretics and anti-
hypertensive medication until the mid-1900s (Norn et al., 2008; Wolf et al., 1966). 
Interactions between elemental mercury, kidneys and decreased SBP merit further 
exploration.  
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This study examined the impact of polymorphisms in GSTs, glutathione 
synthesizing enzymes, and selenoproteins, all implicated in the distribution, metabolism 
and elimination of both elemental mercury and methylmercury in the body, on the 
relationship between biomarkers for elemental mercury and methylmercury exposure and 
hypertension, though no significant and compelling genetic main effects or gene-mercury 
interactions were observed. Genetic factors are known to contribute to etiology of 
hypertension. Polymorphisms in many genes involved with cardiovascular function 
(Adeyemo et al., 2009; reviewed by Kraja et al., 2011) and antioxidant pathways (Bessa 
et al., 2009; Mansego et al., 2011) are associated with increased blood pressure. 
Antioxidant gene polymorphisms furthermore modify the relationship between toxicants 
and biomarkers of oxidative stress, a mechanism linked to hypertension (Ren et al., 
2010), and the accumulation of potentially cardiotoxic chemicals such as elemental 
mercury (Custodio et al., 2005) and methylmercury in the human body (Custodio et al., 
2004; Engström et al., 2008; Gundacker et al., 2007, 2009). The polymorphisms 
genotyped in this study were selected primarily for their involvement in mercury 
toxicokinetics. The glutathione pathway and selenoprotein genes assessed also have the 
potential to impact cardiovascular health through their antioxidant roles as evident by the 
association between hypertension and GSTT1/GSTM1 deletion polymorphisms according 
to Bessa et al. (2009). Even so, this study failed to find significant genetic main effects or 
polymorphism-mercury biomarker interactions in models of adjusted SBP or DBP 
beyond what is expected by chance given the number of models tested. Increasing the 
sample size and studying a population with a wider range of mercury exposures may 
allow for a better assessment of mercury-gene interactions and blood pressure. Several 
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polymorphisms (SEPP1-234, GCLM 5‟, GSTT1 deletion, GSTM3-224) had near 
significant (p<0.10) main effects and/or interaction terms with hair and/or urine mercury 
in SBP and DBP models and should be explored in future studies.          
Even though this study had several limitations, associations were found between 
low-level mercury exposures and blood pressure alterations. Associations and trends 
observed here corroborate several epidemiological (for methylmercury) and animal (for 
elemental mercury) studies, and thus diminish concern of chance-related significant 
outcomes stemming from multiple statistical tests.  The voluntary nature of subject 
participation could have led to selection bias, but this is unlikely since subjects did not 
know their urine or hair mercury levels before participating in the study, and we observed 
mercury distributions that were in agreement with the NHANES survey. Due to the cross-
sectional design, we were unable to assess the impact of past exposures or lifestyle 
changes on blood pressure. Gender stratification was performed on all analyses due to the 
age, BMI, mercury exposure and occupational differences observed between our male 
and female participants, but this may have limited our statistical power due to smaller 
sample size. Significant associations between hair mercury and DBP and urine mercury 
and SBP were still observed in the male population even with the decreased power. 
Gene-mercury interaction analyses were limited in statistical power due to small sample 
sizes in each model (n=205 to 239), and multiple testing (n=44 genetic models).   
Our analyses did not include one major potential confounder- smoking status- as 
this information was not collected from our subjects. While smoking is often considered a 
risk factor for hypertension and has been shown to influence cadmium and lead 
biomarker levels, smoking has not been shown to affect mercury biomarker levels in 
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most studies (Dewailly et al., 2001; Levy et al., 2007), with exceptions (Freire et al., 
2010). Another limitation of this study may be the lack of mercury speciation in 
biomarker samples. While hair and urine are typically deemed biomarkers of 
methylmercury and inorganic mercury exposure, respectively, (Berglund et al., 2005), 
evidence in occupational cohorts with exposure to elemental mercury suggests that a 
fraction of hair mercury may reflect inorganic mercury exposure (Morton et al., 2004; 
Wranová et al., 2008). In the MDA cohort, amalgams were weakly associated with hair 
mercury even though fish consumption was the main predictor. However, mercury 
speciation of the MDA biomarker samples would be predicted to increase the 
significance of the relationships observed (elemental mercury with decreased SBP and 
methylmercury with increased DBP) if the two mercury forms truly have opposing 
associations with blood pressure.      
This study reports significant, albeit borderline significant (0.01<p<0.05) and 
partially outlier influenced, associations between elevated DBP and hair mercury and 
between decreased SBP and urine mercury at exposure levels relevant to the general 
population. Even though these differential relationships were observed in face of many 
study limitations, comparable significant associations were observed (blood mercury with 
increased DBP, p<0.05, and urine mercury with decreased SBP, p<0.0001) using 
NHANES data (n>4,000) after controlling for seven confounders including smoking 
status and race (data not published). Significant interactions between hair or urine 
mercury and genotype of eleven polymorphisms were not observed in this limited study 
of the MDA cohort. Future work on mercury and cardiovascular health should consider 
both elemental mercury and methylmercury at wide ranges of exposure in males and 
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females along with genetic factors to gain a better understanding of how these toxicants 
influence blood pressure and ultimately cardiovascular disease.
  
Tables 
 
Table 4.1 Characteristics of Total and Stratified Study Population (mean ± SD).   
 Total 
Population 
Population with 
Genotype
a 
Gender Occupation Blood Pressure 
Medication 
 Males Females Dentists Non-Dentists No Yes 
n 262 232 99 163 114 148 223 39 
BMI 
(kg/m
2
) 
26.4 (4.5) 26.5 (4.6) 27.2 (3.7) 25.9 (4.9)c 26.6 (3.9) 26.2 (4.9) 26.2 (4.5) 27.8 (4.3)c 
Age 
(years) 
52.3 (12.3) 
 
52.3 (12.1) 60.2 (10.8) 
 
47.5 (10.6)e 
 
57.8 (11.4) 
 
48.0 (11.3)e 
 
50.7 (12.0) 
 
61.4 (9.8)e 
 
SBP 
(mm Hg) 
124 (15.3) 125 (15.4) 133 (13.3) 119 (14.1)e 130 (15.2) 120 (13.9)e 123 (14.6) 135 (15.1)e 
DBP 
(mm Hg) 
73.5 (9.3) 74.0 (9.3) 75.9 (8.2) 72.0 (9.7)d 75.0 (8.7) 72.3 (9.7)c 72.9 (9.2) 76.8 (9.6)c 
Pulse 
(beats/min) 
72.7 (11.8) 73.3 (11.8) 69.1 (12.9) 74.9 (10.5)e 69.8 (12.6) 75.0 (10.6)e 73.3 (11.5) 69.4 (13.1) 
 Alcohol  
(drinks/day) 
0.42 (0.55) 0.42 (0.55) 0.54 (0.65) 0.34 (0.47)d 0.55 (0.66) 0.31 (0.43)d 0.38 (0.52) 0.64 (0.65)d 
Amalgam
 
 
3.58 (3.42) 3.67 (3.44) 4.01 (3.44) 3.33 (3.39) 4.15 (3.59) 3.15 (3.24)c 3.25 (3.12) 5.49 (4.40)e 
Amalgams 
handled
 
27.9 (47.3) 28.2 (47.0) 43.6 (57.1) 18.4 (37.4)e 48.0 (57.1) 12.4 (30.2)e 26.9 (46.9) 33.2 (50.0) 
Hg intake
b
  
(μg/kg bw/day) 
0.08 (0.12) 0.08 (0.12) 0.09 (0.13) 0.07 (0.12) 0.09 (0.13) 0.07 (0.12) 0.07 (0.12) 0.10 (0.14) 
1
1
5
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a
Subjects with genotype for SEPP1 3‟UTR (rs7579) and all other parameters of interest. 
This polymorphism had approximately the average number of subjects with genotype 
compared to all eleven polymorphisms.  
b
Hg intake estimated from reported fish consumption (type, portion size, consumption 
frequency).  
 
c 
p<0.05, ANOVA tests comparing paired categories (male vs. female, dentists vs. non-
dentists, blood pressure medication users vs. non-users) 
d 
p<0.01  
e
 p<0.001  
 
  
  
Table 4.2 Mercury Biomarker Levels in Total and Stratified Population.   
a
NHANES- National Health and Nutrition Examination Survey.  Urine data from CDC 2009; hair data from McDowell et al. 2004.  
b 
p<0.01 and 
c 
p<0.001 for ANOVA comparing natural log-transformed values for paired categories (male vs. female, dentists vs. non-
dentists, BP medication users vs. non-users).   
  n Mean SD 25
th
 % 50
th
 % 75
th
 % 90
th
 % 95
th
 % 
HAIR MERCURY (μg/g)         
 Total 262 0.45 0.53 0.14 0.28 0.55 1.06 1.31 
 NHANES
a 
1726 0.47  0.09 0.19 0.42 1.11 1.73 
Genotyped With genotype 232 0.45 0.55 0.14 0.29 0.55 1.00 1.34 
Gender Males 99 0.65 0.71 0.24 0.50 0.83 1.33 1.43 
 Females 163 0.33
c 
0.34 0.11 0.21 0.43 0.82 1.06 
Occupation Dentists 114 0.64 0.69 0.25 0.48 0.83 1.31 1.69 
 Non-Dentists 148 0.30
c 
0.29 0.11 0.19 0.39 0.72 1.00 
Medication No BP Meds 223 0.41 0.51 0.13 0.26 0.51 0.95 1.31 
 BP Meds 39 0.66
b 
0.63 0.21 0.56 0.90 1.22 1.39 
URINE MERCURY (μg/L)         
 Total  262 0.94 0.99 0.31 0.63 1.18 2.09 2.76 
 NHANES
a 
1529    0.48 1.12 2.20 3.33 
Genotyped With genotype 232 0.95 1.00 0.32 0.61 1.19 2.14 2.96 
Gender Males 99 1.27 1.22 0.51 0.85 1.50 2.66 4.87 
 Females 163 0.74
c 
0.75 0.26 0.47 0.98 1.76 2.20 
Occupation Dentists 114 1.26 1.19 0.49 0.85 1.53 2.56 4.47 
 Non-Dentists 148 0.69
c 
0.70 0.25 0.44 0.92 1.61 2.00 
Medication No BP Meds 223 0.93 1.02 0.29 0.60 1.13 1.94 3.54 
 BP Meds 39 1.01 0.79 0.38 0.66 1.60 2.35 2.46 
1
1
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Table 4.3 Genetic Polymorphisms and Relationship with Select Variables. Results of weighted linear term ANOVA comparing 
genotype groups for each polymorphism are reported.  
 
 
 
 
 
 
 
 
 
 
 
a
Number of subjects with major homozygote, heterozygote, and minor homozygote genotype, respectively. 
b
Adjusted for blood pressure medication use according to the method of Tobin et al. (2005).  
c
Natural log-transformed before comparison.  
  
Polymorphisms ANOVA p-value 
Gene- 
Polymorphism 
db SNP ID n
a
 SBP
b
 DBP
b
 Pulse BMI Age Hair 
Hg
c
 
Urine 
Hg
c
 
GSTP1-114 rs1138272 190, 38, 1 0.84 0.70 0.64 0.27 0.17 0.39 0.73 
GSTP1-105 rs1695 109, 107, 23 0.12 0.41 0.08 0.55 0.05 0.32 0.96 
SEPP1-234 rs3877899 138, 83, 15 0.94 0.45 0.59 0.30 0.40 0.34 0.67 
GCLM  5‟ rs41303970 159, 62, 17 0.46 0.87 0.64 0.02 0.91 0.82 0.55 
SEPP1 3‟UTR rs7579 122, 95, 15 0.09 0.08 0.85 0.05 0.50 0.39 0.14 
GGT1 intron rs5751901 93, 118, 22 0.28 0.90 0.38 0.81 0.61 0.17 0.36 
GSTM3- 224 rs7483 130, 78, 19 0.10 0.05 0.54 0.88 0.56 0.16 0.46 
GSS 5‟ rs3761144 89, 108, 40 0.38 0.10 0.90 0.29 0.58 0.58 0.37 
GSR 5‟ rs1002149 153, 61, 7 0.79 0.72 0.55 0.75 0.16 0.98 0.96 
GSR intron rs2911678 137, 80, 15 0.93 0.58 0.83 0.73 0.38 0.19 0.17 
GSTT1 deletion N/A 166, 39 0.18 1.00 0.26 0.44 0.43 0.62 0.39 
1
1
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Table 4.4 Parameter Estimates for Blood Pressure Models. Blood pressure measurements of individuals using hypertension 
controlling medications were imputed 15 mmHg higher (SBP) or 10 mmHg higher (DBP) according to the method of Tobin et al. 
(2005). 
Dependent 
Variable 
Population n Adj. r
2 
BMI Age Female Hair Hg Urine Hg 
SBP Total 262 0.425 0.97
c 
0.67
c 
-5.74
b 
2.67
 
-1.80
a 
Males 99 0.244 1.17
b 
0.59
c 
 3.15 -3.26
b 
Females 163 0.346 0.86
c 
0.74
c 
 1.54 0.71 
Dentists  114 0.440 1.15
b
 0.72
c
 -7.89
a
 2.07 -3.35
b
 
        
DBP Total 262 0.224 0.83
c 
0.18
b 
-1.26 2.76
a 
-0.32 
Males 99 0.058 0.54
a 
0.05  2.94
a 
-1.13 
Females 163 0.260 0.89
c 
0.27
c 
 1.87 1.10 
 Dentists 114 0.152 0.71
b
 0.12 -3.31 2.11 -0.88 
 
a
 p≤0.05 for β estimate 
b 
p<0.01 
c 
p<0.001  
 
  
1
1
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Table 4.5 Parameter Estimates for Linear Regression Models of SBP, DBP with 
Hair Hg and Genotype. SBP and DBP values are adjusted for anti-hypertensive 
medication use.   
Polymorphism Dependent 
Variable 
Adj. 
r
2 
BMI Age Female Hair 
Hg 
Genotype Genotype* 
Hair Hg 
Base model
a
 SBP 0.428 0.93
d 0.71d -5.91c 1.68   
(n=232) DBP 0.208 0.77d 0.18c -1.76 2.19e   
         
GSTP1-114 SBP 0.428 0.89
d 0.72d -5.88c 6.64 2.84 -3.56 
(n=229) DBP 0.213 0.78d 0.17c -2.18 2.39 -1.18 -0.05 
         
GSTP1-105 SBP 0.427 0.98
d 0.69d -5.37b -2.68 -2.37 2.78 
(n=239) DBP 0.209 0.80d 0.17c -1.18 -1.82 -1.65 2.51 
         
SEPP1-234 SBP 0.433 0.96
d 0.67d -6.80c -5.41 -3.51e 5.19e 
(n=236) DBP 0.215 0.79d 0.16c -2.10 -0.51 -2.32e 2.08 
         
GCLM 5’ SBP 0.432 1.03d 0.69d -5.85c -3.26 0.79 3.47e 
(n=238) DBP 0.204 0.82d 0.17c -1.55 0.16 0.22 1.53 
         
SEPP1 3’UTR SBP 0.430 0.91d 0.69d -6.38c 7.53 -0.15 -3.55 
(n=232) DBP 0.206 0.75d 0.17c -1.87 3.64 -0.77 -0.86 
         
GGT1 intron SBP 0.433 0.96
d 0.73d -5.43b 8.45 -0.24 -3.92 
(n=233) DBP 0.217 0.79d 0.19c -1.89 4.37 0.90 -1.13 
         
GSTM3-224 SBP 0.425 0.93
d 0.71d -5.44b 5.21 -1.18 -2.46 
(n=227) DBP 0.234 0.80d 0.19c -1.80 6.26e -0.54 -3.25 
         
GSS 5’  SBP 0.426 0.97d 0.68d -5.49c -0.86 -0.87 1.79 
(n=237) DBP 0.212 0.79d 0.17c -1.09 1.56 -1.38 0.69 
         
GSR 5’ SBP 0.431 1.00d 0.70d -5.45b 7.02e 2.38 -2.50 
(n=221) DBP 0.216 0.79d 0.17c -1.71 3.52 0.99 -0.38 
         
GSR intron SBP 0.429 0.96
d 0.70d -5.07b 2.57 0.44 0.24 
(n=232) DBP 0.213 0.80d 0.17c -1.42 3.32 -0.39 -0.37 
         
GSTT1 del SBP 0.454 1.04
d 0.71d -4.67b -9.88 -1.82 10.1e 
(n=205) DBP 0.217 0.82d 0.19c -0.69 -5.22 -3.45 6.00 
  
a
Individuals with SEPP1 3‟UTR genotype used to compute the base model. 
b,c,d
p<0.05, <0.01, <0.001 for parameter estimate. 
e
Near significant parameter estimate (p<0.10).  
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Table 4.6 Parameter Estimates for Linear Regression Models of SBP, DBP with 
Urine Hg and Genotype. SBP and DBP are adjusted for anti-hypertensive medication 
use.  
Polymorphism Dependent 
Variable 
Adj. 
r
2 
BMI Age Female Urine 
Hg 
Genotype Genotype* 
Urine Hg 
Base model
a
 SBP 0.435 0.89
d 0.73d -7.12c -1.77e   
(n=232) DBP 0.196 0.74d 0.20c -2.32 -0.06   
         
GSTP1-114 SBP 0.437 0.85
d 0.75d -7.40c -2.02 1.48 -0.08 
(n=229) DBP 0.200 0.75d 0.18c -2.79e 0.07 -0.91 -0.14 
         
GSTP1-105 SBP 0.428 0.93
d 0.71d -6.76c -2.84 -1.78 0.70 
(n=239) DBP 0.186 0.76d 0.19c -1.99 0.08 -0.56 -0.04 
         
SEPP1-234 SBP 0.437 0.90
d 0.71d -7.77d -4.15 -2.78 1.48 
(n=236) DBP 0.199 0.75d 0.18c -2.59e -0.77 -1.90 0.44 
         
GCLM 5’ SBP 0.435 1.00d 0.73d -6.82c 1.23 4.40b -2.12 
(n=238) DBP 0.189 0.79d 0.20c -2.04 1.37 1.99 -1.02 
         
SEPP1 3’UTR SBP 0.435 0.86d 0.72d -7.32c 0.11 -0.61 -1.32 
(n=232) DBP 0.195 0.72d 0.19c -2.45e 1.17 -0.29 -0.86 
         
GGT1 intron SBP 0.430 0.93
d 0.75d -6.66c -0.76 -1.74 -0.30 
(n=233) DBP 0.203 0.77d 0.21d -2.34 1.78 0.95 -0.83 
         
GSTM3-224 SBP 0.426 0.89
d 0.73d -6.46c 1.46 -0.75 -1.68 
(n=227) DBP 0.227 0.76d 0.20d -2.23 3.40e -0.27 -1.92e 
         
GSS 5’ SBP 0.431 0.93d 0.72d -6.91c -0.50 0.67 -0.85 
(n=237) DBP 0.192 0.76d 0.19c -1.89 -0.31 -1.02 0.08 
         
GSR 5’ SBP 0.426 0.95d 0.73d -6.75c -2.62 0.26 1.03 
(n=221) DBP 0.205 0.75d 0.19c -2.41e -1.91 -0.50 1.69 
         
GSR intron SBP 0.434 0.92
d 0.74d -6.57c -0.23 1.99 -1.03 
(n=232) DBP 0.193 0.77d 0.19c -2.20 0.39 -0.14 -0.33 
         
GSTT1 del SBP 0.449 0.99
d 0.72d -5.39b -5.78 -1.00 5.35 
(n=205) DBP 0.219 0.80d 0.19c -1.14 -5.09 -4.27 5.25e 
 
a 
Base model computed including subjects with SEPP1 3‟UTR genotype. 
b,c,d 
p<0.05, <0.01, <0.001 for parameter estimate. 
e 
Near significant parameter estimate (p<0.10).  
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Chapter 5 
Variants of Glutathione S-Transferase Pi 1 Exhibit Differential Enzymatic Activity 
and Inhibition by Heavy Metals
3
 
 
5.1 Introduction 
The influence of gene-environment interactions on the toxicokinetics of chemicals 
and susceptibility to toxicity has recently been considered an important aspect of risk 
assessment (Omenn, 2001). Pharmacological studies have established that genetic factors 
may underlie the immense variability in an individual‟s ability to absorb, distribute, 
metabolize, and eliminate drugs (de Leon et al., 2005; Ingelman-Sundberg, 2004). 
Similarly, in environmental health sciences, inter-individual differences in the 
metabolism and toxicodynamics of hazardous chemicals may be influenced by genetic 
variation.  For example, in human epidemiological studies focused on heavy metals, 
polymorphisms in key metabolic and antioxidant genes have been associated with altered 
metabolism and elimination of methylmercury (MeHg; Custodio et al., 2004; Engström et 
al., 2008; Gundacker et al., 2009), elemental mercury (Custodio et al., 2005), lead 
(Gundacker et al., 2009), and arsenic (Engström et al., 2007; Marcos et al., 2006) using 
common biomarkers of exposure 
Many of the polymorphisms associated with metal biomarker levels are in the 
glutathione s-transferase (GST) family.  GSTs are implicated in phase II detoxification of 
various endogenous metabolic byproducts and environmental chemicals including heavy 
                                                            
3 This chapter has been submitted (in 2011) to Toxicology In Vitro for review. Authors: J.M. Goodrich, N. Basu.  
 130 
metals (e.g. inorganic arsenic, inorganic mercury-HgCl2, MeHg) (Adamis et al., 2004; 
Ballatori and Clarkson, 1985; Hayes et al., 2005; Wang and Lee, 1993). GSTs catalyze 
the conjugation of glutathione (GSH) to electrophilic substrates, resulting in less reactive 
products ready for elimination (Hayes et al., 2005). Conjugation of GSH to HgCl2 and 
MeHg promotes elimination through the biliary system. While GSH is able to conjugate 
spontaneously with Hg, GSTs have also been implicated in the process. The exact role of 
GSTs in Hg conjugation is debated and may involve reaction catalysis, transport of the 
conjugated product, or both (Ballatori and Clarkson, 1985). In vitro results suggest that 
GSH conjugation of arsenic and cadmium and subsequent elimination from cells are 
GST-dependent (Adamis et al., 2004; Wang and Lee, 1993). The aforementioned studies 
highlight the important role that GSTs play in the detoxification of heavy metals. 
However, the interactions between GSTs and heavy metals are further complicated by the 
ability of some metals (e.g., HgCl2, MeHg) to bind and inhibit GSTs (Almar and 
Dierickx, 1990; Dierickx, 1982; Poon and Chu, 2000; Reddy et al., 1981). 
The catalytic efficiency of GSTs varies tremendously among individuals.  Seven 
classes of cytosolic GSTs exist in humans, and polymorphisms are ubiquitous among the 
genes encoding these enzymes (Strange et al., 2000). A search in the NCBI database 
revealed 158 single nucleotide polymorphisms (SNPs) in GSTP1 pi 1 (GSTP1) with 
minor allele frequencies as high as 50% in some populations. Polymorphisms in GSTs 
resulting in altered catalytic activity or expression have been linked to increased risk for 
cancer (Cote et al., 2005; Strange et al., 2000) and differential metabolism of many 
toxicants (Ishimoto and Ali-Osman, 2002; Srivastava et al., 1999) including heavy metals 
(Custodio et al., 2004; Engström et al., 2007, 2008; Gundacker et al., 2009; Marcos et al., 
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2006). GSTP1 is an enzyme of particular interest as it is the most widely expressed GST 
(found in erythrocytes, placenta, lung, brain, muscle, and liver, among other tissues) and 
has two prevalent nonsynonymous SNPs that directly influence enzyme activity (Strange 
et al., 2000; Suzuki et al., 1987). The nonsynonymous SNPs change the 105
th
 amino acid 
from isoleucine to valine (Ile/Val 105) and 114
th
 amino acid from alanine to valine 
(Ala/Val 114). Altering the 105
th
 position affects the geometry of the substrate binding 
site of GSTP1. Consequently, this modification results in an approximately three-fold 
difference in substrate affinity in vitro (Ali-Osman et al., 1997; Hu et al., 1997; Zimniak 
et al., 1994). The 114
th
 amino acid is positioned outside the active site but may still 
influence GSTP1 activity and substrate access to the site (Ali-Osman et al., 1997; Hu et 
al., 1997; Parker et al., 2008).  
These structural changes may affect the interaction of heavy metals with GSTP1, 
but to our knowledge this has not been tested. Epidemiological studies found associations 
between GST polymorphisms (including GSTP1 105 and 114) and inter-individual 
differences in metabolism and elimination of Hg and arsenic as assessed by biomarkers 
(Custodio et al., 2004; Gundacker et al., 2009; Marcos et al., 2006), but effects of 
genotype on GSTP1 interaction with metals at the protein level are unknown. Here, we 
genetically engineered E. coli to express two key GSTP1 polymorphisms (Ile/Val 105 
and Ala/Val 114- four combinations). The goal was to use an in vitro platform to assess 
the functional effects of these polymorphisms on enzyme kinetics and to characterize the 
impact of heavy metal exposure (HgCl2, MeHg, selenium, lead, arsenic, cadmium, and 
manganese) on enzyme function. Such a screening approach has previously been used in 
cancer biology to supplement epidemiological results. We propose a similar scheme to 
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improve mechanistic understanding of environmental epidemiological and toxicological 
studies.  Our work is in line with a recent US National Research Council (NRC, 2007) 
recommendation to develop and validate high throughput in vitro screening assays for 
toxicity testing purposes that may improve understanding of inter-individual variability 
and risk.  
 
5.2 Materials and Methods 
5.2.1 Synthesis of GSTP1 Variant Proteins 
 Four variants of the human GSTP1 gene were genetically engineered using 
commonly employed methods (Chang et al., 1999; Kitteringham et al., 2007). The most 
prevalent version of GSTP1 („IA‟ with genotype Ile105 Ala114) was obtained from 
Harvard University (Plasmid ID HSCD00000618). Two PCR reactions (referred to as 
Steps 1 and 2) using primers detailed in Table 5.1 mutated GSTP1 IA into GSTP1 VA 
(Val105 Ala114).  The QuikChange II Site-directed Mutagenesis Kit (Stratagene, CA, 
USA) was used to mutate GSTP1 to IV (lle105 Val114) and VV (Val105 Val114) using 
primers listed in Table 5.1. Reactions were carried out with a Mastercycler Gradient 
thermocycler (Eppendorf, NY, USA). The four GSTP1 genes were cloned into 
pET100/D-TOPO vectors with N-terminal polyhistidine tags according to the 
manufacturer‟s protocol (Invitrogen, CA, USA). DNA sequencing was performed with 
the 3730 XL Sequencer (Applied Biosystems) to ensure proper sequence of each mutant. 
Constructs were propagated in TOP10 E. coli, and expressed in BL21 Star (DE3) E. coli 
following induction by isopropyl β-D-1-thiogalactopyranoside (IPTG). GSTP1 proteins 
were purified with nickel-affinity chromatography using PerfectPro Ni-NTA resin 
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following manufacturer‟s instructions (5Prime, MD, USA) and were stored in 0.1 M 
potassium phosphate buffer (pH 6.6) at -20 °C until use. The Bradford method 
determined protein concentration (Bradford, 1976).  
 
5.2.2 GST Assays  
Enzyme activity was assessed according to the method of Habig et al. (1974) by 
measuring GSH conjugation with 1-chloro-2,4-dinitrobenzene (CDNB). The HTS 7000 
Plus Bioassay Reader (Perkin Elmer, MA, USA) measured absorption at 340 nm 
signifying product formation. Briefly, all reactions took place in 0.1 M potassium 
phosphate buffer containing 5 μg/mL protein, 0.01-10 mM GSH, and 0.01-3 mM CDNB. 
Each trial contained triplicates for every substrate concentration. Enzyme kinetics (Vmax, 
Km) were calculated for each trial by holding GSH (10 mM) or CDNB (2 mM) constant 
and varying the concentration of the other substrate. Final kinetic parameters are based on 
the mean of four to six kinetic trials. Several failed trials, mainly due to microplate reader 
malfunction, were excluded.  
 
5.2.3 Metal Inhibition 
 Enzyme activity of GSTP1 allozymes was measured after incubation with 1 nM-
1 mM  of methylmercury (II) chloride (MeHg), mercury (II) chloride (HgCl2, 10 pM-320 
µM), manganese (II) chloride, lead (II) acetate, cadmium (II) chloride (100 pM-1 mM), 
sodium selenate, sodium selenite, or sodium arsenate (1 nM-10 mM). Metal doses, 
specifically for MeHg and HgCl2, were selected as ranges encompassing inhibitory 
concentrations of soluble GSTs observed in previous experiments performed by us (data 
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not published) and others (Almar and Dierickx, 1990). Assays contained 5 µg/mL 
purified protein and fixed GSH and CDNB concentrations set to approximately the Km 
values for a given GSTP1 allozyme. These substrate concentrations enable comparison of 
metal inhibition across allozymes as each variant is exposed to substrate concentrations 
associated with 50% maximum enzyme activity for that particular variant. All metals, 
purchased from Sigma Aldrich or Fisher Scientific, were administered from 50-200 mM 
stock solutions in distilled water with the exception of MeHg which was dissolved in 
100% dimethylsulfoxide. MeHg reactions and controls contained a final concentration of 
3% dimethylsulfoxide for dissolving purposes. Enzymes were incubated with metal for 
ten minutes prior to addition of the substrates, GSH and CDNB, and subsequent 
measurement of product formation. Six to eighteen replicates of each Hg treatment were 
analyzed depending on the allozyme. GSTP1 IA and VA were used for method 
development and as such had the most replicates for HgCl2 and MeHg treatment. Three 
to nine replicates of all other heavy metal treatments were analyzed. All failed replicates 
were excluded.  
 
5.2.4 Statistical Analyses  
Enzyme activity data was curve fitted using a non-linear regression program 
(GraphPad Prism Version 3.02, GraphPad Software Inc., CA, USA) to calculate the 
maximum velocity of substrate formation (Vmax) and the Michaelis constant (Km) for 
substrate affinity according to the following equation: 
Y = (Vmax)(S)/Km + S 
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Y represents enzyme activity (μmol/min/mg) and S represents substrate concentration 
(mM). The concentrations of metal inhibiting 50% of enzyme activity (IC50) and 
inhibition constants (Ki) were calculated using GraphPad Prism.  
All statistical analyses were performed with PASW Statistics v. 18 (SPSS, 
Chicago, IL).  Mean kinetic and inhibition parameters were compared among GSTP1 
allozymes using ANOVA tests followed by pairwise comparisons with the Tukey 
method. For variables with unequal variances according to Levene‟s test, Welch ANOVA 
and Dunnett‟s T3 test were used instead. In all statistical tests, p-value <0.05 was 
considered statistically significant. All data are presented as mean ± SEM.  
 
5.3 Results  
5.3.1 GSTP1 Gene Mutation and Protein Synthesis 
The human GSTP1 gene (IA) was mutated to encode GSTP1 VA, IV, and VV. 
DNA sequencing confirmed the desired sequence in all four variants before expression 
via pet-TOPO-d-100 plasmids in BL21 Star E. coli cells. Proteins were purified with 
nickel-resin affinity chromatography, which yielded approximately 1 mg purified 
allozyme per batch. SDS-PAGE 2D gel electrophoresis and Coomassie Blue staining 
confirmed single bands around 25 kDa in the purified fractions used for enzyme activity 
assays. 
 
5.3.2 Enzyme Activity of GSTP1 Allozymes 
 Enzyme activity with varying levels of the substrates CDNB and GSH revealed 
the four allozymes to have different kinetic properties (Table 5.2, Figure 5.1). GSTP1 IA 
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(Km ±SEM=0.33±0.07 mM) and IV (Km=0.28±0.02 mM) had significantly greater 
affinity for CDNB compared with GSTP1 VA and VV (Km=1.15±0.07, 0.63±0.1 mM, 
respectively). VA had the least affinity for CDNB, but the highest Vmax  suggesting it 
requires more available substrate to catalyze efficiently. Overall, IA had significantly 
better catalytic efficiency compared to the three less frequent allozymes as assessed by 
kcat/Km  (IA: 98.2±14 mM
-1
s
-1
 vs. VA: 35.9±6.8, IV 55±9.8, VV 43.4±9.3 mM
-1
s
-1
). 
Kinetic parameters with varying levels of GSH were similar among the four GSTP1 
allozymes. ANOVA revealed a significant difference among the allozymes‟ Km values 
for GSH, though the sole significant pairwise difference was between GSTP1 VA 
(0.93±0.11 mM) and IV (0.48±0.15 mM; p=0.03 for comparison).  
 
5.3.3 GSTP1 and Mercury Inhibition 
The four GSTP1 variants were incubated with a range of HgCl2 (10 pM- 320 µM) 
and MeHg (1 nM- 1mM) doses prior to addition of substrates, and genotype influenced 
sensitivity towards both Hg forms (Table 5.3, Figure 5.2). HgCl2 was the most potent 
inhibitor of all GSTP1 allozymes (p<0.001, test not shown) compared with MeHg 
treatment. Sensitivity of the GSTP1 allozymes followed the same trend for HgCl2 and 
MeHg inhibition (most sensitive first: VA > IA > VV > IV). Pairwise comparisons 
revealed significant differences between IC50s and inhibitory constants (Ki), accounting 
for substrate concentration and allozyme substrate affinity, of all three variant enzymes 
treated with HgCl2 and the respective IC50 and Ki values for GSTP1 IA (Dunnett‟s T3 
test, p<0.05). Furthermore according to Dunnett‟s T3 test, IC50s and Ki values for HgCl2 
were significantly different from one another for all pairwise combinations of GSTP1 
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allozymes excluding GSTP1 IV with VV. MeHg inhibition varied among allozymes to a 
lesser extent as only IC50 values for GSTP1 IV and VV were significantly larger than that 
of the common form, GSTP1 IA (Dunnett‟s T3 test, p<0.05). GSTP1 IV was the most 
resistant allozyme to MeHg inhibition (IC50 ±SEM=480 ±54.1 μM) compared with three 
other variants and was five times less sensitive than GSTP1 VA (IC50=93.9 ±11.3 μM).  
 
5.3.4 GSTP1 and Other Heavy Metals 
The inhibitory effects of two inorganic selenium compounds (sodium selenate, 
sodium selenite) were tested on four GSTP1 allozymes. GSTP1 was not inhibited by 
sodium selenate concentrations as high as 1 mM, while sodium selenite had similar 
potency to HgCl2 (IC50 range for four allozymes: 43.7-62.8 μM; see Table 5.4, Figure 
5.2), and the potency did not vary significantly by allozyme. GSTP1 enzyme activity, 
regardless of amino acid sequence, did not reach 50% inhibition by lead acetate, 
manganese chloride, or cadmium chloride at concentrations up to 1 mM or by sodium 
arsenate at concentrations up to 10 mM.  
 
5.4 Discussion 
Genetic polymorphisms in GSTP1, which encodes an important detoxification 
enzyme that catalyzes the conjugation of GSH with many endogenous and exogenous 
electrophilic substrates, have been linked in epidemiological studies to altered 
metabolism and biomarker levels of toxicants such as arsenic (Marcos et al., 2006) and 
methylmercury (Custodio et al. 2004; Engström et al., 2008; Gundacker et al. 2009). We 
assessed the kinetic properties of four GSTP1 variants encoded by two key 
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nonsynonymous SNPs in GSTP1, Ile/Val 105 and Ala/Val 114, on protein function with 
common substrates in vitro in the presence and absence of mercury (HgCl2, MeHg), 
selenium, arsenic, lead, manganese and cadmium. Kinetic parameters and inhibition by 
HgCl2 and MeHg significantly differed (p<0.05) among the four recombinant allozymes 
suggesting a role for both polymorphisms in altering enzyme function.  
 In the majority of human populations, the major GSTP1 alleles are Ile105 
(frequency >50%) and Ala114 (>90%; NCBI). The two most common allozymes of 
GSTP1 in human populations are GSTP1 IA and VA, though GSTP1 IV and VV exist to 
a limited extent (estimated ≤5% based on allele frequencies in HapMap populations). The 
105 and 114 loci are in linkage disequilibrium in many populations (Moyer et al., 2008) 
including the Michigan Dental Association cohort. For example, in a gene-environment 
study we conducted on 515 Michigan dental professionals, GSTP1 105 and 114 loci were 
in linkage disequilibrium with the Val alleles found together more frequently.  
Previous biochemical characterization of GSTP1 allozymes have focused on 
GSTP1 IA and VA and the few studies incorporating GSTP1 IV and VV had inconsistent 
results (Ali-Osman et al., 1997; Hu et al., 1998; Johansson et al., 1998; Moyer et al., 
2008; Zimniak et al., 1994). In this study, GSTP1 IA and IV had the greatest affinity for 
the electrophilic substrate, CDNB (Km= 0.33 mM (IA), 0.28 mM (IV)), and their 
affinities were 3-4 fold greater than that of GSTP1 VA (Km=1.15 mM). Previous 
biochemical studies of GSTP1 allozymes found similar trends with GSTP1 IA having a 
greater affinity for CDNB (1.6-3.7 fold lower Km) compared with GSTP1 VA (Ali-
Osman et al., 1997; Hu et al., 1997; Johansson et al., 1998; Moyer et al., 2008, Zimniak 
et al., 1994). GSTP1 IA was the most efficient at catalyzing the conjugation of GSH with 
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CDNB (see kcat/Km, Table 5.2). Similar to previous studies, the affinity of GSTP1 IA, 
VA, and VV for GSH were near identical (Ali-Osman et al., 1997; Zimniak et al., 1994). 
Interestingly, GSTP1 IV had a significantly greater affinity for GSH compared to GSTP1 
VA (Km= 0.48 mM (IV) vs. 0.93 mM (VA)). Overall, allozymes with Ile105 (GSTP1 IA, 
IV) performed better in kinetic assays with varying CDNB concentrations compared to 
allozymes with Val105 as noted when comparing Km and kcat/Km between GSTP1 IA and 
VA or IV and VV.  
Crystallography and structural 3D modeling have shown that residue 105 is found 
in the H-site of GSTP1, the site of electrophilic substrate binding (Oakley et al., 1997; 
Parker et al., 2008). Substituting valine for isoleucine in this position alters the 
hydrophobicity and shape of the H-site (Ali-Osman et al., 1997; Zimniak et al., 1994) and 
interaction with the catalytically important residue, Tyr109 (Johansson et al., 1998; 
Parker et al., 2008). This substitution decreases substrate (CDNB) affinity and catalytic 
activity of GSTP1 as observed in the present study. The impact on substrate affinity and 
catalytic efficiency from substituting valine for alanine at residue 114 was much less 
pronounced. While residue 114 is found outside the H-site, it has the potential to 
influence the secondary and tertiary structure of GSTP1 as it partakes in a superhelical 
structure impacting the H-site shape (Ali-Osman et al., 1997; Parker et al., 2008). 
Furthermore, 114 may be involved in a hydrophobic clamp at the opening of the solvent 
channel that leads to both the G- (GSH binding) and H-sites (Hu et al., 1997). Therefore, 
while residue 105 directly impacts the H-site, amino acid substitution at position 114 may 
also indirectly influence active site shape and substrate access.   
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Along with comparing the enzymatic activity of four GSTP1 variants, this study 
assessed the impact of genotype and heavy metal exposure on GSTP1. The four versions 
of GSTP1 were significantly inhibited by HgCl2 and MeHg (Table 5.3). HgCl2 was the 
more potent inhibitor, and this is consistent with other in vitro studies that found enzymes 
and neurochemical receptors were more sensitive to HgCl2 compared with MeHg (Allen 
et al., 2001; Basu et al., 2005). The observed IC50s for HgCl2 (range across allozymes: 
24.1 to 172 μM) and MeHg (93.9 to 480 μM) were within the range (10 to 300 µm) of 
IC50s observed for human, rat, and calf GSTs following HgCl2 (Almar and Dierickx, 
1990; Dierickx, 1982; Poon and Chu, 2000; Reddy et al., 1981) and MeHg treatment 
(Reddy et al., 1981).  
While Dierickx (1982) observed differential inhibition of rat GSTs depending on 
GST isozyme, this is the first study to show that genotype of a specific GST, GSTP1, 
may also influence mercury sensitivity. For both HgCl2 and MeHg treatments, allozymes 
ranked according to sensitivity with the most sensitive first were as follows: GSTP1 
VA>IA>VV>IV. This trend suggests that the Ile105 and Val114 residues may confer 
some protection against inhibition by Hg. Inhibition of GSTP1 activity by Hg likely 
occurs via two mechanisms: direct binding to GSTP1 thiol groups and indirectly by 
conjugation with available GSH. GSTP1 contains four cysteine residues, including one 
residue (Cys48) known to inhibit enzyme function when bound by compounds with high 
thiol affinity and one (Cys102) near the H-site (Oakley et al., 1997). Studies on mercury 
inhibition of GSTs, including the present, have observed that increasing GSH 
concentration partially decreases inhibition, irrespective of CDNB concentration (Almar 
and Dierickx, 1990; Dierickx 1982). Addition of cysteine with HgCl2 also rescued GST 
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activity in previous studies (Almar and Dierickx, 1990; Dierickx 1982). Amino acid 
substitutions at residues 105 and 114 could influence both purposed inhibitory 
mechanisms. Structural alterations accompanying the sequence change may affect the 
positioning of the cysteine residues, and thus the ability of Hg to bind and inhibit the 
enzyme. As previously discussed, substitution of Val for Ile105 changes the structure of 
the H-site and subsequently affinity for CDNB and catalytic efficiency. The impaired 
enzymatic activity of GSTP1 VA and VV compared to GSTP1 IA and IV, respectively, 
may hinder their ability to utilize available GSH efficiently when Hg binds to GSH 
and/or binds and inhibits the enzyme itself.  
 Sodium selenite inhibited GSTP1 activity with similar potency to HgCl2 while 
sodium selenate was not inhibitory (up to 1 mM). Selenium exhibits hormesis as some 
selenium is needed in the body (e.g., for selenoprotein synthesis) but high levels are toxic 
(Chiang et al., 2010). Unlike sodium selenate, selenite is known to bind thiols, including 
GSH, and GSH binding may constitute the main mechanism of GST inhibition observed 
here (Żbikowska et al., 1997). Selenium treatment has been shown to increase GST 
expression and activity levels in several animal species in vivo (El-Sayed et al., 2006; 
Sidhu et al., 1993), an effect which may be organ dependent (Sidhu et al., 1993).  In vitro 
treatment of pig GSTs found selenite inhibited activity while selenate had no effect as 
observed in the present study (Żbikowska et al., 1997). GSTP1 genotype did not affect 
sensitivity to selenite inhibition.  
 GSTP1 activity, regardless of genotype, was not significantly inhibited (>50%) 
after incubation with arsenic, lead, manganese, or cadmium. Previous studies revealed 
arsenic treatment to have no effect on GST activity in human erythrocytes (Poon and 
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Chu, 2000) or to increase GST activity in rat hepatocytes treated in vitro (Kojima et al., 
2006). GSTP1 specifically has been shown to play an important role in increased arsenic 
excretion in a strain of Chinese Hamster Ovarian cells, stemming from increased 
expression (Wang et al., 1993). The lack of inhibition of recombinant GSTP1 in the 
present study is consistent with previous studies suggesting no direct interaction between 
arsenic and GSTs. Though rat studies have implicated lead in increasing GST expression 
and subsequent activity (Daggett et al., 1998), lead has not been shown to directly inhibit 
GST enzyme activity (Dierckx, 1982) as seen here with human GSTP1. Consistent with 
GSTs isolated from rats and calves, recombinant human GSTP1, regardless of genotype, 
was not inhibited by manganese chloride (Dierckx, 1982; Reddy et al., 1981).  
Cadmium inhibited 50% of GST activity in vitro at concentrations between 10 
and 750 µM in calf liver (Reddy et al. 1981), human erythrocytes (Poon and Chu, 2000) 
and of GSTP1 isolated from a hepatoma cell line (Almar and Dierckx, 1990) while 200 
µM decreased the activity of GSTs isolated from rat liver by 37% (Dierckx, 1982). In the 
present study, the IC50 for all GSTP1 allozymes was greater than 1 mM, though 
significant inhibition at 1 mM compared to untreated controls was observed for all 
variants (data not shown, 81-88% of specific activity of control, p<0.05). Species 
differences among GSTs and experimental conditions (substrate concentrations, source 
and concentration of GSTs, GST isoforms) may contribute to the differences observed.  
GSTP1 105 and 114 polymorphisms, which are linked to differences in enzyme 
function and Hg sensitivity in vitro, are significantly associated with altered mercury 
biomarker levels (hair and blood), representing primarily MeHg exposure, at the 
population level. Several studies found significant associations between Val105 and/or 
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Val114 alleles and lower biomarker levels (Engström et al., 2008; Chapter 2, this 
dissertation) while other studies linked higher biomarker levels to Val alleles (Custodio et 
al., 2004; Gundacker et al., 2009). Multiple factors may underlie the discrepant results 
including Hg exposure level, specific biomarkers analyzed, statistical methodologies 
employed (e.g., ANOVA vs. linear regression; modeling effect of single SNP vs. SNP 
combinations), frequency of GSTP1 105 and 114 SNPs in the study populations, and 
linkage with other SNPs influencing GSTP1 expression. Alternatively, given multiple 
testing in many of these epidemiological studies and the opposite direction of 
relationships between GSTP1 genotype and Hg biomarker levels observed across studies, 
the significant associations could be false positives. In arsenic exposed populations, 
deletion polymorphisms in GSTT1 and GSTM1 have been shown to alter the proportion 
of methylated arsenic metabolites in urine. For example, GSTM1 deletion genotype was 
associated with a higher proportion of monomethylated arsenic (MMA), a particularly 
toxic metabolite (Engström et al., 2007). However, GSTP1 Val105 was only associated 
with a near-significant shift in the urinary metabolic profile (Marcos et al., 2006).  
Limited epidemiological associations and in vitro results suggest that GSTP1 105 
and GSTP1 114 genotypes have the potential to influence Hg toxicokinetics. While the 
relationships between GSTP1 genotype, Hg biomarker levels, and ensuing toxicity merit 
future study, several considerations must be employed when interpreting this gene-
environment data. Glutathione-Hg conjugation may be influenced by many factors 
including glutathione availability and oxidation state, Hg exposure (species, dose, 
duration), exposures to other thiol-reactive compounds, and overall functionality of 
GSTs. While Hg spontaneously reacts with GSH intracellularly, GSTs can also aid this 
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important Hg detoxification process by way of reaction catalysis and conjugate transport 
(Ballatori and Clarkson, 1985). Furthermore, GST inhibition by Hg at high doses, as 
observed in this study, may act as a temporary detoxification mechanism, preventing Hg 
from inhibiting other key intracellular proteins. Expression of GST increases following 
Hg exposure, and in rats, the GSTP1 equivalent experiences the most pronounced 
upregulation (11-fold; Brambila et al., 2002). While GSTP1 may be of particular 
importance to the Hg toxicokinetic pathway, it is one of several GSTs which can interact 
with Hg. Likewise, GSTP1 105 and 114 are two of a multitude of polymorphisms in 
GSTP1, many of which are suspected to alter enzyme activity or gene expression (Moyer 
et al., 2008). Thus, while GSTP1 Ile/Val 105 and Ala/Val 114 may significantly influence 
enzyme activity and sensitivity to Hg inhibition in vitro, genotype at two loci in one GST 
isozyme would be expected to have a very minor impact, if any, on Hg toxicokinetics in 
vivo.  
In a broader context, the combined genotype across dozens of key polymorphic 
sites that affect expression or enzymatic activity of several GST isozymes (and of other 
key proteins in the Hg toxicokinetics pathway) has the potential to impact the wide inter-
individual variability observed in Hg metabolism. In vitro characterization of protein 
products encoded by polymorphisms may provide a better understanding of 
epidemiological links between polymorphisms and interaction with metals or other toxic 
exposures (Li and Woods, 2009; Moyer et al., 2008). Nevertheless, careful consideration 
of a multitude of factors (e.g., toxicant exposure source and dose, protein expression, 
SNP prevalence) and synthesis of in vitro and epidemiological data related to all 
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functional SNPs in the pathway must be employed when interpreting gene-environment 
data and incorporating it into risk assessment.                   
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Figures and Tables 
Figure 5.1. Specific Activity of Four GSTP1 Variants with Increasing Concentration 
of the Electrophilic Substrate CDNB. Data points represent mean ± SEM specific 
activity from four or five trials.  
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Figure 5.2. Inhibition of Four GSTP1 Variants by Heavy Metals: A) GSTP1 Ile105 
Ala114; B) GSTP1 Val Ala; C) GSTP1 Ile Val; D) GSTP1 Val Val. GSTP1 allozymes 
were treated with a range of concentrations of HgCl2, MeHg, sodium arsenate, lead 
acetate, cadmium chloride, sodium selenite, or manganese chloride. Specific activities of 
metal-treated enzymes were normalized to specific activity of control for each allozyme. 
Points represent mean ±SEM of 3-18 replicates depending on the metal. Inhibition curves 
for HgCl2, MeHg, and selenium, the only significant inhibitors of GSTP1 activity, are 
emphasized.  
 
  
  
Table 5.1. Primers Used to Mutate GSTP1. 
Primer Purpose Primer Sequence (5’ → 3’) Direction 
Mutate Val105, Step 1 CACCATGCCGCCCTACAC Forward 
Mutate Val105, Step 1 GATGAGGGAGACGTATTTGCAGC  Reverse 
Mutate Val105, Step 2 Megaprimer- product from two previous primers Forward 
Mutate Val105, Step 2 TCACTGTTTCCCGTTGCCATTGATG Reverse 
Mutate Val114 CTACACCAACTATGAGGTGGGCAAGGATGACTATG Forward 
Mutate Val114 CATAGTCATCCTTGCCCACCTCATAGTTGGTGTAG Reverse 
 
  
1
4
8
 
  
Table 5.2. Kinetic Parameters for Conjugation of CDNB and GSH by Four GSTP1 Variants. Data represent mean ± SEM based 
on four to six trials.  For a given row, the p-value is reported for the ANOVA test
a
 comparing the kinetic parameter among GSTP1 
allozymes. Pairwise comparisons with the reference GSTP1 (IA) were made in each row using the Tukey method
a
, and significance is 
indicated: *p<0.05, †p<0.01, ‡p<0.001.  
 
  GSTP1 IA GSTP1 VA GSTP1 IV GSTP1 VV p value
 
Substrate 
 
Amino Acid Ile105 Ala114 Val105 Ala114 Ile105 Val114 Val105 Val114  
CDNB Km 
(mM) 0.33 ± 0.07 1.15 ± 0.07‡ 0.28 ± 0.02 0.63 ± 0.1* <0.001 
Vmax 
(µmol/min/mg) 68.1 ± 8.2 93.4 ± 16.8 33.0 ± 3.7*
 
57.0 ± 5.0 0.006 
Kcat/Km 
(mM
-1
s
-1
) 98.2 ± 14 35.9 ± 6.8† 55.0 ± 9.8* 43.4 ± 9.3* 0.003 
GSH Km 
(mM) 0.90 ± 0.02 0.93 ± 0.11 0.48 ± 0.15 0.81 ± 0.08 0.04 
Vmax 
(µmol/min/mg) 70.2 ± 14.1 59.1 ± 11.1 47.6 ± 5.1 42.6 ± 7.2 0.41 
Kcat/Km 
(mM
-1
s
-1
) 33.6 ± 6.1 28.3 ± 4.8 52.5 ± 11.2 23.4 ± 4.1 0.05 
 
a
 For Vmax (both CDNB and GSH), p-value reported from Welch ANOVA due to unequal variances. For these parameters, pairwise 
comparison used Dunnett‟s T3 test instead of the Tukey method.   
1
4
9
 
  
Table 5.3. Inhibitory Concentrations (IC50) and Constants (Ki) of Two Hg species on Four GSTP1 Variants (mean ± SEM based 
on at least six replicates). The p-value for the Welch ANOVA test, used to compare means in each row, is indicated. For all variables, 
comparisons of each allozyme to the reference, GSTP1 IA, were made with Dunnett‟s T3 test and significance is labeled as follows: 
*p<0.05, †p<0.01, ‡p<0.001.   
  
GSTP1 IA GSTP1 VA GSTP1 IV GSTP1 VV p value 
HgCl2
 IC50 (µM) 53.7 ± 4.4 24.1 ± 2.7‡ 172 ± 22.8* 96.8 ± 9.9* <0.001 
 Ki [CDNB] (µM) 24.7 ± 2.0 12.6 ± 1.6‡ 81.5 ± 10.8* 48.4 ± 5.0‡ <0.001 
 Ki [GSH] (µM) 29.3 ± 2.4 12.8 ± 1.3‡ 61.4 ± 8.2* 45.6 ± 4.7* <0.001 
MeHg IC50 (µM) 135 ± 16.4 93.9 ± 11.3 480 ± 54.1† 196 ± 7.4* <0.001 
 Ki [CDNB] (µM) 61.9 ± 7.5 48.8 ± 5.9 227 ± 25.6† 98.1 ± 3.7† <0.001 
 Ki [GSH] (µM) 73.5 ± 8.9 51.2 ± 6.2 171 ± 19.3* 92.4 ± 3.5 <0.001 
 
 
 
  
1
5
0
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Table 5.4. Inhibitory Concentrations (IC50) of Five Heavy Metals on Four GSTP1 
Variants (mean ± SEM based on at least three replicates).  
 
Metal Form 
IC50 (μM) 
GSTP1 IA 
IC50 (μM) 
GSTP1 VA 
IC50 (μM) 
GSTP1 IV 
IC50 (μM) 
GSTP1 VV 
As sodium arsenate >10,000 >10,000 >10,000 >10,000 
Pb lead (II) acetate >1000 >1000 >1000 >1000 
Mn manganese (II) chloride >1000 >1000 >1000 >1000 
Se sodium selenite 52.6 ± 3.4 62.8 ± 10.5 60.7 ± 4.9 43.7 ± 4.1 
Cd cadmium (II) chloride >1000 >1000 >1000 >1000 
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Chapter 6 
Conclusion 
 
6.1 Objectives 
This dissertation aims to further the growing understanding of genetic impact on Hg 
accumulation and toxicity using epidemiological and in vitro methodologies.  
Polymorphisms in selenoprotein and GSH pathway genes, two families implicated in Hg 
distribution, metabolism and elimination, are hypothesized to influence inter-individual 
variability observed in methylmercury and/or inorganic Hg accumulation in exposure 
biomarkers and to modify the interaction between Hg and blood pressure. This project 
expands upon a limited body of literature on genetics and Hg accumulation as it evaluates 
several exposure routes (fish consumption, dental amalgams), Hg biomarkers (urine, hair, 
and blood), and 23 polymorphisms (selenoprotein and GSH pathway genes) in two 
genetically distinct populations (Michigan dental professionals of the MDA cohort and 
Mexican mother-child pairs of the ELEMENT cohort). Knowledge gaps in Hg biomarker 
assessment are addressed in the aforementioned cohorts, and the influence of low level 
methylmercury and inorganic Hg exposure on blood pressure is explored in the MDA 
group. This work further investigates possible mechanisms underlying epidemiological 
genetic associations by means of in vitro enzymatic tests on four genetically engineered 
variants of GSTP1 that assess the way Hg interacts with variant proteins to influence 
activity. 
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6.2 Major Results and Discussion 
6.2.1 Mercury Exposure Assessment 
 Validated methods for Hg exposure assessment exist, and data on Hg body burden 
estimated from biomarkers for methylmercury (blood, hair) and inorganic Hg exposure 
(urine) has been collected for many populations. However, general population data on Hg 
levels remains unknown in some countries (e.g., Mexico), and exposures of certain 
occupational groups (dentists) merit monitoring due to the potential susceptibility to Hg-
related health effects from elevated exposures. Table 6.1 summarizes Hg levels measured 
in biomarker samples collected from Michigan dental professionals (hair, urine) of the 
MDA cohort, and Mexican mothers (hair) and children (hair, blood, urine) from the 
ELEMENT cohort. As expected, estimated Hg intake from reported fish consumption 
was the main predictor of MDA hair Hg concentrations (Table 2.5) while amalgams (in 
subjects‟ mouths and handled in the dental office) and occupation correlated with urine 
Hg levels (Table 2.4). Overall, dentists had higher hair and urine Hg levels compared 
with non-dentists (dental hygienists, assistants, etc.), and this corresponds with greater 
exposures through fish consumption and dental amalgams, though only the latter 
difference was statistically significant when comparing the two occupational groups 
(Table 2.1). Eleven percent of the MDA cohort exceeded 1.1 µg/g hair Hg, a 
concentration that approximately corresponds to the US EPA reference dose for 
methylmercury exposure (NRC, 2000), and most of the individuals with elevated hair Hg 
were male dentists. Though the median urine Hg concentration of dentists was 80% 
higher than that of the US adult population according to NHANES (CDC, 2009), no 
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MDA subjects had urine Hg >10 µg/L, possibly reflecting reduction of amalgam use for 
dental restorations and/or safer occupational handling of Hg (Eklund, 2010).   
 The ELEMENT cohort data provides the first estimate, to our knowledge, of Hg 
exposures via biomarker measurements in a sample of the general Mexican population. 
While Mexican mothers had higher median hair Hg values compared to American 
women of child-bearing age (McDowell et al., 2004), a similar proportion (8%) exceed 
the recommended hair Hg limit (1.1 µg/g) and children born to these mothers could be at 
risk for neurodevelopmental toxicity (NRC, 2000). Mexican children exhibited higher Hg 
biomarker levels compared with American children, and this was particularly pronounced 
in hair and blood- biomarkers of methylmercury exposure (ATSDR and CDC, 2009; 
Caldwell et al., 2009; McDowell et al., 2004). Although Mexican children may 
experience higher Hg exposures than American children, exposures are relatively low as 
few exceeded biomarker concentrations of concern set by various regulatory bodies 
(<10% with hair Hg >1.1 µg/g, <5% with blood Hg >5.8 µg/L, 0% with urine Hg >10 
µg/L). Data on sources of exposure (e.g., fish consumption frequency, number of dental 
amalgams) was not available from ELEMENT cohort participants. Fish consumption is 
expected to be the major contributor to hair and blood Hg levels observed in the 
ELEMENT cohort as analytical Hg quantification in fish samples from Mexico reveal 
elevated Hg levels in commonly consumed species (Soto-Jiménez et al., 2010; Trasande 
et al., 2010).    
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6.2.2 Cardiovascular Health Impacts 
 Methylmercury has been linked to cardiotoxic effects including increased blood 
pressure, though these associations were observed in populations with relatively high 
exposures from fish or marine mammal consumption (see review: Roman et al., 2011). 
Animal studies suggest inorganic Hg may have the opposite effect on blood pressure, 
though epidemiological studies assessing this relationship are non-existent (Massaroni et 
al., 1995; Rhee and Choi, 1989). In the MDA cohort (2010 subjects, n=262), we provide 
the first evidence for associations between low level methylmercury and elemental Hg 
exposures and systolic and diastolic blood pressure (SBP, DBP) alterations (Table 4.4). 
In SBP and DBP models, after adjustment for several covariates (age, BMI, gender, anti-
hypertensive medication), hair Hg levels trended towards a positive association with 
blood pressure regardless of population stratification (total, by gender, by occupation), 
though this relationship only attained statistical significance in models of DBP with the 
total population or males alone. This result, obtained from a group with general 
population-level methylmercury body burden, correlates well with associations between 
blood Hg and SBP/DBP observed among highly exposed individuals (Choi et al., 2009).  
 Elemental Hg exposure, represented by urine Hg, displayed the opposite 
relationship with blood pressure (Table 4.4). In adjusted models, urine Hg levels were 
significantly associated with decreasing SBP, and this relationship seemed to be driven 
by the males/dentists. Hypotensive tendencies of high doses of inorganic Hg have been 
observed in animal models (Massaroni et al., 1995; Rhee and Choi, 1989). Intriguingly, 
mercurial compounds were prescribed as anti-hypertensive medications due to their 
diuretic properties in the early 1900s before their toxicity was discovered (Norn et al., 
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2008). This is the first study to suggest a hypotensive association between low level 
elemental Hg exposure and blood pressure in humans. Due to several study limitations 
(e.g., small sample size, several influential data points, lack of smoking data), the results 
should be interpreted cautiously, and the relationship between elemental Hg and blood 
pressure should be analyzed in other epidemiological cohorts. We observed a similar 
relationship between urine Hg levels and decreasing SBP using 2003 to 2008 NHANES 
data collected from adults (>19 years), pointing to a greater need for future study of this 
outcome (unpublished data).       
 
6.2.3 Genetic Variability and Mercury 
 Exposure assessment and health hazard characterization are two key components 
to the risk assessment of toxicants such as methylmercury and elemental Hg. Due to the 
immense inter-individual variability observed in Hg ADME and toxicity, elucidation of 
genetic factors contributing to this variability is also vital to the risk assessment process. 
In the past decade, research exploring genetic influence on Hg accumulation (Custodio et 
al., 2004, 2005; Engström et al., 2008; Gundacker et al., 2007, 2009) and modification of 
Hg-related health effects (Echeverria et al., 2005, 2006, 2010) has commenced, though 
few polymorphisms were analyzed and significant associations were inconsistent across 
studies (see Table 1.1). This dissertation examined the association of 23 polymorphisms 
in 14 GSH synthesizing, GST and selenoprotein genes implicated in Hg distribution, 
metabolism and elimination with Hg biomarker levels in two epidemiological cohorts. 
Given the number of Hg biomarker models including genetic polymorphisms in 
both the MDA and ELEMENT cohorts (n>200), few significant (p<0.05) genetic terms 
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were observed. Furthermore, none of the significant polymorphism-Hg biomarker 
relationships observed remained statistically significant after correcting for multiple 
testing. The nominally significant findings should thus be viewed as trends and 
potentially important polymorphisms, even though no conclusive evidence can be 
garnered from these genetic associations. Tables 6.2 and 6.3 summarize the significant 
(p<0.05) associations observed between polymorphisms and hair or urine Hg biomarker 
levels. Models addressing ELEMENT children‟s blood Hg, hair:blood, and blood:urine 
are not reported due to a lack of nominally significant (p<0.05) genetic associations. 
Multivariate analyses using the MDA data are better suited to detect genetic associations 
because they control for exposures (fish consumption or dental amalgams) and test for 
interaction between exposure source and genotype on hair or urine Hg levels. Statistical 
analyses were limited in the ELEMENT cohort since exposure data was not available, 
and this may be reflected in the number of significant genetic terms observed in MDA 
models (n=9) compared with ELEMENT models (n=1).  
Overall, five polymorphisms were associated (p<0.05) with hair Hg levels (GSS 
rs3761144; GSTP1 rs1695, rs1138272), urine Hg levels (GSTT1 deletion) or both 
(SEPP1 rs7579) in various statistical analyses, primarily in the MDA cohort. The GSTP1 
SNPs have been implicated in Hg toxicokinetics in previous studies (Custodio et al., 
2004; Engström et al., 2008; Gundacker et al., 2009), though the direction of the 
relationships we observed (decreasing biomarker levels associated with minor alleles of 
rs1695 and rs1138272) only correlate with the results of one study (Engström et al., 2008; 
see Figure 6.1). Polymorphisms in GSS, a gene important to GSH synthesis, have not 
been related to Hg exposure biomarkers in past studies, and the relationship we observed 
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(higher hair Hg per intake from fish consumption with each variant allele) should be 
analyzed in other cohorts.  
Results from both the MDA and ELEMENT cohorts suggest that a 3‟UTR 
polymorphism in SEPP1 (rs7579, C>T) may influence inter-individual variability in Hg 
body burden, and this relationship should be further investigated in future studies. Figure 
6.2 simplifies the ADME pathway for methylmercury and elemental Hg with SEPP1 
implicated primarily in the distribution phase. The findings of several studies, including 
the MDA and ELEMENT cohort work, pertaining to SEPP1 genotype are also 
summarized in Figure 6.2. SEPP1 binds both inorganic Hg (with selenium, in the form 
Hg-Se) and methylmercury via its selenocysteine and cysteine residues (Khan and Wang, 
2009). In rats, co-exposure to selenite and HgCl2 results in less urinary excretion of Hg, 
and this may be due to SEPP1 binding of Hg-Se and subsequently less Hg distribution to 
the kidneys (Jureša et al., 2005). Previous epidemiological studies designate the 3‟UTR 
SNP (rs7579) as a modifier of gene expression and protein synthesis. The T allele is 
associated with increased plasma SEPP1, though this relationship is partially dependent 
on selenium levels (Méplan et al., 2007). Furthermore, SEPP1 3‟UTR T led to a higher 
proportion of the SEPP1 isoform containing more selenocysteine residues (Méplan et al., 
2009).  
In the MDA and ELEMENT cohorts, SEPP1 3‟UTR T significantly associated 
with lower urine Hg concentrations. Coupling our associative findings with that of 
previous toxicological studies suggests that decreased urinary Hg could result from 
increased Hg retention via binding to SEPP1 and less urinary excretion. The relationship 
between Hg and SEPP1 genotype may be further complicated by selenium status (not 
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quantified here), Hg exposure level, and Hg species. In MDA cohort models of urine Hg, 
a significant positive interaction was observed between SEPP1 genotype and amalgams 
(Table 6.3). At lower exposure levels (<5 dental amalgams, few handled in the dental 
office), individuals with CT/TT genotypes had lower urine Hg compared with CC while 
the opposite was observed at higher exposures. Furthermore, SEPP1 may impact 
methylmercury distribution and retention as reflected in hair Hg levels. The 3‟UTR T 
allele is associated with lower hair Hg per unit of Hg intake from fish consumption 
(Table 6.2). Results must be interpreted cautiously due to limitations in both the MDA 
and ELEMENT cohorts. Due to multiple testing, the SEPP1 SNP-Hg associations could 
have occurred by chance alone in either cohort. Furthermore, confounding related to 
percent ancestry in the ELEMENT cohort may have influenced the result. Nevertheless, 
SEPP1 genotype potentially impacts retention of inorganic Hg and methylmercury and 
should be considered in future gene-Hg studies.  
In addition to the association between genetic polymorphisms and Hg biomarker 
levels, we examined the modification of polymorphisms on the relationship between 
blood pressure and hair Hg or urine Hg. Out of 44 models of SBP and DBP including hair 
or urine Hg and one polymorphism per model, one significant genetic main effect was 
observed (Table 4.6, GCLM  rs41303970 in SBP model), and this finding may have 
occurred by chance. The lack of significant (p<0.05) interactions (between genotype and 
biomarker) or other significant genotype main effects in multivariate linear regression 
models for SBP or DBP could be due to polymorphism selection. The polymorphisms 
assessed were chosen because of their involvement in Hg ADME. As such, these genetic 
variants might not impact the mechanisms through which elemental Hg and 
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methylmercury affect cardiovascular function. Furthermore, we may have lacked the 
statistical power to detect weak associations due to small sample size (n=205 to 239 
depending on the polymorphism).      
 
6.2.4 GSTP1 In Vitro Characterization 
We explored the impact of GSTP1 genotype of two nonsynonymous SNPs 
(rs1695, Ile/Val 105; rs1138272, Ala/Val 114) on enzyme function in vitro, following 
several significant, albeit inconsistent, epidemiological associations observed between 
these SNPs and Hg biomarker levels in the MDA cohort and other studies (Custodio et 
al., 2004; Engström et al., 2008; Gundacker et al., 2009). Figure 6.1 summarizes both in 
vitro and epidemiological associations pertaining to GSTP1 105 and 114 SNPs. Four 
allozymes of GSTP1 (IA, VA, IV, VV) displayed significantly different kinetic 
parameters and sensitivity to HgCl2 and MeHg inhibition (Tables 5.2 and 5.3). Enzymes 
with the more common Ile105 had the greatest affinity for the electrophilic substrate, 
CDNB and the best catalytic efficiency (kcat/Km). This residue is found in the 
electrophilic substrate binding site, and valine substitution may alter the shape and 
hydrophobicity of the site (Zimniak et al., 1994). All GSTP1 allozymes were inhibited by 
HgCl2, MeHg, and sodium selenite but resistant to arsenic, lead, manganese, and 
cadmium treatment. Genotype influenced potency of Hg inhibition with allozymes 
ordered according to sensitivity to both Hg species as follows: GSTP1 VA>IA>VV>IV. 
Overall, GSTP1 VA had the poorest performance in enzyme activity assays and was the 
most sensitive to HgCl2 and MeHg inhibition.   
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Laboratory based assessments as described with GSTP1 provide quick and high-
throughput screening for the functional impact of polymorphisms, and such methods are 
in line with goals of twenty-first century toxicity testing (NRC, 2007). However, in light 
of inconsistent associations observed between Hg biomarkers and GSTP1 genotype in the 
MDA cohort and previous epidemiological studies (see Figure 6.1), it is clear that gene-
Hg biomarker relationships are complex with contributing factors beyond biochemical 
differences apparent at the in vitro level.  
 
6.3 Future Research 
 The known dangers of methylmercury and inorganic Hg and the uncertainty about 
safe exposure levels due to inter-individual differences in Hg accumulation and toxicity 
necessitate consideration of genetics in the Hg risk assessment process. The work 
presented in this dissertation and a handful of other studies constitute the infancy of gene-
Hg work, and there is a need for future research. Future studies assessing genetics and Hg 
accumulation would benefit from larger cohorts (>1000) of various genetic backgrounds 
as this would increase statistical power to detect significant relationships, allow for the 
analysis of more polymorphisms, and allow for multiple testing correction to decrease the 
chance of false positive discovery. Epidemiological studies should collect detailed 
information on exposures to both methylmercury (e.g., reported fish consumption or 
biomarker measurement of polyunsaturated fatty acids) and elemental Hg (e.g., number 
of amalgam surfaces) and relate exposures to Hg levels (total or speciated) in hair, blood, 
and urine. Statistical analyses accounting for estimated Hg exposures when assessing 
polymorphism-Hg biomarker relationships will produce more meaningful results. 
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Furthermore, the influence of selenium status, measured in biomarker samples, on Hg-
SNP associations should be examined, especially when analyzing selenoprotein SNPs. 
While future Hg research can continue to explore the influence of glutathione pathway 
and selenoprotein SNPs, polymorphisms in other gene families involved in Hg 
metabolism (e.g., metallothioneins; transporters such as MRP1, MRP2, OAT1) merit 
investigation. Analysis of polymorphism combinations or haplotypes might aid the 
discovery of influential genes. If large cohorts are available, genome-wide association 
studies (GWAS) could be employed to scan for undiscovered polymorphic regions that 
potentially influence Hg toxicokinetics. Given the paucity of GWAS or large cohort 
(n>1000) candidate gene studies in the fields of toxicology and environmental health, an 
alternative approach would be to perform a meta-analysis comparing trends and 
significant associations observed across all small-scale, epidemiological studies focusing 
on candidate gene-Hg relationships. 
 Coupling epidemiological results with in vitro assays may provide insight into 
possible mechanisms (e.g., alterations in protein structure and function or gene 
expression) underlying associations. In the case of SEPP1, in vitro determination of gene 
expression and Hg binding capacity according to rs7579 genotype, oxidation state, 
various concentrations of Hg (inorganic or methylmercury) and selenium treatment 
would increase our understanding of Hg biomarker associations observed in the MDA 
and ELEMENT cohorts. 
 While the toxic effects of methylmercury and inorganic Hg have been studied for 
decades, their involvement with cardiovascular health, specifically blood pressure, has 
only recently been addressed and requires further research. Future epidemiological 
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studies should consider the relationships between SBP, DBP, pulse pressure, and other 
markers of cardiovascular health and both forms of Hg using hair and urine biomarkers in 
populations with a range of exposure levels. To better control for confounding that may 
have underscored the divergent associations observed in the MDA cohort with hair and 
urine Hg and blood pressure, future studies should control for a multitude of factors 
including gender, race, smoking status, physical activity, and nutrient status (e.g., 
polyunsaturated fatty acids, selenium). In vitro and in vivo toxicological studies are 
needed to understand the mechanisms through which methylmercury and inorganic Hg 
might influence cardiovascular activity and blood pressure. Mechanistic and 
epidemiological data relating inorganic Hg to cardiovascular outcomes are particularly 
scarce, and require future evaluation given our preliminary findings in a limited cohort 
with low-level exposure. In general, studies assessing Hg toxicity may also investigate 
the modification of genetic polymorphisms involved in Hg toxicokinetics or specifically 
with the system of interest (e.g., nervous, cardiovascular) on Hg-health outcome 
relationships to better comprehend variability observed in Hg toxicity.   
 Gene-environment research has the potential to increase our understanding of the 
immense variability in the normative risk assessment of Hg and to enable risk managers 
to make objective and informed decisions about the true health risks of Hg. However, 
more gene-environment studies pertaining to Hg, both epidemiological and in vitro, are 
necessary. No single polymorphism-Hg association or study is meaningful on its own as 
causality cannot be determined from epidemiological association studies or in vitro 
assays. Furthermore, a given polymorphism is expected to have a minor, if any, impact 
on the actual variability observed in Hg toxicokinetics (<1%). In future research, the 
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synthesis of association data obtained from dozens of key polymorphisms in the Hg 
toxicokinetic pathway explored in multiple epidemiological cohorts with polymorphism 
functionality data (e.g., alterations to gene expression or enzyme activity) may provide a 
better picture of the multi-loci genetic contribution to Hg toxicokinetic variability.    
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Figures and Tables 
Figure 6.1. GSTP1 Genotype and Hg: Inconclusive Epidemiological and In Vitro 
Data. The simplified diagram below places biomarkers analyzed in this dissertation in 
the ADME pathways for Hg vapor and MeHg. GSTs are expected to primarily influence 
the metabolism and elimination of Hg. Significant associations observed between GSTP1 
genotype and Hg biomarkers from various epidemiological studies (e.g., differences 
between unadjusted means or medians, effect modification of fish consumption-
biomarker relationship) are listed from the following studies: 
1
Gundacker et al., 2009; 
2
Engström et al., 2008; 
3
Custodio et al., 2004; 
4
MDA Cohort study. Enzymatic property 
differences observed based on genotype at the in vitro level are also reported. While the 
Ile/Val 105 and Ala/Val 114 SNPs appear to influence enzyme activity and interaction 
with Hg, epidemiological findings pertaining to Hg body burden and genotype remain 
inconsistent.  
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Figure 6.2. SEPP1 Genotype and Hg Body Burden. An overview of the ADME 
pathway for MeHg
+
 and Hg
0
 exposure is depicted below with a focus on Hg biomarkers 
analyzed in the MDA and ELEMENT cohorts. SEPP1 is proposed to influence this 
pathway primarily through binding of Hg-selenium or MeHg via its selenocysteine and 
cysteine residues. Statistically significant (p<0.05) associations between SEPP1 3‟UTR 
genotype (rs7579, C>T) and biomarkers observed in the MDA and ELEMENT cohorts 
are reported along with impacts of this SNP on protein expression and synthesis as 
observed in by others (
1
Méplan et al., 2007; 
2
Méplan et al., 2009).  
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Table 6.1. Mercury Biomarker Levels: MDA and ELEMENT Cohorts. Mean (SD) 
are reported with selected stratifications of both cohorts.  
 
 Hair Hg (µg/g) Blood Hg 
(µg/L) 
Urine Hg 
(µg/L) 
 
Population 
 
Mean (SD) 
% Over  
RfD
a 
 
Mean (SD) 
 
Mean (SD) 
MDA, Total 0.49 (0.63) 10.9% -- 1.04 (1.18) 
MDA, Dentists 0.69 (0.81) 19.7% -- 1.37 (1.30) 
MDA, Non-dentists 0.31 (0.33) 3.0% -- 0.75 (0.97) 
ELEMENT, Mothers 0.53 (0.47) 7.9% -- -- 
ELEMENT, children 6-11 yrs 0.55 (0.49) 9.4% 1.80 (1.42) 0.87 (1.13) 
ELEMENT, children 13-15 yrs 0.42 (0.35) 4.1% 1.53 (1.22) 0.65 (0.80) 
 
a
 Individuals with hair Hg greater than 1.1 µg/g. This hair Hg level approximately 
corresponds with the US EPA reference dose (RfD) for methylmercury exposure (NRC, 
2000). Reference value comparisons are not reported for blood or urine Hg as <5% of 
individuals exceeded limits suggested by various regulatory bodies.  
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Table 6.2. Genotype and Hair Hg: Compare Models from MDA and ELEMENT 
Cohorts. Parameter estimates for nominally significant (p<0.05) genotype variables are 
reported from various models of hair Hg (described in Sections 2.3.5 and 3.3.5). Shading 
corresponds to p-value of estimate: p>0.05, p<0.05, p<0.01. Not all polymorphisms were 
analyzed in both cohorts (white boxes).  
 
Gene  db SNP ID 
Minor Allele 
Frequency MDA 
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GCLC rs17883901 0.08 0.04             
 GCLM rs41303970 0.19 0.08               
GSTP1 rs1695
a 
0.32 0.45 -0.22 -0.22 
 
        
GSTP1 rs1138272 0.08 0.01   -0.31 
 
        
GSTM3 rs7483 0.26 0.47               
SEPP1 rs3877899 0.24 0.09               
SEPP1 rs7579 0.28 0.43   
 
-1.61         
GPX4 rs713041 0.45 0.29             
 GSTT1 deletion 0.41                 
GSTM1 deletion 0.32                 
GGT1 rs5751901 0.36     
  
      
 GSS rs3761144 0.4     
 
1.88         
GSR rs1002149 0.18                 
GSR rs2911678 0.24                 
GPX1 rs1050450 0.28                 
GSTP1 rs749174 
 
0.13       
 
      
GSTP1 rs6591256 
 
0.16               
GSTP1 rs947895 
 
0.13       
 
      
GSTO1 rs4925 
 
0.16               
GSTO1 rs11509438 
 
0.003               
GSTM1 rs1065411 
 
0.04               
GSTM3 rs1332018 
 
0.34               
GPX2 rs4902346 
 
0.21           
 
  
GPX2 rs2737844   0.4               
 
a
Minor allele encodes Val105 in the MDA cohort but Ile105 in the ELEMENT cohort.   
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Table 6.3. Genotype and Urine Hg: Compare Models from MDA and ELEMENT 
Cohorts. Parameter estimates for nominally significant (p<0.05) genotype variables are 
reported from various models of urine Hg (described in Sections 2.3.4 and 3.3.5). 
Shading corresponds to p-value of estimate: p>0.05, p<0.05, p<0.01. White boxes denote 
polymorphism was not analyzed in that cohort. 
Gene  db SNP ID 
Minor Allele 
Frequency MDA 
ELEMENT 
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GCLC rs17883901 0.08 0.04           
GCLM rs41303970 0.19 0.08           
GSTP1 rs1695
a
 0.32 0.45           
GSTP1 rs1138272 0.08 0.01           
GSTM3 rs7483 0.26 0.47   
  
    
SEPP1 rs3877899 0.24 0.09           
SEPP1 rs7579 0.28 0.43 -0.16 -0.26 0.04 
 
-0.14 
GPX4 rs713041 0.45 0.29           
GSTT1 N/A 0.41   -0.27         
GSTM1 N/A 0.32             
GGT1 rs5751901 0.36             
GSS rs3761144 0.4             
GSR rs1002149 0.18             
GSR rs2911678 0.24             
GPX1 rs1050450 0.28             
GSTP1 rs749174 
 
0.13           
GSTP1 rs6591256 
 
0.16   
 
      
GSTP1 rs947895 
 
0.13   
 
      
GSTO1 rs4925 
 
0.16   
 
      
GSTO1 rs11509438 
 
0.003   
 
      
GSTM1 rs1065411 
 
0.04   
 
      
GSTM3 rs1332018 
 
0.34   
 
      
GPX2 rs4902346 
 
0.21   
 
      
GPX2 rs2737844   0.4           
 
a
MDA and ELEMENT cohorts do not have the same minor allele for rs1695 (Val105 for 
MDA, Ile105 for ELEMENT).  
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